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1.1. InTroducTIon
In nature, highly efficient biological motors perform complicated tasks by converting fuel, 
typically adenosine triphosphate (ATP), into mechanical motion.[1] These natural motors are 
involved in almost every aspect of cell life including division, growth and migration.[2] Inspired 
by this and in an attempt to realize controlled manipulation at micro/nano/molecular regime, 
scientists from multiple disciplines have focused their research enthusiasm on developing 
miniaturized motors. For controlled motion at a molecular level, sophisticated molecular 
machines with complex structures, such as molecular cars and molecular elevators have 
been engineered.[3] These interesting studies and their profound application potential have 
been warranted with a Nobel prize for chemistry in 2016. To achieve motion at nanometer 
or micrometer scale, profound efforts have been devoted and interesting advances are being 
made. Early works include the integration of natural motors with synthetic components. 
Montemagno’s team integrated biomolecular motor F1-ATPase enzyme with nickel rod 
nanopropeller.[4] The F1-ATPase enzyme was found to convert ATP into rotary toque. Then 
a centimeter sized synthetic motor prototype was devised by Whitesides’ group in 2002.
[5] The motor comprised of a poly(dimethylsiloxane) (PDMS) plate with integrated platinum 
coated glass. By decomposing hydrogen peroxide into oxygen gas, thrust was generated 
and the motor was pushed forward. After that scientists at Pennsylvania State University 
proposed to shrink the size of motors to micron scale.[6] Other interesting systems include 
the one engineered by Zettl’s team.[7] They attached a metal plate rotor to a multi-walled 
carbon nanotube. The nanotube was anchored to a supporting pad, which were both 
conductive. With applied voltage, the metal plate demonstrated controlled rotation. These 
works were quickly followed by development of various synthetic micro[8]/nanomotors[9] 
based on different materials[10] and different shapes (tube,[11] Janus sphere[8] and irregular[12]). 
These artificial machines converted external fuel into movement including rotation[13] and 
shuttling[14] at micro- or nanometer scale, promising microscopic transportation in an 
efficient and effective manner. To further improve the cargo transporting abilities[15] and 
expand applications [16] of the micro/nanoswimmers, last decade has witnessed substantial 
efforts devoted to explore diverse fabrication methods[17]/fuels[18]/control methods[19] as well 
as to gain in-depth understanding of the propulsion mechanisms.[20] For instance, early metal 
based motors were in general produced with a non-assembling approach, which was usually 
limited by material choice, complicated instrumentation and output. In 2012 Wilson/Van 
Hest et al[21] and He’s team[22] pioneered the motor fabrication with assembling approach. 
The versatile approach makes it feasible for large scale motor production, easy motor 
functionalization and readily cargo loading.[23]  With regard to fuel source, the input energy 
for motors now is not only limited to chemical fuel hydrogen peroxide.[24] Hydrogen peroxide 
is a common fuel for early catalytic metal based motors yet it may present oxidative pressure 
on environment. In addition in biological media hydrogen peroxide is found at relatively 
9
MICRO/NANOMOTORS TOWARDS IN VIVO APPLICATION
PS_FP_vs1.indd   9 04-05-17   11:19
low concentrations. For catalytic motors, more biocompatible energy source including 
glucose,[25] urea[16a, 26] and even water[27] were recently introduced.  For motors that utilize 
the energy from external environment, light, magnetic, ultrasound and electric field are all 
great options.[28] The external factors including light,[29] magnetic field,[30] topography[31] and 
temperature[32] etc can also be used as stimulus to achieve movement control. 
With these advances, motors demonstrate tremendous potential to revolutionize various 
fields including environmental remediation,[33] battery[34] and transportation of cargos.[35] 
Extending the application of the motor systems and translating initial proof-of-concept 
research into realistic practice has become a central issue for researchers in the field. 
Biomedical application in vivo, a major concern for general people, has been and continues 
to be a strong research interest. Motors with strong towing power and functionalities 
promise to be highly attractive platforms for addressing complicated in vivo problems. For 
instance, current therapeutic process in vivo involves the usage of macroscopic medical 
devices which leads to high chances of postoperative complications, tissue trauma and 
patient discomfort.[36] Available micro/nanometer sized motors and the ongoing efforts 
to shrink the nanomotors even further provide an excellent opportunity to develop 
minimal invasive tools for surgery. Another nice example involves drug delivery. Due to 
the hydrophobic nature of cell membranes and tissue barriers,[37] it is difficult for common 
drug delivery vehicles such as liposomes, polymersomes, dendrimers or micelles to access 
and enter the targeted diseased tissue. Micro/nanomotors with efficient cargo towing 
and effective penetrating abilities make them excellent candidates for next generation of 
therapeutic carriers in vivo.
Figure 1.1. Summary of various applications for motor systems at cellular, tissue level and in body fluid/matrix.
10
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Here we present an overview of emerging applications of motors towards in vivo 
application (at different levels including cellular level, tissue level and body fluids/matrix) 
(Figure 1.1) and highlight recent efforts in translating initial proof of concept into clinical 
practice. In the end an outlook of current challenges and future prospects is also provided.
1.2. desIgn oF MoTors
In this section we will provide a brief introduction of current design and fabrication 
methods for micro/nanomotors before we discuss their applications towards in vivo. For 
in-depth knowledge of the motor fabrication approach, other comprehensive reviews are 
strongly recommended. [19, 38] When functioning at a micro/nanometer regime and in a 
viscous biological environment, Brownian motion becomes dominant and inertia driven 
motion is no longer possible. Therefore careful design is important and fundamental for 
realization of practical applications. First of all, to achieve directed motion asymmetric 
geometry is crucial for asymmetric accumulation of catalytic products which form the net 
driving force. The experienced drag force in biological media is expected to be influenced 
by motor geometry/shape as well as surface chemistry. Easiness to scale-up and cost are 
also important factors to consider for future realistic use. Here we intend to illustrate 
various fabrication techniques with representative examples and discuss the respective 
advantages/disadvantages for different production strategies. In general synthetic motor 
engineering strategies can be classified as non-assembling and assembling approach. 
There are also ongoing efforts to develop new motor production methods by combining 
these two approaches.
1.2.1. NoN-assembliNg approach
The first microsized platinum-gold catalytic motor was prepared by deposition 
technique.[6] This important non-assembling approach provides the possibility for 
fabricating structures with varied geometries,8, 59 different materials58 and diverse 
dimensions ranging from nanometer to micrometer. In general, both chemical 
deposition and physical deposition are used. For chemical deposition, desired 
materials (usually metal) are deposited onto a template via a redox reaction.[39] 
For preparation of rod motors, commonly used templates include cylindrical pores 
containing polycarbonate membranes and alumina membranes. Firstly the porous 
membrane template is pre-deposited with conductive metal at one side to act as 
working electrode. Then the template is placed in a plating chamber for deposition. 
The deposition process takes place inside the membrane pores (Figure 1.2I).[40]  
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Besides single metal deposition, sequential deposition of multiple metals is also possible. 
After dissolution of the membrane template, bi-metal or multi-stripe metal rods can be 
obtained. This method allows the production of rigid rod motors with good yield and high 
uniformity. By tuning the pore diameter and external charge, both the diameter and length 
of the rod can be varied. For segmented metal motors with catalytic platinum/palladium, 
they can propel in hydrogen peroxide mainly via self-electrophoresis mechanism.[41] for 
instance, in the Au-Pt biometal rod motors, hydrogen peroxide is oxidized at the Pt segment 
and reduced at the Au section. Due to anisotropic ion distribution throughout the rod, the 
self generated electricity field can propel the motor forward. Yet with increased solution 
conductivity (high ionic biological environments), the mobility of this type of motors will 
Figure 1.2. (I) Fabrication of metal wire motors through an aluminum membrane template based on chemical 
deposition, adapted from reference[39b]. (II) PANI/Pt tube motors prepared through a 2-step chemical deposition, 
electropolymerization of aniline and electro chemical reduction of platinum in a polycarbonate membrane, reproduced 
with permission[42], Copyright 2011, American Chemical Society. (III) Schematic diagram of the fabrication of Janus 
sphere motor via bipolar electrodeposition, reproduced with permission[43], Copyright 2012, American Chemical 
Society. (IV) Formation of Janus sphere motors by vapor deposition with vapor flux coming at a vertical/glanced angle 
to the substrate, adapted from reference[44]. (V) Schematic illustration of the rolled-up technology. Metal is evaporated 
and deposited at a tilting angle on a patterned photoresist sacrificial layer. The shadow window produces a gap for 
etching the sacrificial layer and guides the roll-up of the stressed membrane, reproduced with permission[45], Copyright 
2008, Wiley-VCH.
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be undermined. To explore other propulsion less affected by biological environment, 
such as magnetic field propulsion, researchers introduced flexibility in the segmented 
rod motors by selectively etching the metal section in the middle.[46] When incorporated 
with magnetic responsive metal like nickel, the wire motors with flexible hinges were 
actuated by an external rotating magnetic field. The field can induce planar bending 
and undulation, thus propulsion. Another possibility to power rod motors is ultrasound. 
Etching away the sacrificial layer in rod motors and introducing concave structure enable 
acoustic propulsion as the concave resulted asymmetric distribution of acoustic pressure 
can cause motion.[47] The moving abilities of such external field powered motors are not 
compromised in biological media. Besides rod like motors, tubular motors can also be 
fabricated with the electrodeposition approach.[42, 48] In a typical approach, a layer of 
polyaniline is formed in a porous membrane by electropolymerization from its monomer, 
followed by subsequent deposition of a metal layer as inner wall of the tube (Figure 
1.2II). By catalytic decomposition (typically hydrogen peroxide) or alkali metal oxidation 
(in water), the propulsion of the tubular motors relies on the ejection of gas (oxygen 
or hydrogen) bubbles from the opening. With relatively high speed and little influence 
from biological medium, motors propelling by bubble recoil promise great potential in 
biomedical applications.[49] In addition to rod and tubular motors, Janus sphere motors 
can also be prepared through chemical deposition. Instead of using a static membrane as 
template, conductive beads when placed between two electrodes can undergo polarized 
electrochemical deposition at one hemisphere of the bead, giving rise to Janus particle 
(Figure 1.2III).[43] Metals or semiconductor materials can be deposited in this way. The 
Janus motors developed have been found to be driven by different mechanisms, bubble 
recoil, self-electrophoresis and self-diffusiophoresis.[19] Self-diffusiophoresis is a process 
in which a colloid can be propelled in the gradient of products from an asymmetric 
reaction, due to unbalanced interaction between solute and the colloid.[50] As both self-
electrophoresis and self-diffusiophoresis would be influenced by the highly ionic and 
complicated biological media, bubble propelled Janus motors are more favourable. Besides 
chemical reduction, physical deposition technique is a commonly used method for motor 
production. The vapor deposition is a major technique for generating Janus sphere motors.
[18, 44, 53] In this method metal atoms are vaporized and released into gas by bombardment 
of either an electron beam or ionized argon gas. Then the material in the vapor phase can 
condensate on the surface of target silica/polystyrene sphere and form a thin metallic 
film. Partial shielding of the sphere is required to ensure the asymmetry of the sphere. 
The resulting asymmetry of sphere motors, thus the anisotropic accumulation of products, 
is a key factor for directional motion. The vapor flux/substrate angle can be varied from 
90 degrees to tilting angle (glancing angle).[17a, 44, 54]  For the glancing angle deposition, 
partially sputtered sphere motors can be easily obtained due to the self-shadowing 
effect (Figure 1.2IV). Combining deposition at an oblique angle with substrate rotation, 
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the glancing angle deposition or dynamic shadow growth strategy allow the fabrication 
of motors more complicated in shape including V-shaped,[55] tadpole shaped[56] or helical 
shaped[57] with good homogeneity.  The helical shaped motors with a magnetic component 
incorporated allow efficient propelling in biological media under rotating magnetic field. 
For both types of deposition approaches, the main component is a metal scaffold with 
limited functionalization and biodegradability possibilities. To incorporate functional 
units, mixing polymers during deposition may provide a solution. Yet subsequent steps 
are required. In addition to the deposition approach, the rolled-up technique is a versatile 
approach for the production of tubular motors (Figure 1.2V).[45] In this technique, multiple 
layers of membranes are physically deposited on a photolithography sacrificial layer. Then 
the sacrificial layer is etched to release the multilayer.[58] Making use of the inherent strain 
difference of different layers, the expansion of the bottom layer and shrinking of the top 
layer during the etching process generate the rolled-up architecture. The top layer which 
becomes the inner tube wall usually consists of catalytic metal while gold is frequently 
used for subsequent functionalization with biological molecules. By changing the thickness 
of each layer, the diameter of the opening can be well tuned in the micrometer range. 
Yet the complicated fabrication procedure, the ability to scale the production up and the 
accompanying costs are remaining challenges to be addressed. 
1.2.2. assembliNg approach
For micro/nano architecture fabrication, the assembling approach provides an easy and 
effective strategy to integrate diverse miniature and multicomponent elements, ranging 
from lipids, polymers to catalytic entities such as enzymes and inorganic nanoparticles.[23] 
As the units are integrated via non-covalent interactions, the resulting responsiveness to 
environmental clues affords motors with multiple functionality. The morphology and size of 
the assembled structures can be well controlled. Another advantage of the supramolecular 
approach is the readily encapsulation of drug and nanoparticles, facilitating various 
delivery purposes. Wilson/Van Hest et al pioneered a fully assembling approach using 
the self-assembly of amphiphilic polymeric molecules poly(ethylene glycol)-b-polystyrene 
and the controlled shape transformation from sphere polymersomes to bowl-shaped 
stomatocytes.[21]  
During the transformation process, catalytic platinum nanoparticles (PtNPs) can be 
efficiently entrapped into the outer cavity of the stomatocytes (Figure 1.3IV). Fuel molecules 
enter into the cavity through a nanometer sized opening and are decomposed, providing 
forward propulsion. He’s group reported the fabrication of sphere/tubular vesicles based 
motors with a layer-by-layer technique. This technique relies on the alternating deposition 
of two oppositely charged materials onto a sacrificial template.[59] After removing the 
template, hollow sphere/tubular shaped vesicles can be obtained (Figure 1.3I, II). Then 
the capsules were equipped with catalytic nanoparticles or enzyme asymmetrically. In the 
PS_FP_vs1.indd   14 04-05-17   11:19
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presence of fuel, the catalytic particles/enzymes generate thrust, achieving autonomous 
motion.[22] Using silica precursor and surfactants via a “sol-gel” process, Sanchez’s group 
successfully prepared mesoporous silica nanoparticles of difference sizes.[24] With electron 
beam evaporation technique and platinum deposition at one side, silica nanoparticles 
could be turned into platinum half coated motors. The mesopores were used for cargo 
loading. Besides solid silica nanoparticles, they also made use of hollow mesoporous silica 
nanoparticles (HMSNP).[16a, 25] The hollow structures promise high cargo loading capacity. 
After shielding one side with silicon dioxide, amine functionalized HMSNP could be readily 
modified with different enzymes (catalase, urease, glucose oxidase). The enzyme motors 
were powered by biocompatible fuel including glucose and urea. In addition to the silica 
sphere motors, the same group also devised other shape motors including hollow reverse 
Janus and tube motors via “sol-gel” chemistry on silver nanowire template.[60] Different 
Figure 1.3. (I) Preparation of Janus sphere motors. The capsule formed from polystyrene sulfonate (PSS)/polyallylamine 
hydrochloride through layer-by-layer technique. Then asymmetric functionalization of catalytic dendritic platinum 
nanoparticles was achieved by microcontact printing, reproduced with permission[22], Copyright 2012, American 
Chemical Society. (II) Polycarbonate membrane assisted layer-by-layer assembly of positively charged chitosan (CHI) 
and negatively charged sodium alginate (ALG) based tubular motors. Platinum nanoparticles were co-mixed into the 
polyelectrolyte multilayers during the assembly, reproduced with permissin[51], Copyright 2013, Wiley-VCH. (III) With 
the assembly of copper ions and chelating ligands, a metal organic framework based motor is fabricated, reproduced 
with permission[52], Copyright 2012, Nature Publishing group. (IV) Formation of catalytic platinum nanoparticle loaded 
stomatocyte polymersome motor through the self-assembly of amphiphilic polymer poly(ethylene glycol)-b-polystyrene 
and nanoparticles, reproduced with permission[21], Copyright 2012, Nature publishing group. (V) Schematic illustration 
of the formation of polycaprolactone based polymer single crystal and the functionalization with catalytic platinum 
particles, reproduced with permission[10b], Copyright 2013, American Chemical Society.
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from previous tube motors powered by bubble recoil, the biocatalytic reaction triggered 
by urease on the internal/external surface of the tube propelled the nanotube motors 
via a jet of liquid. With this mechanism, accumulation of bubbles in the environment is 
avoided, making it advantageous for practical applications in biological environments. 
Another assembling approach for motor fabrication involves the self-assembly of inorganic 
nanoparticles (including catalytic PtNPs) on polymer single crystals (Figure 1.3V). The 
polymer single crystal was fabricated through crystallization of polycaprolactone.[10b, 61] 
Alternative building blocks for self-assembled motors include metal–organic framework 
(MOF) (Figure 1.3III). Matsui’s team reported the fabrication of a [Cu2l2ted]n based MOF 
motor (Cu is copper, L is 1,4-benzenedicarboxylate, ted is triethylenediamine). It was 
found the hydrophobic diphenylalanine (DPA) peptide could assemble into the nanometer 
sized pore of the coordination framework at the water/MOF interface. By means of the 
Marangoni effect, the caused surface tension difference drives the MOF motor forward.
[52] Recently there has also been increasing efforts to integrate the synthetic motors with 
natural motile units. Wang’s team explored to integrate magnetic nanoparticles into 
red blood cells.[62] The asymmetric distribution of nanoparticles inside the cells enables 
ultrasound propulsion. Another interesting example is flexible synthetic flagella or a chain 
of magnetic iron oxide particles linked by double stranded DNA.[63] The artificial flagella can 
propel forward under a rotating magnetic field.
1.3. micro/NaNomotors towards iN vivo applicatioN: 
        cell, tissue aNd biofluid 
Over the last decade, various micro and nanomotors have been fabricated and tested in 
various environments including sea water or organic solvent.[33b] Yet there is relatively little 
knowledge about the performance and behaviour of motor systems in a biological cell 
culture, tissue and biofluid. More work in this field is now being carried out in order to 
bridge the micro- and nanomotors with clinical practice.    
1.3.1. applicatioNs at cellular level
1.3.1.1. drug delivery 
Catalytic motors for drug delivery
One of the main challenges of nanomedicine is to overcome the limited efficiency of 
delivering therapeutic agents to cell,[64] in particular in areas related to the treatment of 
cancer, heart and vasculature diseases.[65] To address the issue, micro/nanomotors with 
efficient cargo towing and transporting abilities have been given growing attention. 
PS_FP_vs1.indd   16 04-05-17   11:19
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He’s group proposed the first example of tubular polyelectrolyte based motor created 
with the lay-by-layer technique and used it as a drug delivery carrier to cells (Figure 1.4I). 
The fabricated multilayered nanotube motors were porous and allowed easy incorporation 
of catalytic platinum nanoparticles, magnetic iron oxide particles and antitumor model 
drug doxorubicin into the inner layer of tubular motors. The loading of iron oxide particles 
facilitated directional control of the motor with an external magnetic field. In a human 
cervical cancer (Hela) cell culture (the medium was supplemented with 3% hydrogen 
peroxide), the nanorocket displayed bubble recoiled propulsion. Under magnetic navigation, 
the tubular motor moved towards the cell and attached to it. It was shown by SEM that the 
polyelectrolyte nanorocket was bound to the outer surface of the cell membrane. Upon 
sonication, the intactness of polyelectrolyte nanorockets was lost, resulting in fast release 
of the doxorubicin from the outer layer of the nanotube motors.[51]
The same group later compared the efficacy of using active motors or passive carriers 
for drug delivery. They made use of platinum sputtered mesoporous silica nanoparticles 
as Janus nanomotors while unsputtered particles were used as passive control (Figure 
1.4II). Doxorubicin could be loaded by physical absorption into the porous channels of 
silica particles. In the presence of 0.2% hydrogen peroxide containing Hela cell culture, 
more uptake was observed for platinum capped mesoporous silica nanoparticles than 
unsputtered mesoporous silica nanoparticles. It exhibited the advantage of active drug 
delivering method. Upon entering into Hela cells, egg phosphatidylcholine bilayer covered 
on the surface of silica nanoparticles was slowly degraded to release the doxorubicin.[66]
Sanchez’s team reported the platinum sputtered mesoporous silica nanomotors of 
different sizes (40 nm, 65 nm and 90 nm).[24] Model cargo FITC, Rhodamine B and methylene 
blue were loaded to the nanomotor by covalent linking or incorporation into mesopores. For 
Rhodamine B and methylene blue loaded into mesopores, sustained release was observed 
in the presence/absence of hydrogen peroxide. With a ratchet shaped microchip, the 
nanomotors can be actively guided to a target chamber. Compared to passive mesoporous 
silica nanoparticles, the active nanomotors showed enhanced accumulation at the target 
chamber. 
For realistic applications in vivo, biocompatibility is however an important issue to 
consider. To increase the biocompatibility of the motors, He’s group utilized a biodegradable 
micromotor for drug delivery. A bovine serum albumin/poly-L-lysine (BSA/PLL) based 
multilayer tube motor was fabricated and loaded with gelatin, gold nanoparticles (near 
infrared agent), magnetic particles (for external steering), doxorubicin (antitumor drug) 
and catalase (motor). The main body of the protein based micro-rocket was degradable 
in presence of α-chymotrypsin. With the hydrogen peroxide decomposing abilities of 
catalase, the tubular motors were propelled forward. When precisely guided with an 
external magnetic field to the vicinity of Hela cells, doxorubicin was released under near 
infra-red trigger (Figure 1.4III). This is because gold nanoparticles generate heat locally with 
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near infrared irradiati on, facilitati ng the sol-gel transiti on of gelati n and thus release of 
doxorubicin.[67] 
Despite the fact that some of the present motor systems are considered safe towards 
cells,[68] the toxicity of the fuel itself hydrogen peroxide (the most commonly used fuel 
for propulsion) and other chemical fuels has been under much debate.[69] As hydrogen 
peroxide is considered to induce oxidati ve stress to cells and causes protein denaturati on, 
it is considered to limit the long-term applicati on towards cells and in vivo. For successful in 
vivo applicati on, the fuel source of motors needs to be extended towards more biofriendly 
molecules at biologically relevant concentrati ons.
The use of locally available chemicals or bio-relevant molecules as fuel source for micro- 
and nanomotors provides an excellent soluti on to the biocompati bility problem. Att empts 
involved the use of glucose and urea as fuel source.[16a, 25, 60a, 70] Sanchez’s team introduced 
a catalyti c enzyme (glucose oxidase and urease) functi onlized Janus hollow mesoporous 
silica nanomotor.[25] The biocatalyti c reacti on with biocompati ble and nontoxic substrate 
(glucose and urea) was used to power the motor. This possibility shed new lights to the 
development of motors in the biomedical context. Städler et al. reported a poly(dopamine) 
(PDA) coated silica based motor.[70] Via a wax-in-water Pickering emulsion technique, one 
hemisphere of PDA silica nanoparti cle was PEGylated while the other half was used for 
catalase and glucose oxidase modifi cati on. With the cascade reacti on of enzymes, glucose 
can be used to propel the silica motor. In tumour ti ssues anaerobic glucose metabolism 
produces lacti c acid as byproduct, leading to an acidic tumor microenvironment.[71] Guix 
Figure 1.4. (I) Fabricati on of (ALG/CHI)2-Fe3o4-(CHI/ALG)14-Pt NP tubular motors with layer-by-layer technique; the 
tubular motors penetrated into Hela cells and the doxorubicin incorporated in the tube wall was released upon 
ultrasound treatment, reproduced from reference[51], Copyright 2013, Wiley-VCH. (II) Preparati on of Janus mesoporous 
silica nanomotors by plati num sputt ering onto single layer of mesoporous silica spheres (MSN); doxorubicin was released 
once the egg PC bilayers on surface of uptaken nanomotors degraded in Hela cells. Acti ve MSN motors exhibit more 
cell entry than the passive MSN parti cles, reproduced with permission[66], Copyright 2014, Wiley-VCH. (III) Near infra-
red irradiati on triggered release of doxorubicin from (PLL/BSA)10-DOX-CAT-AuNPs-gelati n motors to cells. The diff using 
out red doxorubicin can be clearly seen, reproduced with permission[67], Copyright 2015, American Chemical Society.
14	
	
Figure	 1.4.	 (I)	 Fabrication	 of	 (ALG/CHI)2-Fe3O4-(CHI/ALG)14-Pt NP	 tubular	 motors	 with	 layer-by-layer	
technique;	the	tubular	motors	penetrated	into	Hela	cells	and	the	doxorubicin	incorporated	in	the	tube	
wall	was	 released	 upon	 ultrasound	 treatment,	 reproduced	 from	 reference[51],	 Copyright	 2013,	Wiley-
VCH.	(II)	Preparation	of	Janus	mesoporous	silica	nanomotors	by	platinum	sputtering	onto	single	layer	of	
mesoporous	 silica	 spheres	 (MSN);	 doxorubicin	 was	 released	 once	 the	 egg	 PC	 bilayers	 on	 surface	 of	
uptaken	nanomotors	degraded	in	Hela	cells.	Active	MSN	motors	exhibit	more	cell	entry	than	the	passive	
MSN	particles,		reproduced	with	permission[66]	Copyright	2014,	Wiley-VCH.	(III)	Near	infra-red	irradiation	
triggered	release	of	doxorubicin	from	(PLL/BSA)10-DOX-CAT-AuNPs-gelatin	motors	to	cells.	The	diffusing	
out	 red	 doxorubicin	 can	 be	 clearly	 seen,	 reproduced	 with	 permission[67],	 Copyright	 2015,	 American	
Chemical	Society.	
The	same	group	later	compared	the	efficacy	of	using	active	motors	or	passive	carriers	for	drug	delivery.	
They	 made	 use	 f	 pl tinum	 sputtered	 mesoporous	 silica	 nanoparticles	 as	 J nus	 nanomotors	 while	
unsputtered	 particles	 were	 used	 as	 passive	 control	 (Figure	 1.4II).	 Doxorubicin	 could	 be	 loaded	 by	
physical	 absorption	 into	 the	 porous	 channels	 of	 silica	 particles.	 In	 the	 presence	 of	 0.2%	 hydrogen	
peroxide	containing	Hela	cell	culture,	more	uptake	was	observed	for	platinum	capped	mesoporous	silica	
nanoparticles	 than	 unsputtered	mesoporous	 silica	 nanoparticles.	 It	 exhibited	 the	 advantage	 of	 active	
drug	delivering	method.	Upon	entering	into	Hela	cells,	egg	phosphatidylcholine	bilayer	covered	on	the	
surface	of	silica	nanoparticles	was	slowly	degraded	to	release	the	doxorubicin.[66]	
Sanchez’s	 team	 reported	 the	platinum	 sputtered	mesoporous	 silica	nanomotors	of	 different	 sizes	 (40	
nm,	 65	 nm	 and	 90	 nm).[24]	Model	 cargo	 FITC,	 Rhodamine	 B	 and	methylene	 blue	were	 loaded	 to	 the	
nanomotor	by	covalent	linking	or	incorporation	into	mesopores.	For	Rhodamine	B	and	methylene	blue	
loaded	into	m sop res,	sustained	release	was	observed	in	 he	presence/absence	of	hydrogen	per xide.	
With	 a	 ratchet	 shaped	 microchip,	 the	 nanomotors	 can	 be	 actively	 guided	 to	 a	 target	 chamber.	
Compared	 to	 passive	 mesoporous	 silica	 nanoparticles,	 the	 active	 nanomotors	 showed	 enhanced	
accumulation	at	the	target	chamber.		
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and Schmidt et al. created a calcium carbonate microparticle with cobalt partially deposited 
on the surface, generating a Janus micromotor. In the acidic environment produced by Hela 
cells, the Janus micromotor demonstrated a continuously directed motion with a speed 
of 0.544 µm/s. The motion was attributed to the gradual dissolution of calcium carbonate 
microparticles in acid.[72] Molecules such as glucose, urea, lactate can be found in cell 
microenvironment and do not present toxicity to the cell. However either the concentration 
required for propulsion is usually higher than the level available in vivo making the motors 
propel at a relatively slow speed. Motors with higher conversion efficiency are required for 
practical purposes.
Another important factor to consider for propulsion of catalytic motors[73] in a cell medium 
is the propulsion mechanism. It is generally accepted that motors can be propelled via four 
mechanisms: generated bubble thrust (bubble propulsion), inhomogeneous distribution of 
reaction products (diffusiophoresis)/surface tension around motors or electric gradients 
(electrophoresis) inside the metal motors.[20] As motors based on electrophoresis and 
diffusiophoresis would be influenced and even paralyzed in high ionic strength medium 
(such as cell culture medium which is complex in its composition), motors propelled by 
bubble propulsion are functional for realistic applications in/towards cells. 
Fuel free motors for drug delivery 
Motors propelled by external field (ultrasound field, magnetic field, optical field and electric 
field etc) have received increasing attention.[74] When eliminating the use of chemical fuel 
source, the application of motors is not restricted by the adverse influence of fuel or lack 
of local fuel supply. 
Using electrophoretic and dielectrophoretic forces, Levchenko and coworkers 
manipulated a gold nanowire and precisely transported it into a target Hela cell. After 
coating the gold nanowire with cytokine tumor necrosis factor alpha (TNFα), the team 
successfully stimulated canonical nuclear factor-kappaB signaling in a single cell (Figure 
1.5I).[75] 
Among the external fields, magnetic field is the most attractive concerning its flexibility, 
tunable force and minimal invasiveness to cells. Nelson reported a helical microswimmer 
resembling bacterial flagella. Under the control of three orthogonal electromagnetic coil 
pairs, the microswimmer can be manipulated to push a polystyrene microsphere.[76] Fischer’s 
group devised helical nanoswimmers with shadow growth technique and the swimmers 
show great potential in cargo delivery.[57] Wang and co-workers used external magnetic 
field to manipulate motor for drug delivery. Magnetic nickel containing alloy nanorods were 
able to pick up magnetic payloads of different sizes (100 nm–3.0 μm) through magnetic 
attraction. The cargos could be transported and delivered along a determined route.[77] 
By incorporating a nickel segment into a Ru-Au nanorod, Mallouk et al. gained directional 
control over the acoustically powered rod motors with an external magnetic field. With 
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the steering of magnetic field, Ru-Ni-Au nanorod motors can target to Hela cells with 
micrometer precision.[78] 
Another interesting example was proposed by Liu and coworkers. They fabricated a 
wormlike mesoporous silica nanotube. By depositing magnetic CoFe2o4 nanoparticles 
onto the tube surface, the nanotubes were imparted with magnetic properties. Via free 
diffusion, the dye carboxyfluorescein was loaded into the nanopores of silica nanotubes. 
Then the nanotube surface was covered with a layer of DNA G-quadruplexes, which 
can fold into G-quartets structures to prevent the leakage of carboxyfluorescein. With 
an alternating magnetic field to heat up CoFe
2o4 locally, the G-quadruplex structure 
underwent a conformational change to random single strand structure leading to release 
of carboxyfluorescein from nanopores of silica nanotubes into Hela cells within 1 hr (Figure 
1.5II).[79] 
Alternatively, ultrasound field has also been considered safe and used extensively in the 
biomedical field such as cross section imaging in vivo.[80] Wang’s group devised a porous 
gold nanowire based motors by etching away the silver component from the silver-gold 
nanowires. Under ultrasonication, the local pressure gradient resulted from concave 
geometry at one end of the wire propelled the nanostructure forward (Figure 1.5III). 
The porous structure as well as anionic polymer poly(acrylic) acid (PAA) coating on the 
nanowire surface ensured an efficient loading of cationic model drug doxorubicin. After 
approaching the Hela cells, controlled release of doxorubicin was triggered with a sudden 
increase in temperature from 20°C to 40°C by near infrared irradiation.[81] Besides chemical 
drugs, the nanomotors can also be used for delivering bioactive genes and cytokines to 
cells. Wang’s group and Chen et al. modified gold nanowire with small interfering RNA 
(siRNA). The siRNA, an important tool for gene therapy, is used for formation of RNA-
induced silencing complex in cells to avoid the expression of undesirable proteins. Gene 
modified MCF-7 cells expressing green fluorescent protein (GFP) were used as model 
cells. With ultrasound propulsion, the siRNA modified nanowires were rapidly delivered 
into a model MCF-7 cells (Figure 1.5IV). The siRNA was engineered to target for GFP 
expression. A 13 fold improvement of gene silencing was observed compared to static 
nanowires.[82] 
The external fields could provide not only propulsion but also offer further directional 
control of the movement. At the micro/nanometer regime, the Brownian randomization 
significantly interferes with the moving direction of motors and undermines their potential 
for practical uses. Therefore directional control is necessary. The external fields such as 
electrical field, magnetic field and optical field can provide possibilities for such directional 
control. Other steering approaches besides external fields have also been explored and to 
be mentioned in the next section. 
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Figure 1.5. (I) With an electric field, gold nanowire was precisely manipulated and cytokine tumor necrosis factor 
alpha was delivered into cells, reproduced with permission[75],  Copyright 2010, Nature Publishing Group. (II) 
Preparation of CoFe2o4 nanoparticles loaded wormlike silica nanotubes; alternating magnetic field triggered release of 
carboxyfluorescein into cells, reproduced with permission[79], Copyright 2015, American Chemical Society. (III) Fabrication 
of porous gold nanowire motor and its propulsion under ultrasound exposure. Upon near infra-red irradiation the locally 
increased temperature led to release of doxorubicin from the motor surface, reproduced with permission[81], Copyright 
2014, Wiley-VCH. (IV) Rapid delivery of small interfering RNA into cells via ultrasound propelled gold nanowires and 
subsequent silencing of GFP expression, reproduced with permission[82], Copyright 2016, American Chemical Society.
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Targeted drug delivery
For nanoparticle mediated drug delivery, precise and targeted delivery of therapeutic cargo 
to diseased cells remains a hurdle and a bottleneck.[83] Current targeting delivery strategies 
rely on passive deposition of therapeutic nanoparticles in the vicinity of diseased tissues. 
For instance, tumor targeting therapy uses the enhanced permeation and retention effect. 
That is, in the fast growing tumor area (especially in an experimental model of tumor bearing 
immune defect mice, tumor usually develops in a very rapid manner), the tumor vasculature is 
leaky and therapeutic particles get retained there. Yet such targeting therapy achieved limited 
clinical success due to the much less leaky vasculature system in general patients that develop 
tumors over a prolonged period of time. The systematic toxicity caused by drugs failing to reach 
the target tissues is high. By combining self-powered motor systems with external fields or 
stimuli gradients, precisely navigated motors promise to be efficient delivery vehicles capable 
of reaching the exact diseased cells, thus reducing side effects caused by off target drugs.
External fields can not only provide the propulsion source but also offer the opportunity 
of guiding the motors and achieving noncontact manipulation. Wang and coworkers 
developed a flexible nickel-silver nanoswimmer. Under a weak external rotating magnetic 
field, the nanoswimmers could be propelled forward at a relatively high speed (more than 
10 μm s−1). The nickel segment permitted the pick-up of drug loaded magnetic pol(D,L-lactic-
co–glycolic acid) (PLGA)  microparticles through magnetic interaction (Figure 1.6I). With 
this it was demonstrated that motors could generate high enough force to load even heavy 
particle cargoes. Via precise magnetic guidance, PLGA loaded nanoswimmers were able 
to transport from the loading reservoir through a channel to the predetermined chamber 
where Hela cells were seeded.[84] In this case, the use of chemical fuel was circumvented 
and the presence of magnetic field facilitated directed delivery. 
Mhanna and Nelson et al. at ETH exploited artificial bacteria flagella (ABF) for precise drug 
delivery. With rotating magnetic field, the magnetic actuated helical microdevices could be 
propelled forward (Figure 1.6II). Through physical absorption to the surface of ABF, model 
drug calcein incorporated into liposomes were loaded to the microswimmer. After reaching 
the target C2C12 mouse myoblasts cells under magnetic guidance, the model drug calcein 
could be released precisely into the target single cell by fusion with the cell membrane or 
uptake via endocytosis.[85] By using temperature-sensitive dipalmitoylphosphatidylcholine 
(DPPC)-based liposomes, the same group showed efficient controlled release of calcein 
after elevating the temperature from 37°C to 41°C.[86]
Taking advantage of the local chemical stimuli gradient has proven to be an alternative 
approach for steering motors towards cells. Wilson’s group demonstrated that stomatocyte 
nanomotors could move and be guided by a gradient of hydrogen peroxide. This will be 
described in detail in Chapter 2. Interesting future direction would involve the usage of 
other disease signal chemical gradients. Combining multiple targeting strategies would also 
be beneficial for improving the targeting efficiency.
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These micro/nanoshuttles transporting therapeutic payloads to predetermined areas 
following remote guidance or locally environmental stimuli show great potential in selective 
and precise delivery. To further increase the efficacy, functionalization of motors with 
targeting ligands or moieties will be beneficial.[88] Stimuli sensitive linkers besides physical 
adsorption between cargoes and motor systems are to be introduced to avoid unwanted 
release of carried cargoes during transportation. It is also necessary to improve the drug 
loading efficiencies (especially for metal rod based motors). With micro/nanomotors carrying 
multiple therapeutic/imaging agents, synergistic therapeutic efficiencies are to be tested.
1.3.1.2. cell penetrating tools 
Micro- and nanomotors can accomplish propulsion inside and towards cells. With the great 
thrust generated, the motors penetrate, cleave and stab into cells as a cell penetration 
Figure 1.6. (I) Flexible magnetic nickel-silver nanoswimmers approached, picked up and transported drug loaded 
magnetic pol(D,L-lactic-co–glycolic acid) (PLGA)  particles from the left reservoir to the right chamber. The particle 
cargo was then delivered to the vicinity of a target cell, with the steering of an external magnetic field, reproduced 
with permission[84], Copyright 2011, Wiley-VCH. (II) Under a rotating magnetic field, helical microdevices transported 
calcein loaded liposomes precisely to target cell. Through fusion with the cell membrane or endocytosis, calcein can 
be delivered into the cell. Even after the removal of liposome functionalized artificial bacteria flagella (fABF), the 
fluorescence inside the cell was still visible, reproduced with permission[85], Copyright 2014, Wiley-VCH. (III) Doxorubicin 
loaded stomatocytes nanomotors moved along the hydrogen peroxide gradient towards neutrophils cells. The 
neutrophils were seeded on a substrate network, reproduced with permission[87], Copyright 2015, Wiley-VCH.
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tool. The micro/nano motors are extremely promising to overcome cell barrier and directly 
deliver drug payloads to target cells. Compared to passive drug loaded nanoparti cles, 
micro/nanomotors may be superior in accessing for instance solid tumor ti ssue cells where 
the high pressure built-up basically blocks the entry of external molecules.
cai et al. reported the fabricati on of carbon nanotube with a nickel ti p via plasma 
enhanced chemical vapour depositi on.[89] Responsive to a rotati ng magneti c fi eld, the 
nanotubes could spear into cells on a substrate. Then with a stati c gradient fi eld, the 
nanotubes could further penetrate deeper into the cells. By att aching plasmid DNA 
containing enhanced green fl uorescence protein (EGFP) sequence to the nanotube, the 
penetrati on of nanotubes into cells led to high transducti on effi  ciency for diff erent cell lines 
including Bal17 B lymphoma, primary B cells and primary neurons.
With a rolled-up technology, Sanchez’ group prepared InGaAs/GaAs/Cr/Pt based tubular 
motors. The catalyti c tubular motors demonstrated propulsive moti on when immersed in 
the hydrogen peroxide soluti on (20% v/v). With a thin layer of iron, the moti on could be 
controlled with an external magneti c fi eld. By exploiti ng the corkscrew moti on patt ern, the 
tubular motors with a sharp ti p could penetrate a fi xed Hela cell (Figure 1.7I).[90] This is a 
nice example of tubular motors as cell-penetrati ng tool however the hydrogen peroxide 
level used in the experiment is too high for realisti c cellular delivery.
Due to the asymmetric scatt ering of sound waves at the convex end of gold nanorods, the 
nanorod motors prepared by Mallouk’s group showed fast axial propulsion in cells. Aft er 
Figure 1.7. (I) Fabricati on of InGaAs/GaAs/Cr/Pt tubular motors with sharp ti ps. By roll-up at an angle, tube motors with 
a sharp ti p can be obtained. In the presence of hydrogen peroxide fuel, the motors can penetrate into a fi xed Hela cell, 
reproduced with permission[90], Copyright 2012, American Chemical Society. (II) Iron and ti tanium coated microneedles 
(derived from plant Dracaena sp.) drilled into Hela cells with a rotati ng magneti c fi eld, reproduced with permission[92], 
Copyright 2015, Wiley-VCH.
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micro/nanomotors	carrying	multiple	therapeutic/imaging	agents,	synergistic	therapeutic	efficiencies	are	
to	be	tested.	
1.3.1.2.	Cell	penetrating	tools		
Micro-	 and	 nanomotors	 can	 accomplish	 propulsion	 inside	 and	 towards	 cells.	 With	 the	 great	 thrust	
generated,	the	motors	penetrate,	cleave	and	stab	into	cells	as	a	cell	penetration	tool.	The	micro/nano	
motors	 are	extremely	promising	 to	overcome	 cell	 barrier	 and	directly	deliver	drug	payloads	 to	 target	
cells.	Compared	to	passive	drug	loaded	nanoparticles,	micro/nanomotors	may	be	superior	in	accessing	
for	 instance	 solid	 tumor	 tissue	 cells	 where	 the	 high	 pressure	 built-up	 basically	 blocks	 the	 entry	 of	
external	molecules.	
Figure	1.7.	 (I)	Fabrication	of	 InGaAs/ aAs/Cr/Pt	tubular	motors	with	sharp	tips.	By	roll-up	at	an	angle,	
tube	motors	with	a	sharp	tip	can	be	obtained.	 In	the	presence	of	hydrogen	peroxide	fuel,	 the	motors	
can	penetrate	into	a	fixed	Hela	cell,	reproduced	with	permission[90],	Copyright	2012,	American	Chemical	
Society.	 (II)	 Iron	and	titanium	coated	microneedles	 (derived	from	plant	Dracaena	sp.)	drilled	 into	Hela	
cells	with	a	rotating	magnetic	field,	reproduced	with	permission[92],	Copyright	2015,	Wiley-VCH.	
Cai	et	al.	 reported	the	fabrication	of	carbon	nanotube	with	a	nickel	 tip	via	plasma	enhanced	chemical	
vapour	deposition.[89]	Responsive	to	a	rotating	magnetic	field,	the	nanotubes	could	spear	into	cells	on	a	
substrate.	Then	with	a	static	gradient	field,	the	nanotubes	could	further	penetrate	deeper	into	the	cells.	
By	 attaching	 plasmid	 DNA	 containing	 enhanced	 green	 fluorescence	 protein	 (EGFP)	 sequence	 to	 the	
nanotube,	 the	penetration	of	nanotubes	 into	cells	 led	to	high	transduction	efficiency	 for	different	cell	
lines	including	Bal17	B	lymphoma,	primary	B	cells	and	primary	neurons.	
With	 a	 rolled-up	 technology,	 Sanchez’	 group	 prepared	 InGaAs/GaAs/Cr/Pt	 based	 tubular	motors.	 The	
catalytic	 tubular	 motors	 demonstrated	 propulsive	motion	 when	 immersed	 in	 the	 hydrogen	 peroxide	
solution	(20%	v/v).	With	a	thin	layer	of	iron,	the	motion	could	be	controlled	with	an	external	magnetic	
field.	By	exploiting	the	corkscrew	motion	pattern,	the	tubular	motors	with	a	sharp	tip	could	penetrate	a	
fixed	Hela	cell	(Figure	1.7I).[90]	This	is	a	nice	example	of	tubular	motors	as	cell-penetrating	tool	however	
the	hydrogen	peroxide	level	used	in	the	experiment	is	too	high	for	realistic	cellular	delivery.	
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24 hours of incubati on with Hela cells, the nanorods could enter into the cells and remain 
ultrasound responsive aft er their uptake. Without additi onal chemical fuel, propulsion 
inside the cells was observed.[91] 
Developing motor systems based on the natural occurring micro/nano structures has 
become a new approach for motor fabricati on. Srivastava and Schmidt et al. derived 
calcifi ed porous microneedles (40–60 μm in length) from Dracaena sp. (a type of plant). 
With electron beam depositi on method, the microneedles were coated with a layer of iron 
and ti tanium. By incubati ng with camptothecin (anti tumor drug) for 3 days, the drug was 
loaded into the porous microneedles. Under a rotati ng magneti c fi eld, the Fe-Ti coated 
microtubes drilled into the Hela cells (Figure 1.7II). The penetrati on of microneedles into 
the cell membrane resulted in cell death as confi rmed with cell viability assay. Without 
external magneti c fi eld, the drug-loaded microneedles could inhibit Hela cell growth 
and lead to aberrant cell divisions. By combining the cell penetrati ng abiliti es and drug 
transporti ng properti es, the microneedle motors demonstrated potenti als as new drug 
delivery vehicles.[92]
For cell penetrati on micro/nanomotors manipulated or actuated with a rotati ng magneti c 
fi eld, the moving directi on could be precisely controlled with the rotati on fi eld. In this way 
it was possible to precisely locate target areas and perform surgery tasks. For other type 
of surgery tools (powered for instance by ultrasound), precise directi onal/temporal control 
and targeti ng to surgery cells remain questi ons to be answered.
Wilson’s group reported the conjugati on of natural cell penetrati ng pepti des (tat) to 
the surface of stomatocytes polymersomes motors. It was found the pepti de modifi ed 
stomatocytes motors enhanced the penetrati ng effi  ciency of the delivery agents into intact 
Hela cells.[93] This part will be described later in Chapter 3.
1.3.1.3. therapeuti c agents 
Besides acti ng as delivery agents for therapeuti c molecules, the motors themselves can 
perform as therapeuti c agents.
He and coworkers described an approach to produce plati num nanoparti cles loaded 
polyelectrolyte microtube motors with gold nanoshells and a tumor targeti ng pepti de T7 
(containing the HAIYPRH sequence) coated on the surface. Aft er localizing to the vicinity of 
tumor cells, micromotors recognized and targeted selecti vely the HeLa cells. When mixing 
red blood cells (as control cells) with the tumor cells, no binding to the red blood cells was 
observed. The dissipated heat resulted from the gold plasmon resonance upon using near 
infra-red led to a temperature increase of approximately 10 °C in a 70 µm range around 
the micromotors. A subsequent apoptosis of the targeted cells was observed. In this case, 
the micromotors demonstrated their applicati on as a photothermal agent for selecti ve 
eradicati on of cancer cells.[94]
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1.3.1.4. cell sensing
Current sensing techniques involve time consuming sample preparation. Fast/selective 
targeting and sensing in unprocessed biological samples are particularly interesting. 
Utilizing autonomously moving motors functionalized with bioreceptors was demonstrated 
to be a promising approach.
Wang’s team described a method using motors for detecting rRNA released from E. coli 
16S bacteria. A nucleic acid containing sample was firstly incubated with a surface bound 
oligonucleotide followed by addition of a silver nanoparticle-tagged detector probe. At 
higher target nucleic acid concentration, more silver nanoparticles were captured. With 
addition of hydrogen peroxide and Au-Ni-Au–Pt nanomotors, the silver particle quickly 
dissolved into silver ion and accelerated the motion of the nanomotors. As the moving 
speed of nanomotors correlates with the level of rRNA and corresponding bacteria 
concentration, the motion readout provides a new approach for detection of rRNA or other 
biomolecules.[95]
Besides detecting RNA secreted by cells, motor system has proven capable of detecting 
RNA in a cell. The same team described a single step method for rapid detection of target 
miRNA inside cells with ultrasound powered nanomotors. With EDC-NHS conjugation, 
a graphene-oxide sheet was introduced to a cysteamine functionalized gold nanowire. 
Single strand DNA-fluorescein amidine (fluorescent dye, FAM) was absorbed onto the 
graphene-oxide surface through π-π stacking interactions between the nucleotide bases 
ring (in the single strand DNA) and the graphene-oxide sheet. Due to this close distance 
between fluorescein amidine and grapheme oxide, the fluorescence of fluorescein amidine 
was rapidly quenched via fluorescence resonance energy transfer. Driven by ultrasound 
propulsion, the DNA-FAM functionalized grapheme oxide/gold nanowires were delivered to 
intact cells within a few seconds. As single stranded DNA has a higher affinity for miRNA in 
cells, the DNA-FAM was displaced from the surface of graphene-oxide and bound to target 
miRNA, leading to fluorescence recovery. As the fluorescence signal was correlated with the 
amount of target miRNA-21 which was overproduced in metastatic breast cells, the proof of 
concept experiments demonstrated a fast and precise cancer screening with MCF-7 cells.[96]
Fan’s team employed a one dimensional (1D) plasmonic-magnetic (PM) nanotube for in 
situ cell membrane composition sensing.[97] The nanotube was incorporated with nickel 
nanomagnets and dual-surface-coated plasmonic silver nanoparticles. The embedded 
nanomagnets and silver nanoparticles facilitated magnetic maneuvering and surface-
enhanced Raman scattering (SERS) detection, respectively. With external magnetic field, 
the PM nanotube transported to the target single CHO cell and came into contact with the 
cell membrane. The resulted SERS spectra showed characteristic peaks of lipid and protein. 
This precise and sensitive method is also expected to be applicable to other adherent 
animal/human cells. 
In general, the addition of external chemical fuel may interfere with the detection results. 
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Therefore motor systems that can make use of sample media or components are highly 
desirable. However the possible impact of motor reaction products or resulting pH changes 
on the sensing results shall be taken into future consideration.
1.3.1.5. cell transportation and sorting
With the cargo towing abilities, the motors not only transport small molecule drugs, genes, 
cytokines but also demonstrate capabilities to pickup and transport cells in a biological 
environment. With complicated biological samples, motors with built-in recognition 
moieties or external control demonstrate a possibility for fast transportation and selective 
isolation of target cell cargoes.
Sanchez et al. proposed the idea of using micromotors for loading, transporting and 
delivering cells.[98] They fabricated microtube motors with rolled-up technology. The 
diameter of the tubular motors was optimized to accommodate the model murine CAD 
cell. As the bubble generation and migration inside the tubular motors would induce fluid 
pumping, it was expected the cell would be sucked and picked up. With the alignment of 
an external magnetic field, the cell loaded microtube motors transported the cell under 
guidance. By abruptly changing field direction, the cell could be released and delivered.
The team later also used rolled-up nanotubes for transporting of yeast cells.[90] It was 
expected that the yeast cell attached to the outer surface of the nanotubes through van der 
Waals interaction. After loading three yeast cells, the tubular motor experienced a speed 
decrease. As the drag force during motion weakened the interaction, the cells eventually 
got released.
Zhang and Nelson et al. reported a nickel nanowire demonstrating a tumbling motion with 
a rotating magnetic field. For cell manipulation, flagellated microorganisms or red blood 
cells were loaded to the nickel based nanowires through entanglement and attachment. 
The blood cell was transported and positioned on the top of an epidermal cell.[99] This 
provides a new strategy for precise cell transportation and manipulation.
Schmidt and Sanchez et al. successfully trapped bull sperm cell inside a conically shaped 
magnetic Ti/Fe microtube. While the sperm cell provides the propulsion, the magnetic 
microtube allows remote magnetic control (Figure 1.8I). With an external magnetic field, 
the cell loaded microtube could be oriented and was able to move from a reservoir chamber 
to a collecting chamber.[100]
Later the same group fabricated a polymer micro-helix with a NiTi bilayer coating. Sperm 
cell could be captured by the synthetic helical micromotor with its tail confined inside the 
inner part of the micro-helix and its head sticking out at the front end of the helix. By 
a rotating magnetic field, the helix-sperm hybrid motors became actuated (Figure 1.8II). 
By transporting an immotile sperm cell to the oocyte cell and releasing the sperm cell, 
the motor system showed great potential in treating infertility.[101] Additional systematic 
screening and selecting of the sperm cells may be needed.
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Figure 1.8. (I) Sperm cells trapped inside a conically shaped Ti/Fe microtube were transported and isolated, reproduced 
with permission[100], Copyright 2013, Wiley-VCH. (II) Immotile sperm cell captured by microhelices was delivered to an 
oocyte cell, reproduced with permission[101], Copyright 2016, American Chemical Society. (III) An anti-carcinoembryonic 
antigen (anti-CEA) monoclonal antibody tubular motor specifically picked up a CEA+ pancreatic cancer cell, reproduced 
with permission[104], Copyright 2011, Wiley-VCH. (IV) Poly(3-aminophenylboronic acid) (PAPBA)/Ni/Pt microtubular 
motor selectively sorted yeast cell out, reproduced with permission[105], Copyright 2012, American Chemical Society.
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The selective interaction between metal and bacteria cell can be used to form the cell-
motor hybrid. Sanchez’s team reported Escherichia coli (E. coli) preferentially adhered to Pt 
cap of Janus particles over Fe, Ti or Au.[102]
Suzuki et al. fabricated a polystyrene based micromotor with platinum and zinc 
hemispheres formed. Autonomous movement of the microparticle was powered by 
reaction of zinc and water on the particle surface. Hydrophobic interactions were used 
to capture Escherichia coli (E. coli) cell which adhered to a self-assembled monolayer of 
alkanethiolates on the platinum part of the micromotor. By adjusting the free zinc ion in 
solution and controlling the dissolution of zinc from the micro motor, E. coli cells were 
shown to be released in a controlled manner.[103]
Besides using physical interaction between motors and cells, functionalization of motors 
with specific groups facilitates selective binding of motors to cells and subsequent sorting.
Circulating tumor cells are primarily responsible for tumor metastasis. Wang’s team 
successfully functionalized tubular microswimmers with an anti-carcinoembryonic antigen 
(anti-CEA) monoclonal antibody specifically for a surface antigen over-expressed in 
approximately 95% of colorectal, gastric and pancreatic cancer cells. The inner platinum 
layer of the micromotor was responsible for propulsion in hydrogen peroxide containing 
medium (including dilute serum). After capturing CEA+ pancreatic cancer cell in diluted 
human serum, the high speed of micromotors was only slightly decreased from 85 μm 
s−1 to 80 μm s−1 and the trajectory was not compromised. Additionally, in a mixture of cell 
suspensions, anti-CEA functionalized micromotors could selectively bind and pickup target 
cells (Figure 1.8III).[104] 
The same group reported the preparation of a poly(3-aminophenylboronic acid) (PAPBA)/
Ni/Pt microtubular motor. The boric acid in the motor could be used for recognition and 
interaction with monosaccharide moieties. Yeast cells with glucose residues on the cell 
walls were selectively recognized and picked up by the (PAPBA)/Ni/Pt microtube (Figure 
1.8IV). In the presence of 3% hydrogen peroxide, the microtube was able to transport yeast 
cells with speed of 20 μm s−1. After addition of fructose (with higher affinity for boronic 
acid), the yeast cells detached due to the competitive binding of fructose.[105] 
With the new capabilities of motors discussed above, it would be interesting to transport 
not only circulating cells in suspension but also move and manipulate cells that are 
adherent to surfaces. It would also be exciting to integrate these cell sensing and sorting 
functions into a micro/nanochip or electronic device which might represent a significant 
step towards biologically integrative systems combining functions from diagnostic to post-
therapy evaluation. 
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1.3.2. applicatioNs at tissue level
1.3.2.1. wound healing
During a natural injury or surgery process, wounds are introduced into the human or animal 
body. The open tissues highly increase the chances of bacterial infection and implicated 
syndromes. To heal the wound, a complicated process is involved with several stages 
including clotting, wound contraction, tissue formation etc.[109] Recent exploration of wound 
healing with motors presents excellent examples of healing assistance in different stages.
The early stage of wound healing involves blood clotting. Kastrup’s group developed a 
porous calcium carbonate microparticle based motor system to assist this process. The 
microparticles developed were mixed with protonated tranexamic acid, the fuel. By reacting 
with the acid and releasing CO
2, the motor could propel laterally while rising buoyantly 
(Figure 1.9I). At a relatively high speed at maximum 5.9 mm/s, the motor system was 
capable of transporting against blood flow. When loading the porous calcium carbonate 
based micromotor with thrombin (a serine protease that activates the coagulation system 
in vivo), the motors were found penetrating deep into the wound (amputated mouse tail) 
and shortened the bleeding time significantly from 14 min (for non propelled thrombin) to 
4 min.[110]
Next stage of wound healing associates wound closure. To assist this process, He’s group 
fabricated a silica nanoparticle based Janus motor through layer by layer self-assembly 
(Figure 1.9II).
A layer of gold was sputtered onto the silica surface. When administered to the wounded 
tissue area, the particles and particle agglomeration would generate local heating under 
NIR laser irradiation. The heat leads to melting of blood cells and formation of a film. 
Additionally, at this elevated temperature, collagen in local tissue was denatured, leading 
to tissue melting and subsequent wound condensation and closure upon cooling. This 
motor particle assisted tissue welding was demonstrated in beef liver, beef meat and 
chicken meat. This approach demonstrated advantage with wound healing of a mouse 
when compared with medical sutures and laser only welding.[107] The nanomotor based 
approach is not only minimally invasive (as it is not introducing new trauma and wounds as 
conventional stitches) but also controllable at nanometer scale (tissue glues are usually not 
controllable and correctable once applied at the wound area).
To achieve bone crack area targeted drug delivery and spur growth of new bone 
tissues, Sen’s group utilized positive ion gradients generated by bone cracks for guiding 
of charged therapeutic particles (Figure 1.9III). Negatively charged particles (quantum 
dots and enzymes urease) moved towards cracks while positively charged particles moved 
away from cracks. When loading negatively charged poly(lactic-co-glycolic acid) (PLGA) 
nanoparticles with sodium alendronate, drug for treating osteoporosis, the particles could 
migrate towards the bone crack and achieve targeted delivery.[108] 
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Figure 1.9. (I) Protonated tranexamic acid (fuel) loaded calcium carbonate microparti cles can propel autonomously and 
travel inside an amputated mouse tail vessel. When incorporati ng green fl uorescent cargo FITC-dextran, their presence 
in blood vessel can be clearly seen. Loaded with coagulati on acti vati ng thrombin, the micromotors penetrati ng deep 
into wound can shorten the bleeding ti me effi  ciently aft er the tails being amputated, reproduced with permission[110], 
Copyright 2015, AAAS. (II) With near-infra red irradiati on, gold sputt ered silica Janus motors can facilitate wound welding. 
With a mouse model, it was shown that aft er 9 days the motor based ti ssue glue was superior (picture in the bott om, 
D) in assisti ng wound healing compared with no treatment, laser welding and suturing, reproduced with permission[107], 
Copyright 2016, Wiley-VCH. (III) Negati vely charged quantum dots (red fl uorescent) can be att racted towards cracked 
bone following ion gradients generated in the crack vicinity. The increasing fl uorescence along prolonging ti me near 
the crack indicates the parti cle accumulati on process,  reproduced with permission[108], Copyright 2013, Wiley-VCH.
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Figure	 1.9.	 (I)	 Protonated	 tranexamic	 acid	 (fuel)	 loaded	 calcium	 carbonate	microparticles	 can	 propel	
autonomously	and	travel	inside	an	amputate 	mouse	tail	vessel.	When	incorporating	green	fl orescent	
cargo	 FITC-dextran,	 their	 presence	 in	 blood	 vessel	 can	 be	 clearly	 seen.	 Loaded	 with	 coagulation	
activating	 thrombin,	 the	 micromotors	 pene rating	 d ep	 into	 wound	 can	 short n	 the	 bleed ng	 time	
efficiently	after	 the	 tails	being	amputated,	 reproduced	with	permission[110],	Copyright	2015,	AAAS.	 (II)	
With	near-infra	red	irradiati n,	gol 	sputter d	silica	Janus	motors	can	facilitate	wound	w lding.	With	a	
mouse	model,	 it	was	shown	that	after	9	days	the	motor	based	tissue	glue	was	superior	(picture	in	the	
bottom,	 D)	 in	 assisting	 wound	 he ling	 compared	 with	 no	 treatme t,	 laser	 welding	 and	 suturing,	
reproduced	with	permission[107],	Copyright	2016,	Wiley-VCH.	(III)	Negatively	charged	quantum	dots	(red	
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1.3.2.2. Thrombolysis
We have presented above many application examples of nanomotors demonstrating 
linear movements. Besides the translational motors, rotary motors in nature are also 
responsible for many important biological events. For instance, F0F1-ATP synthase is a type 
of rotary motor complex which comprises of F0 motor protein, F1 motor protein and a 
rotary shaft. F0 protein is embedded in the membrane while F1 is the extramembrane 
part of the synthase.[114] With a proton gradient across the mitochondria membrane and 
proton passing through F0, the complex can undergo a conformational change (rotation of 
central shaft) and F1 convert adenosine diphosphate (ADP) to ATP. ATP is the energy source 
for almost every biological process. Efforts have also been made to fabricate synthetic 
rotating motors and put them to application. Zhao’s group used a local fluid flow produced 
by rotating motors for rapid drug dispensing and blood clotting treatment in a controlled 
way. Blood clotting in cerebral blood vessels and the resulting stroke are considered to be 
second leading cause for death and disability in adult human. Yet administration of free 
diffusing tissue plasminogen activator (t-PA), a therapeutic drug, to the body could result 
in systematic intracranial haemorrhages. With an external rotating magnetic field, nickel 
nanorods fabricated by Zhao’s team rotated in the suspension. After setting up a blood 
clot model in a PDMS channel, magnetized nanorods and t-PA were placed in the vicinity 
of the blood clots. The nanomotors were activated with external rotating magnetic field 
and the rotation of nanorods was found to enhance the convection and accelerated the 
thrombolysis speed up to 2 fold. The drug dispensing process can be highly controlled by 
varying both the nanorod concentration and the magnetic field efficiency. The efficiency 
of the nanomotor enhanced thrombolysis has also been demonstrated in a rat embolic 
model.[115] 
1.3.2.3. surgical tools
Since the concept of minimal invasive surgery being brought up, the effort to reduce 
the operation trauma at each stage is ever growing.[116] Minimal incision/robot assisted 
precision cutting is the first step to start with. To do this, minimal invasive surgical tools or 
miniaturized surgical devices are used. The results of current minimal invasive practice are 
encouraging yet it remains a bottleneck for treating malign tissues deep inside or tissues 
localized closely to the vasculature systems. To realize the goal of treating more while 
hurting less, there is a demanding need for novel minimal invasive tools. Various types of 
micromotors were developed for minimal invasive surgery tools.  Being micro or nanometer 
scale, the motors present minimal invasive cuts and are beneficial for subsequent wound 
recovery.
Using a multilayer microfabrication, Gracias’ group designed microgrippers with 
sizes varied from 300 µm to 1.5 mm. The microgrippers consisted of two parts: a rigid 
region composed of ferromagnetic nickel and a flexible stress powered actuators with a 
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Figure 1.10. (I) Thermal actuati on of microgrippers; ti ssue excision with a thermally triggered microgripper, reproduced 
with permission[117], Copyright 2014, Wiley-VCH. (II) Under sonicati on, perfl uorocarbon emulsion loaded in tubular 
motors vaporized rapidly and propelled the motor forward; the thrust was used for penetrati ng lamb ti ssue, reproduced 
with permission[112], Copyright 2012, Wiley-VCH. (III) Water powered PEDOT-Mg motor stabbed into mucus layer of a 
mouse stomach and retained even aft er 12 h, reproduced with permission[48], Copyright 2015, American Chemical 
Society. (IV) PEDOT-Mg motor with enteric coati ng selecti vely acti vated in intesti ne and penetrated into intesti nal wall, 
the fl uorescently labeled motors were retained and visible aft er 12 h, reproduced with permission[113], Copyright 2016, 
American Chemical Society.
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manipulation.	With	a	pig	liver	section,	the	ferromagnetic	microtube	could	be	guided	to	target	location,	
start	drilling	and	make	incision.	
Figure	 1.10.	 (I)	 Thermal	 actuation	 of	 microgrippers;	 tissue	 excision	 with	 a	 thermally	 triggered	
microgripper,	 reprodu ed	 with	 permission[117],	 Copyright	 2014,	 Wiley-VCH.	 (II)	 Under	 sonication,	
perfluorocarbon	emulsion	loaded	in	tubular	motors	vaporized	rapidly	and	propelled	the	motor	forward;	
the	thrust	was	used	for	penetrating	lamb	tissue,	reproduced	with	permission[112],	Copyright	2012,	Wiley-
VCH.	(III)	Water	powered	PEDOT-Mg	motor	stabbed	into	mucus	layer	of	a	mouse	stomach	and	retained	
even	after	12	h,	reproduced	with	permission[48],	Copyright	2015,	American	Chemical	Society.	(IV)	PEDOT-
Mg	motor	with	enteric	coating	selectively	activated	in	intestine	and	penetrated	into	intestinal	wall,	the	
fluorescently	 labeled	 motors	 were	 retained	 and	 visible	 after	 12	 h,	 reproduced	 with	 permission[113],	
Copyright	2016,	American	Chemical	Society.	
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thermosensitive polymer poly(N-isopropylacrylamide) (pNIPAM)  layer. The nickel segment 
allows for easy guidance and retrieval with a magnetic catheter. The microgrippers 
stayed open at room temperature and closed within 10 minutes after temperature 
was elevated to body temperature. It was found feasible to perform tissue excision 
with the microgrippers from a real organ (bile duct of porcine liver).[111] To increase the 
multifunctionality of the microgrippers, in another investigation by the same group, model 
drug doxorubicin, mesalamine and fluorescein were loaded into the porous network poly(N-
isopropylacrylamide-co-acrylic acid) (pNIPAM-AAc) (Figure 1.10I). The loaded model drug 
eluted from the microgrippers up to 7 days.[117] In this case the micromachines functioned 
as both surgical tools and drug delivery carriers.
Sanchez’s group reported the use of a ferromagnetic rolled-up microtube with a sharp 
tip for tissue surgery.[118] Incorporation of a thin ferromagnetic iron layer facilitated external 
magnetic field manipulation. With a pig liver section, the ferromagnetic microtube could 
be guided to target location, start drilling and make incision.
For surgical tools with greater thrust, Wang and coworkers made use of ultrasound 
powered perfluorocarbon (PFC)-loaded microbullets (MB) for tissue penetration and 
cleaving. Anionic perfluorocarbon emulsion was confined into the cysteamine decorated 
interior of a tubular micromotor through electrostatic interaction. Ultrasound pulses 
triggered the vaporization of perfluorocarbon emulsion from the interior of the tubular 
micromotor (Figure 1.10II). The generated great thrust produced linear motion with 
ultrafast speed of 6.3 m s−1. The PFC-loaded MB was shown to penetrate, cleave and expand 
a dense lamb kidney tissue.[112] 
A PEDOT acid driven microtube motor with acid reactive zinc deposited on its surface 
developed by the same group was found to be able to use locally available gastric acid 
as fuel and generate hydrogen bubbles as propulsion thrust. The microtubular motors 
remained stable and functional for 10 min in the stomach environment. The propulsion 
of the micromotors was demonstrated to improve the penetration into the gel like mucus 
layer of the stomach wall as well as increasing their retention time (Figure 1.10III). After 
12 hours of administration, micromotors were still observed in the stomach tissue despite 
acid degradation and digestive system movement.[48]
Using similar magnesium microparticles loaded PEDOT/Au microtubes, the same group 
later demonstrated the possibility of gastrointestinal (GI) tract delivery. The reaction of Mg 
and water generated robust propulsion for the whole system. By covering the micromotors 
with a pH sensitive enteric coating which only dissolves in intestinal fluid (pH 6-7), the 
micromotors were only activated in the intestinal segment when Mg was exposed (Figure 
10IV). By loading a fluorescent dye Rhodamine 6G to the micromotor, the biodistribution of 
microtubular motors after oral administration could be examined by fluorescence imaging. 
It was found the coating thickness had a strong influence on the microtube biodistribution. 
Compared with inert silica particles loaded microtubes, the Mg incorporated microtube 
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motors demonstrated an increased retention in the gastrointestinal (GI) tract as higher 
fluorescence signal was observed. This was attributed to the propulsion of microtubes and 
increased chance of collision/penetration into intestinal mucus layer.[113] 
Excellent examples have been demonstrated with a wide range of micro/nanomotors 
piercing into various tissues. Yet there are many steps to go before using these motors 
in surgery. Firstly, intelligent surgical tools responsive to the diseased environments are 
needed. For precise and site specific surgery, more control including speed and direction 
over the micro/nano surgical tools needs to be gained. It is also necessary to develop 
techniques to retrieve the micro/nano tools after incision, otherwise biodegradable tools 
are necessary. Micro/nanomotors capable of performing multiple incisions consecutively 
are required for solving complicated medical tasks. More micro/nanomotors with varied 
shape and size are to be developed to expand the toolbox for micro/nano surgery and 
address different needs.
1.3.2.4. Imaging
The advance of medicine is accelerated by enhanced tools of observation and imaging. 
Nowadays medical vision is at the core of accurate diagnosis and is essential for precise 
surgery.[119] Only precise imaging can make it possible for surgeons to remove small 
patches of malignant tissues. Yet for diseased tissue specific imaging, novel imaging 
tools are demandingly needed. Researchers have endeavoured to apply nanomotors in 
the field of imaging. Deploying the catalytic decomposition of endogenous hydrogen 
peroxide generated by inflamed tissues, ultrasonic sensing combined with a motor system 
made it possible to detect abscess in vivo. Mattrey’s group manufactured layer by layer 
catalase-coated nanosphere converters for hydrogen peroxide detection and imaging in 
an abscess model in rats. The highly efficient nanosphere converters consumed hydrogen 
peroxide from the local environment and produced microbubbles which were detectable 
by ultrasound imaging. In the case of abscess induced by bacterial invasion, activated 
neutrophils released excessive hydrogen peroxide. With catalase-coated nanosphere 
converters, ultrasound signals were detected at the abscess area.[120] Since inflammation 
is central to the development of various disorders, from atherosclerosis to cancer, the 
application scope and potential of this technique are highly relevant.
Despite recent progress made in applications with tissues, many challenges remain. In 
most cases, motor applications were demonstrated with tissues ex vivo or more static 
tissues. New applications at tissue level are in need to be developed.
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1.3.3. applicatioNs iN body fluid aNd matrix
1.3.3.1. transportation in blood 
For intraveneously administrated micro/nanoparticles, blood is the first medium of contact 
as well as hurdle before reaching target tissues.[121] Once entering the blood stream, 
synthetic micro/nanomotors face destructive attack from blood which is composed of 
a complex mixture of water, protein and cells. In a process named opsonization, plasma 
proteins bind to external particles and result in subsequent particle removal by macrophage 
cells in liver and spleen. In addition to blood protein, blood cells can interact with foreign 
particles leading to shortened blood retention or systematic elimination. For both 
prolonged blood retention time and continuous functioning in blood, motors need to be 
specially designed or functionalized with specific coatings. Much research was devoted to 
investigate the performance/potential application of motors in blood and ways to improve 
their transporting abilities. Wang and his team successfully loaded iron oxide nanoparticles 
into red blood cells (RBC) using a hypotonic dilution/encapsulation method (Figure 1.11I). 
While the asymmetric distribution of loaded magnetic nanoparticles/aggregates inside 
the blood cell facilitates propulsion by ultrasound, the blood cell membrane on its surface 
provides good blood biocompatibility and reduces immune attack possibility. When guided 
by external magnetic field, the motor could navigate precisely along a predetermined route 
in undiluted whole blood. With J774 murine microphage uptake assay, it confirmed the 
assumption that the RBC motor evaded the uptake by microphages.[62] 
With knowledge about the nonfouling property of red blood cell membrane, Wang and 
Zhang et al. wrapped gold nanowires with red blood cells membrane to serve as biomimetic 
sponge. The presence of the red blood cell membrane coating on the surface of the motors 
provided superior compatibility and alleviated the possibility of biofouling (unspecific 
protein adsorption) in biological medium. In the presence of red blood cell membrane 
perforating toxin melittin, the motors can act as decoy and protect red blood cells from 
lysis efficiently.[122]
Guan et al. fabricated a Mg/Pt-Poly(N-isopropylacrylamide) (pNIPAM) Janus micromotor. 
Through reaction between Mg and H2O, the micromotors can autonomously move in 
simulated body fluid and human blood plasma despite the high viscosity and possible 
protein attachment to catalytic active sites (Figure 1.11II). With a layer of thermosensitive 
PNIPAM hydrogel, model drug FITC could be loaded into the PNIPAM hydrogel shell of 
micromotors at 4 °C and subsequently released at elevated temperature (20 °C, 37 °C). 
The release mechanism is due to molecules being squeezed out when PNIPAM layer 
shrank above its volume phase transition temperature as well as the faster diffusion of 
molecules at higher temperature. Via a hemolysis experiment, no significant hemoglobin 
release was observed indicating the blood compatibility of the motor system and the 
induced motion.[123]
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In additi on to using metal-water reacti on to provide propulsion in blood, enzymes or 
enzyme cascades can be a good opti on. Wilson/Van Hest and coworkers designed an 
enzymati c network driven motor consisti ng of four cycles (Figure 1.11III). The metabolic 
pathway enabled the conversion of glucose and phosphoenolpyruvate into oxygen. 
Encapsulati ng the metabolic network into the outer compartment of stomatocytes 
polymersome, the locally produced oxygen could propel the polymersome motor. With 
multi ple feedback loops, the oxygen conversion could be sustained at an “out of equilibrium 
state” and rati onally tuned by the network components. Using human blood serum as the 
Figure 1.11. (I) Iron oxide loaded red blood cells moved under magneti c navigati on in whole blood, reproduced with 
permission[62], Copyright 2014, American Chemical Society. (II) Fabricati on process of Mg/Pt-Poly(N-isopropylacrylamide) 
(PNIPAM) Janus micromotor and its propulsion in human plasma, reproduced with permission[123], Copyright 2014, 
American Chemical Society. (III) Encapulati on of metabolic network into stomatocytes motors allows conversion of 
blood glucose into moti on, reproduced with permission[124], Copyright 2016, American Chemical Society. (IV) Helical 
nanopropellers moved in fresh human blood jammed with red blood cells, reproduced with permission[125], Copyright 
2014, American Chemical Society. (V) Helical microswimmers derived from water conducti ng vessels of plants moved in 
serum, reproduced with permission[126], Copyright 2014, American Chemical Society.
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hypotonic	 dilution/encapsulation	method	 (Figure	 1.11I).	While	 the	 asymmetric	 distribution	 of	 loaded	
magnetic	nanoparticles/aggregates	inside	the	blood	cell	facilitates	propulsion	by	ultrasound,	the	blood	
cell	 membrane	 on	 its	 surface	 provides	 good	 blood	 biocompatibility	 and	 reduces	 immune	 attack	
possibility.	 When	 guided	 by	 external	 magnetic	 field,	 the	 motor	 could	 navigate	 precisely	 along	 a	
predetermined	 route	 in	 undiluted	 whole	 blood.	 With	 J774	 murine	 microphage	 uptake	 assay,	 it	
confirmed	the	assumption	that	the	RBC	motor	evaded	the	uptake	by	microphages.[62]		
Figure	 1.11.	 (I)	 Iron	 oxide	 loaded	 red	 blood	 cells	 moved	 under	magnetic	 navigation	 in	 whole	 blood,	
reproduced	with	permission[62],	Copyright	2014,	American	Chemical	Society.	 (II)	Fabrication	process	of	
Mg/Pt-Poly(N-isopropylacrylamide)	 (PNIPAM)	 Janus	micromotor	 and	 its	 propulsion	 in	 human	 plasma,	
reproduced	 with	 permission[123],	 Copyright	 2014,	 American	 Chemical	 Society.	 (III)	 Encapulation	 of	
metabolic	 network	 into	 stomatocytes	 motors	 allows	 conversion	 of	 blood	 glucose	 into	 motion,	
reproduced	with	permission[124],	Copyright	2016,	American	Chemical	Society.	(IV)	Helical	nanopropellers	
moved	 in	 fresh	human	blood	 jammed	with	red	blood	cells,	 reproduced	with	permission[125],	Copyright	
2014,	American	Chemical	Society.	(V)	Helical	microswimmers	derived	from	water	conducting	vessels	of	
plants	moved	 in	 serum,	 reproduced	with	 permission[126],	 Copyright	 2014,	 American	 Chemical	 Society.	
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medium, the glucose (4 mM) and L-lactate (0.08 mM) in the blood were sufficient to power 
the motion of the whole system.[124]
While rod or sphere motors have shown to be mobile in blood, it has been hypothesised 
that helical shaped motors would be more efficient in overcoming drag of viscous blood. 
Ghosh et al. used a magnetic helical nanoswimmer and explored the improvement in 
chemical stability towards biofluids with ferrite coatings on its surface (Figure 1.11IV).
With a rotating magnetic field, the ferrite coated helical motors propelled in fresh human 
blood via a corkscrew movement, which was considered advantageous for overcoming high 
viscosity drag. The nanopropellers showed an interesting stick and slip dynamics in this 
media which was thought to be related to jamming and subsequent unjamming of red blood 
cells.[125] Helical architectures can also be found in nature. Wang’s group used spiral water-
conducting vessels from different plants as template and deposited titanium and nickel on 
its surface to fabricate a new type of biohybrid helical microswimmers (Figure 1.11V). Under 
rotating magnetic field, the plant derived microswimmers demonstrated a fast motion (85 
μm/s) in human serum. Compared to its velocity in pure water (90 μm/s), no significant 
decline in speed indicates negligible impact of body fluids on the propulsion behavior.[126] 
The possible influence of motor shape on speed in blood and interaction between plasma 
proteins remain however to be explored. Only a few researchers have set out to investigate 
the relationship between motor surface coating and stability. It has been demonstrated 
that coating micro/nanomotors with a layer of biocompatible materials is a direct and easy 
way to increase biocompatibility and stability. Yet more research efforts are needed for 
comprehensive knowledge of blood motor interaction and optimal motor configuration. 
The performance of motors, especially nanomotors in the presence of more realistic 
dynamic blood flow is to be investigated. While the nanomotors, compared to its micron 
sized counterparts, can readily access diseased sites through blood vessels even capillaries, 
they are more susceptible to Brownian motion due to the small size. The swimming velocity, 
energy conversion efficiency and directional control are important parameters still to be 
improved.
1.3.3.2. transportation in urine and saliva
Urine and saliva are two types of biological fluids that are both complicated in composition. 
Urine, a byproduct of body metabolism, constitutes of water, inorganic salts, hormones, 
proteins and various metabolites such as urea and uric acid. Saliva, a watery substance 
secreted by salivary glands, is rich in electrolytes, glycoproteins, antimicrobial agents, 
enzymes and epithelial cells. In both cases catalytic motors propelled by diffusiophoresis, 
electrophoresis will suffer efficiency loss and metal motors are susceptible to corrosion. 
Here external field driven motors are superior. For propulsion in urine, Wang’s team 
fabricated a magnetically powered flexible gold-silver-nickel nanowire motor by partially 
etching away the middle silver segment of a rigid gold-silver-nickel rod. In resemblance of 
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microorganisms moving with rotati ng fl agella, the nanowire could be propelled forward or 
backward with a clockwise/anti clockwise rotati ng magneti c fi eld (Figure 1.12I). In undiluted 
urine sample (high salt medium), the nanowire sti ll displayed an effi  cient locomoti on.[46] 
For propelling in saliva, the same team used ultrasound as fuel source. Through a 
template electrodepositi on method, they developed a three segment Au/Ni/Au (0.25 μm in 
diameter, 0.8 μm/0.2 μm/0.8 μm respecti vely in length) nanowire. A sacrifi cial copper layer 
was deposited at one end for later creati on of a concave structure. The asymmetric shape 
allowed for fast propulsion with ultrasound. The nickel segment facilitated precise magneti c 
manoeuvring. By modifying the motor surface with lecti n and Con A, the micromotor was 
shown to selecti vely capture E. coli bacteria and S. Aureus bacteria.
The motor could retain its moving abiliti es in untreated serum and saliva (Figure 1.12II). 
Yet in saliva a substanti al decrease in motor speed was observed as saliva is of high viscosity 
and of complicated molecular compositi on. With an electropolymerizati on approach, a 
negati vely charged polypyrrole-polystyrene sulfonate segment was introduced to the Au/
Figure 1.12. (I) With a rotati ng magneti c fi eld, gold-silver-nickel nanowire propelled in urine sample, reproduced 
with permission[46], Copyright 2010, American Chemical Society. (II) Under ultrasound fi eld, Au/Ni/Au nanowires 
demonstrated directi onal moti on in various biological media including saliva, reproduced with permission[127], Copyright 
2013, American Chemical Society.
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For	 propelling	 in	 saliva,	 the	 same	 team	 used	 ultrasound	 as	 fuel	 source.	 Through	 a	 template	
electrodeposition	method,	they	developed	a	three	segment	Au/Ni/Au	(0.25	μm	in	diameter,	0.8	μm/0.2	
μm/0.8	μm	respectively	in	length)	nanowire.	A	sacrificial	copper	layer	was	deposited	at	one	end	for	later	
creation	of	a	concave	structure.	The	asymmetric	shape	allowed	for	fast	propulsion	with	ultrasound.	The	
nickel	 segment	 facilitated	 precise	magnetic	manoeuvring.	 By	modifying	 the	motor	 surface	with	 lectin	
and	Con	A,	the	micromotor	was	shown	to	selectively	capture	E.	coli	bacteria	and	S.	Aureus	bacteria.	
Figure	 1.12.	 (I)	With	 a	 rotating	magnetic	 field,	 gold-silver-nickel	 nanowire	 propelled	 in	 urine	 sample,	
reproduced	with	permission[46],	Copyright	2010,	American	Chemical	Society.	(II)	Under	ultrasound	field,	
Au/Ni/Au	 nanowires	 de onstrated	 directional	 motio 	 in	 various	 biological	 media	 including	 saliva,	
reproduced	with	permission[127],	Copyright	2013,	American	Chemical	Society.	
The	motor	could	retain	its	moving	abilities	in	untreated	serum	and	saliva	(Figure	1.12II).	Yet	in	saliva	a	
substantial	 decrease	 in	 motor	 speed	 was	 observed	 as	 saliva	 is	 of	 hi h	 viscosity	 and	 of	 complicated	
molecular	 composition.	 With	 an	 electropolymerization	 approach,	 a	 negatively	 charged	 polypyrrole-
polystyrene	sulfonate	segment	was	introduced	to	the	Au/Ni/Au	motor.	Through	electrostatic	interaction,	
brilliant	 gr en	 (BG)	 odel	 antiseptic	 drug	was	 absorbed	 and	 l aded.	 By	 hanging	 to	 an	 acidic	media	
after	drug	loading,	up	to	95%	release	in	the	first	120	min	was	demonstrated.[127]	
1.3.3.3.	Transportation	in	biological	matrix	
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Ni/Au motor. Through electrostatic interaction, brilliant green (BG) model antiseptic drug 
was absorbed and loaded. By changing to an acidic media after drug loading, up to 95% 
release in the first 120 min was demonstrated.[127]
1.3.3.3. transportation in biological matrix
As one out of two important components of tissue (the other is cell), the extracellular matrix 
is an interconnected gel-like mesh network of fibrous proteins or glycosaminoglycans (GAGs) 
to provide biochemical and structural support for the cells. Major components include 
collagen, elastin, fibronectin, hyaluronan (HA) and heparin sulfate. Fischer and coworkers 
demonstrated a gel model with HA. HA has been reported to form strong interconnected 
network and is found in high concentration in vitreous humor of the eye and synovial fluid of 
the joint. The group engineered a silica-nickel based helical nanopropeller with the glancing 
angle deposition technique (GLAD). After being magnetized in plane, the nanoscrews were 
responsive to a rotating magnetic field and rotated along their long axis. With their chiral 
shape, these nanoscrews displayed efficient propulsion in viscous medium including 3 mg/
mL HA solution. The concentration used corresponds to that in synovial fluid.[128] 
The same group later reported the use of screw-like propellers for penetration into 
mucin gel. The mucin gel formed from mucin glycoproteins upon acidification is a major 
composition of viscoelastic layer on the surface of the stomach which prevents the efficient 
entrance of drug carriers. Inspired by the bacterium Helicobacter pylori which uses urease 
catalyzed urea hydrolysis to increase local pH and liquefy the mucin gel, the group coupled 
urease to helical micropropellers fabricated through the GLAD technique. A shell of alumina 
(Al
2o3) was deposited on the surface to protect the propellers from acid corrosion. While 
urease free micropropellers rotated in response to a rotating field, forward propulsion was 
not observed which was due to absorption and immobilization to the mucus gel matrix. In 
the presence of urea, urease functionalized micropropellers were able to liquefy the gel 
and actively propel/penetrate into the mucin gel.[106] 
Besides pure gel, Wilson and coworkers demonstrated motion in a tumor cell laden 
collagen gel in mimicking tumor tissue.[129] This part will be demonstrated in Chapter 4.
For propulsion in body fluids, biocompatibility of fuel/motors and stability of motors are 
important issues.[130] Alkali metal based motor systems use biological friendly water for 
propulsion. Generated hydrogen bubbles are responsible for propulsion once the systems 
come into contact with water. However the metallic engines undergo gradual corrosion 
in the media and release harmful metal ions. The dramatic galvanic corrosion also leads 
to another side effect, shortened lifespan of micro/nanomotors themselves. Biological 
media parameters such as pH and ionic strength could even speed up the process.[131] 
More attention is to be given towards development of resistant motors and discovery of 
alternative biocompatible fuels.
Besides problems related to the design of the motor systems, the inherent properties of 
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body fluid also remain a huge hurdle for real application of nanomotors. The presence of 
biomolecules such as protein, sugar, high ionic strength and pH may lead to inactivation of 
catalytic spots and motor paralysis (especially motors propelled via diffusiophoresis and 
electrophoresis mechanism). For motors powered by bubble recoil, biological molecules 
can suppress bubble detachment. Biomolecules in body fluid may react and attach 
unspecifically to the motor systems. Physical properties of blood and other body fluids 
affect the motors performance. In the highly viscous biological fluids, inertia cannot sustain 
movement while applied momentum can be quickly counteracted by the viscous drag from 
the medium. The cargo towing forces of current synthetic motors have to be improved to 
transport heavy cargoes. 
 
1.4. coNclusioNs
Still in its infancy, the potential scope for in vivo application of the micro- and nanomotors 
are very broad and still expands.[132] In this paper we have highlighted recent excellent 
examples of micro/nanomotors in cellular, tissue and body fluid/biological matrix 
applications. Over the last decade pronounced efforts have been made for the design and 
fabrication of synthetic motors. Due to the extended availability of motor types and fuels, 
it becomes feasible to expand the in vivo application scope of the artificial machines even 
further to what is already discussed here. The limitation to the field may only be limited by 
imagination concerning the practical applications with these new entities. 
While significant progresses have been made, challenges remain. For more broad 
application scope, micro/nanomotors with increased sophistication and versatility shall be 
developed. Functionalizing motors with different functional groups and targeting moieties 
is an important step for using motors as an integral platform for multiple aims. Adaptive 
motors with multiple operation mechanism and functions are required for addressing 
complicated real life tasks. As the relatively large drag force of body fluid presents a problem, 
motors with higher fuel conversion efficiency are needed for more efficient delivery in vivo. 
Intelligent motors able to follow environmental physical (temperature) or chemical cues 
(pH, signaling molecules) are desirable for autoguidance. Such self-navigating capabilities 
may ensure the motor systems not going astray in vivo in complicated vasculature systems 
before reaching the targeted diseased sites. Biocompatibility and biodegradability of 
synthetic motors are pressing issues considering motors’ fate after mission completion and 
long term impact on the body.
Yet with multidisciplinary cooperation going on, the field is growing at a very fast pace. 
We envision the application of micro/nanomotors in vivo to be very useful and maybe not 
far away from its first trial in clinical practice.
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1.5. aim of research
Improving healthcare is one of society’s main concerns, and has been topic of decades of 
intense research. Although much has been achieved, progress is still regarded limited when 
cancer, diabetes and other chronic diseases are considered. For instance, the 5 year survival 
rate for people bearing glioblastoma is only 4-17% (age dependent) while the side effects 
caused by antitumor therapies are high. The low success rate of treating these diseases is 
in a large extent caused by the limitation of current drug delivery strategies. For current 
delivery strategies, on one hand non-specific targeting drugs or off-target drugs can cause 
harm to healthy cells and diseased cells simultaneously; on another hand many drugs or 
drug carriers have difficulty to enter the target cells efficiently even after locating to the 
vicinity of the diseased cells. Therefore low targeting specificity and cell entry efficiency 
remain challenges to solve for biomedical researchers. 
Concerning the specific drug delivery, current and conventional targeted drug delivery 
in chemotherapy is divided into passive targeting and active targeting. In the passive 
mode, drugs circulate in the vascular system until passing through leaky tumor vasculature 
formed by rapid tissue growth found in tumors. Leaky vasculature allows drugs to diffuse 
out of the vessels and consequently become retained in the surrounding extracellular 
matrix. In the active mode, although carriers may be similar to that in the passive method, 
targeting moieties are attached to drug carriers leading to increased interaction between 
drug carriers and specific receptors on tumor cells and consequently an enhanced entry 
into the cells. However both of these methods require drug carriers to be deposited 
passively in the vicinity of the tumor tissue. The efficiency of targeted drug delivery by 
current methodologies is limited and drugs failing to reach target areas result in systemic 
non-specific toxic effects. Therefore an exploration of alternative approaches for effective 
targeting delivery is required. In this thesis we use bowl-shaped polymer vesicles, named 
stomatocytes, which are loaded with catalytic particles that enable the particles to move in 
presence of fuel molecules. In chapter 2 we pursue the use of the concept of chemotaxis 
(controlled movement in a gradient of fuel) to guide the stomatocyte nanomotor carriers 
to target cells. Chemotaxis is a strategy nature adopted to guide the motion of organisms 
and cells. For instance sperm can be steered towards egg during fertilization in this way. 
We hypothesize if nanomotors demonstrated a fuel concentration dependent motion 
increase, then the motors are expected to demonstrate more displacement at the fuel 
richer side than the fuel poorer side when placed in a fuel gradient. A net displacement 
towards the fuel rich zone is expected. We then set out to test whether our anti-tumor 
drug (doxorubicin) loaded stomatocytes nanomotors exhibit such behavior. 
After achieving targeted delivery to the vicinity of the cells, we need to go one step 
further “into the cell”. With the conventional drug carriers, even when the therapeutic 
agents are located in the vicinity of target cells, the interaction between carriers and 
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tumor cells is more or less a random and passive process. The hydrophobic and intact 
cell membrane protects cells from the entry of foreign molecules, making effective and 
efficient penetration of therapeutic agents into cells a challenging problem. In chapter 3 
we modified our stomatocyte nanomotor with the tat peptide, a basic domain from HIV tat 
protein. The tat protein is known to be responsible for assisting the virus entry into host 
cells. In addition we expected the fast movement of motors in the cell culture medium 
will increase chances of impact and interaction with cells and would further increase the 
chances of cellular entry. We then investigated and compared the cell entry efficiency of a 
passive drug carrier and an active drug carrier functionalized with natural cell penetrating 
peptides with both flow cytometry and confocal fluorescence microscopy technology.
The tumor tissue microenvironment differs significantly from the cell culture used 
for evaluation (in chapter 2 and 3). It would be interesting and relevant to explore the 
behavior as well as targeting delivery possibility of active motor delivery vehicles in a 
tumor tissue related environment. In chapter 4 by seeding tumor model HeLa cells into a 
three dimensional collagen gel network matrix, we established a tumor tissue mimicking 
model. We planned to use the idea of magnetotaxis to steer the motion in the tissue 
mimicking model. The magnetic (or other external) field provides guiding possibilities on 
long distances. We introduced magnetic nickel metal in situ using the catalytic activity of 
platinum nanoparticles. By controlling the nickel deposition time, the catalytic activity of 
platinum nanoparticles was retained. We then explored the possibility of (magnetically/
catalytically) powering and (magnetically) steering the motor system in solution and the 
tumor mimicking model.
In previous chapters we used bowl-shaped polymer vesicle based nanomotors. In 
biological systems, the blood and other body liquids are the first media to encounter for 
drug delivery agents. Shape and size affect the motor performance and circulation time. 
Therefore we set out to develop motors of different shapes. In an effort to develop motors 
of different shape/size in a continuous way, we explored the use of flow focusing fluidic 
channels in chapter 5. We firstly explored the possibility of obtaining vesicles of different 
shape and size by tuning the flow rate/ratio of the fluidic device as well as the initial 
polymer concentration. We then investigated whether catalytic platinum nanoparticles can 
be loaded into these vesicles to turn them into motors. 
in chapter 6, we reflect on the development of the motor field concerning the work 
described here. We also provide a general outlook and suggestions for future research 
based on the achievements provided in this thesis.
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2.1. InTroducTIon
Chemotaxis in nature allows bacteria and immune cells to navigate along a concentration 
gradient towards chemical attractants or away from repellants.[1] This natural phenomenon 
has inspired scientists to construct synthetic motors able to demonstrate a similar behavior 
in vitro. Sen’s group discovered that bimetallic rods and even single enzymes could show 
chemotactic behavior and move autonomously towards their substrates.[2] Schmidt and 
Sanchez’s team reported that tubular microjets and Janus motors showed a deviation 
towards areas with a higher concentration of hydrogen peroxide.[3] Chattopadhyay and 
coworkers described hydrogen peroxide-driven catalytic microspheres that were guided 
towards alkali-rich regions.[4] These motors with chemotactic behavior offer the possibility,[5] 
besides application of external magnetic[6] or electric fields[7], to achieve precise directional 
control,[8] which is still lacking in most artificial motors. However most current chemotaxis 
motors suffer from limited cargo loading potential, and their size dimensions limit possible 
applications, for example with regard to drug delivery.
Several approaches have been followed towards biomedical application of nanomotors.
[9] Nanosized self-assembled motors which can be loaded with cargo and which show 
chemotactic behavior have however not been demonstrated before. An interesting 
biologically relevant chemical signaling compound for induction of chemotaxis is hydrogen 
peroxide.[10] Compared to normal tissue, hydrogen peroxide is overproduced by tumor 
cells, which facilitates cancer cell invasion and metastasis.[11] A drug delivery system that 
could autonomously move in interstitial tissue, seek out the hydrogen peroxide source and 
deliver the antitumor agent would be a great improvement to current passively targeted 
drug delivery systems.
In this chapter we present a nanomotor, which meets the requirements regarding size, 
loading capability and directional movement. The nanomotor is based on a polymersome 
stomatocyte which is functionalized with platinum nanoparticles (PtNP) and loaded with 
a model anticancer drug, doxorubicin (Dox) as cargo. Furthermore, we demonstrate that 
these nanomotors show motion towards higher concentrations of hydrogen peroxide, not 
only artificially created chemical gradients in a microfluidic device, but also in presence of 
hydrogen peroxide-excreting neutrophils.
2.2. results aNd discussioN
Through self-assembly[12], Dox and PtNP loaded stomatocytes with an average size of 
308 nm (Table 2.1) were obtained. Results from transmission electron microscopy (TEM) 
(Figure 2.1a-b), cryogenic transmission electron microscopy (cryo TEM)(Figure 2.2b) and 3D 
reconstruction (Figure 2.2c-e) indicated that the vesicles have a bowl-shaped morphology 
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with the PtNP entrapped in the outer cavity, while confocal laser scanning microscopy (CLSM) 
(Figure 2.2i) and energy-dispersive X-ray spectroscopy (EDX) (Figure 2.2h) corroborated the 
successful incorporation of doxorubicin. (For Dox and PtNP encapsulation efficiency, PtNP - 
59.8% the percentage of stomatocytes carrying PtNP, Dox - 78.1% the percentage of loaded 
Dox based on the added amount, see Figure 2.3)
Table 2.1. Dynamic light scattering data of PtNP, empty stomatocytes, Dox-PtNP loaded stomatocytes, Dox loaded 
stomatocytes and PtNP loaded stomatocytes.
Once the structure of the nanomotor was confirmed to have incorporated both the engine 
(PtNP) and the cargo (Dox) we subsequently analysed the speed of the nanomotors by 
using nanoparticle tracking analysis. Upon applying hydrogen peroxide, the PtNP containing 
stomatocytes showed a fuel concentration-dependent diffusion enhancement (Figure 
2.4). The diffusion coefficient of PtNP stomatocytes experienced a remarkable increase 
from 1.74 × 10-8 cm2/s in water to 2.68 × 10-8 cm2/s upon addition of 5% (v/v) of hydrogen 
peroxide (final concentration was 0.15 % v/v).
Figure 2.1. (a, b). TEM images of platinum nanoparticles and doxorubicin loaded stomatocytes, scale bar represents 100 nm.
 Size(nm) PDI
PtNP 73.9 0.109±0.03
pS-b-PEG stomatocyte 351.3 0.097±0.03
pS-b-PEG DOX PtNP stomatocyte 307.7 0.208±0.03
pS-b-PEG DOX stomatocyte 356.6 0.108±0.02
pS-b-PEG PtNP stomatocyte 325.4 0.168±0.03
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Figure 2.2. a) Procedure for preparing Doxorubicin (Dox) and platinum nanoparticle (PtNP) loaded stomatocytes; b) 
cryo-TEM images of Dox and PtNP loaded stomatocytes. (c-e) 3D reconstructed images of the loaded vesicle (dotted 
white line square in b) from cryo-TEM tomography at different angles; f) TEM images and EDX of  g) Pt and h) N mapping 
of Dox and PtNP loaded stomatocytes. All scale bars are 300 nm; i) confocal images of PtNP and fluorescent Dox-loaded 
stomatocytes.
PS_FP_vs1.indd   55 04-05-17   11:20
56
chapter 2
Figure 2.3. a) Field flow fractionation spectra from top to bottom of Dox and PtNP-loaded stomatocytes (red), Dox-
loaded stomatocytes (green), PtNP-loaded stomatocytes (blue), empty stomatocytes (purple) and polymersomes 
(brown); b) Fitting of the peak area of Dox and PtNP-loaded stomatocytes. HPLC spectra of c) liberated Dox from Dox 
and PtNP-loaded stomatocytes and d) free Dox.
Figure 2.4. Average mean square displacement of platinum nanoparticles and doxorubicin loaded stomatocytes 
with addition of 0% (black circles), 0.5% (red squares) and 5% (v/v) of hydrogen peroxide (blue triangles), the final 
concentration of hydrogen peroxide is 0%, 0.015%, 0.15% (v/v), respectively.
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To evaluate and demonstrate the chemotactic behavior of our Dox and PtNP loaded 
stomatocytes, a glass flow device, similar to a PP chamber[13] for cell chemotaxis evaluation, 
was designed (Figure 2.5a) and confocal fluorescence microscopy was employed. The 
design of the channel including its size and shape was chosen so that to minimize possible 
drift and convection effects caused by the addition of the hydrogen peroxide/stomatocytes 
solution. The hydrogen peroxide concentration gradient was first demonstrated by using 
a hydrogen peroxide sensitive dye 2,7-dichlorodihydrofluorescein from which an optimal 
observation region (red spot between position 3 and 4, Figure 2.5a) was determined. In the 
experiment group, 5 µl of freshly prepared Dox and PtNP loaded stomatocytes was added 
to position 5 after the glass channel was filled with deionized water, and 5 µl of a hydrogen 
Figure 2.5. Chemotaxis evaluation in a glass channel a) the glass channel design b) average velocity of Dox and PtNP 
loaded stomatocytes upon addition of H2O, 0.5% v/v H2o2 and 0.05% v/v H2o2 at position 1, or Dox loaded stomatocytes 
upon addition of 0.5% H2o2 (ctrl) after tracking 30 nanoparticles for each group; c) Motion of Dox and PtNP loaded 
stomatocytes upon addition of H2O or (d) 0.5% H2o2. In the green circles the movement of a single particle is tracked. 
Scale bars represent 4 µm.
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peroxide solution was added to position 1 to generate a concentration gradient. In case 
of the 0.5% H2o2 experiment it was observed at the red spot position (Figure 2.5a) that 
tracked particles (overlaid with green circles) showed a net movement to the left where the 
hydrogen peroxide levels were higher (Figure 2.5d). 
Similar directional movement was also observed for Dox and PtNP loaded stomatocytes 
in the presence of 0.05% of hydrogen peroxide, at a lower velocity (Figure 2.5b). An increase 
in rate along the hydrogen peroxide concentration gradient was observed.
Motors at position 4 with an average velocity of 15.47 µm/s accelerated to 19.64 µm/s 
at the red spot position with addition of 0.5% hydrogen peroxide, while motors with 0.05% 
hydrogen peroxide addition experienced a slight increase from 10.06 µm/s to 10.33 µm/s 
from position 4 to the red spot, confirming thus the results from the nanoparticle tracking 
analysis  experiment. When moving up the gradient, motors travelled longer distances than 
by moving in the opposite direction, resulting in net motion towards the hydrogen peroxide 
rich area, which accounts for their chemotactic behaviour. 
Control experiments were further performed and possible influences of the Marangoni 
effect,[14] drift effects, channel wall interaction,[15]and convection gradients[16] were ruled 
out. The net displacement of the nanomotors was also confirmed by observations with 
both microscopy and the naked eye. As the cluster of Pt-loaded nanomotors appeared 
dark, their displacement could be directly observed. The lack of movement in the negative 
control samples explains the reason we observe fewer particles in Figure 2.5c than in Figure 
2.5d.
To further demonstrate the chemotactic behaviour of Dox and PtNP loaded stomatocytes, 
a microfluidic 2-inlet 1-outlet flow device was used (Figure 2.6). The design of the device offers 
Figure 2.6. Chemotaxis evaluation in a microfluidic channel. (left) Schematic representation of the microfluidic 
channel. Lateral shifts of Dox and PtNP loaded stomatocytes in the presence of 0.05% H2o2 a) bright field b) fluorescent 
imaging, no deviation towards the fuel of the only Dox loaded stomatocytes in presence of 0.05% H2o2 c) bright field 
d) fluorescent imaging.
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high controllability and flexibility over the fluid flow and concentration gradient generation. 
In order to establish a hydrogen peroxide concentration gradient with the least possible 
diffusion, the optimal flow rate through each inlet was investigated and determined to be 
600 µL/h, which was maintained constant throughout the whole flow device experiment. 
Dox and PtNP loaded stomatocytes were pumped into the device through inlet 2 while 
hydrogen peroxide of 0.05% v/v was injected through inlet 1. Hydrogen peroxide with a 
relatively low concentration of 0.05% was chosen so as to make sure no visible oxygen 
bubbles would be produced immediately thereby possibly perturbing the flow profile. The 
particle concentration was maintained the same during the flow experiments. 
Measurements started after a steady-state profile was obtained. The motors exhibited 
a lateral shift towards channel 1 (Figure 2.6a-b) while in the case of water instead of 
hydrogen peroxide only straight motion was observed and the deviation angle was close 
to zero (Figure 2.7).
It is possible that convection may cause bulk fluid distortion; to exclude the flow effects, 
control experiments with Dox only-loaded stomatocytes were performed. No deviation 
towards the hydrogen peroxide containing channel was observed in this case (Figure 2.6c-
d). To further rule out a possible influence of the channel asymmetry or channel flow 
differences on the flow profile, Dox and PtNP containing stomatocytes were injected into 
inlet 1 and hydrogen peroxide through inlet 2. A lateral shift towards inlet 2 was observed 
for Dox and PtNP loaded stomatocytes (Figure 2.8, 2.7b) confirming that they move towards 
higher concentrations of hydrogen peroxide irrespective of the channel used.
Figure 2.7. Average intensity of stacks plotted against the width of the microfluidic channel. a) Dox and PtNP loaded 
stomatocytes in the presence of 0.05 % hydrogen peroxide versus in the presence of water; b) Experiment in which the 
inlets have been inverted; Dox and PtNP loaded stomatocytes in the presence of 0.05 % hydrogen peroxide versus in 
the presence of water.
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After establishing the chemotactic behavior of these nanomotors, we set out to investigate 
if they could also respond to hydrogen peroxide gradients provided by model cells. This 
would provide the proof of concept of active delivery vehicles able to guide their movement 
towards diseased cells. We explored this possibility by using activated neutrophils as a 
hydrogen peroxide source.[17] Neutrophils were isolated from fresh heparinized rabbit blood.
[18] The survival rate and neutrophils density of the obtained preparation was determined to 
be 90.9% and 1.8 × 108 cells/mL using trypan blue staining and hemocytometer counting. 
Then phorbol 12-myristate 13-acetate activated neutrophils were seeded into a HBSS 
soaked cell culture substrate before being placed into the center of a petri dish filled with 
Dox and PtNP loaded stomatocytes. At an observation time of 1.5 h, the nanomotors were 
found to be translating towards the activated neutrophils. 
Figure 2.8. Bright field images of a) Dox and PtNP loaded stomatocytes in the presence of water, c) Dox and PtNP loaded 
stomatocytes in the presence of 0.05 % hydrogen peroxide with inverted inlets, e) Dox and PtNP loaded stomatocytes 
in the presence of water with inverted inlets. Fluorescence images of b) Dox and PtNP loaded stomatocytes in the 
presence of water, d) Dox and PtNP loaded stomatocytes in the presence of 0.05 % hydrogen peroxide with inverted 
inlets, f) Dox and PtNP loaded stomatocytes in the presence of water with inverted inlets.
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As a control, we placed only HBSS soaked substrate into the nanomotor-filled petri dish. 
No such phenomenon was observed in this case. As the substrate was immersed in the 
HBSS solution for 30 minutes and was kept inside the solution during the experiment, no 
capillary forces[19] between the substrate and air were expected to cause any directional 
motion of the nanomotors. Furthermore a lack of directional motion was also observed 
when activated neutrophils were placed into a solution of Dox-only loaded stomatocytes. 
After normalizing the starting point of a number of stomatocytes to zero, trajectories of 
particles over first 5 consecutive frames (total time interval = 1.34 s) from 3 groups could 
be compared. As shown from Figure 2.9 d, e, f, only the group with active neutrophils and 
nanomotors showed a directional movement. Shown in Figure 2.9 d, e, f is the tracking 
paths of nanoparticles at position 1. For the nanomotors with activated cells group, the 
motion at position 2 and 3 is less directional than at position 1. The distance between the 
center of mass or the spatial average end point and the point of origin (displacement of 
Figure 2.9. a) Experiment group set up for chemotaxis evaluation with neutrophils as hydrogen peroxide source and 
Dox-PtNP loaded stomatocytes in the solution; b) Control group set up using either Dox-PtNP loaded stomatocytes 
without cells, or neutrophils with Dox-only loaded stomatocytes; c) Bright field microscopy image of the center of 
the petri dish with the cells immobilized onto the cell culture substrate. The activated neutrophils can be observed 
at higher magnification in the inset; d) Tracking paths over 5 consecutive frames of the Dox-PtNP loaded nanomotors 
moving directionally towards the activated neutrophils, e) PtNP loaded nanomotors without activated neutrophils, f) 
Dox-only loaded stomatocytes with activated neutrophils, at position 1; g) Velocity distribution at position 1, 2, 3 for 
the experiment group a.
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center of mass) were also compared. As the nanomotors showed a preferred migration and 
directional movement in the presence of activated neutrophils, the displacement value of 
the center of mass was higher than the displacement values of the control group, which 
was close to zero (Table 2.2). 
Table 2.2. Displacement of the center of mass of Dox-PtNP stomatocytes in presence of activated neutrophils cells (cells 
+ motor); Dox-PtNP stomatocytes without activated neutrophils cells (HBSS + motor); Dox stomatocytes in presence of 
activated neutrophils cells (cells + stomatocyte) at different positions.
It was also shown that the velocity of the nanomotors gradually increased as they were 
moving closer to substrate, varying from an average velocity of 12.4 µm/s at position 3 
to an average velocity of 15.6 µm/s at position 1  (Figure 2.9g). We assume the directional 
motion is attributed to an enhanced motion of motors at a higher concentration 
of hydrogen peroxide. The multimodality of the velocity distribution could be due to 
the loading difference of catalytic PtNP between vesicles as observed with TEM/cryo-
TEM.
2.3. coNclusioN
We have demonstrated that nanosized soft polymer stomatocytes, loaded with platinum 
nanoparticles and the model drug doxorubicin, display chemotactic behavior in the presence 
of hydrogen peroxide gradients. Furthermore these structures can also sense hydrogen-
peroxide producing cells by guiding their motion towards activated neutrophils. Chemotactic 
behavior can be explained by the fact that the nanomotors travel longer distances in the 
presence of higher concentration of fuels as their speed increases with fuel concentration, 
than in the opposite direction, leading to motors moving up the fuel gradient. While recent 
theoretical calculations pointed out the extent of enhanced tumbling/rotating motion at 
higher fuel zone would determine the chemotaxis direction (positive/negative) of motors,[20] 
the exact chemotaxis mechanism remains to be an open question.
The motors’ nanosized dimensions and their ability to transport cargo make them an 
Displacement of center  Cells+ motor HBSS+ motor Cells+stomatocyte
of mass (µm)
Position 1 11.2  0.4 0.7
Position 2 8.6 2 4.4
Position 3 7.3 1.2 2.4
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interesting starting point for the development of drug carrier systems with chemotactic 
potential. Nanomotors with chemotactic behavior which could move against flow may find 
application in delivering drugs to late-stage tumours where high interstitial pressure[21] 
inhibits entrance of current delivery agents.[22]
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2.5. experimeNtal sectioN
Materials
Unless otherwise indicated all reagents are used as received. Poly(vinyl pyrrolidone) 
(Mn10000), potassium tetrachloroplatinate (II), L (+) ascorbic acid, DMF, and dichloro-
dihydro-fluorescein diacetate (DCFH-DA) were purchased from Sigma-Aldrich. Doxorubicin 
(Dox) was purchased from Bioconnect. BV. Methanol of HPLC grade was purchased from 
Avantor Performance Materials and used without further purification. Spectra/Por dialysis 
membrane with a MW cut-off of 12000-14000 was used for dialysis. All solutions were 
prepared with MilliQ water, which was obtained with a MilliQ QPOD purification system, 
with an electrical resistance > 18.2 MΩ. 
Instruments 
Dynamic light scattering (DLS) analysis was performed on Malvern Zetasizer Nano S with 
following settings: temperature 20 °C, He-Ne laser wavelength 633 nm and detector 
angle 173°. High performance liquid chromatography spectra were obtained on a HPLC 
analytical Agilent 1120. Fluorescence spectra of samples were recorded on a Perkin Elmer 
LS 55 Fluorescence spectrometer. For transmission electron microscopy, a JEOL 1010 
Transmission Electron Microscope with MegaView Soft Imaging camera at an acceleration 
voltage of 60 kV was used. Cryogenic transmission microscopy and 3D electron tomography 
were performed on a JEOL TEM 2100 with high-quality Gatan 895 ultrascan 4000 bottom 
mount camera (4080x4080 pixels) incorporated.
synthesis of poly(ethylene glycol)
44-b-polystyrene190 (Peg44-b-Ps190)
Poly(ethylene glycol)44-b-polystyrene190 was synthesized according to a modified literature 
method. 1H NMR and GPC were used for monitoring the polymerization process by 
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determining the molecular weight of the block copolymer. The reaction was terminated 
once the desired MW of 24000 was attained. A block copolymer was obtained with a PDI 
of 1.07, according to the GPC.
preparation of ptNp with pvp coating
20 mg poly(vinyl pyrrolidone) (PVP, MW≈ 10,000) was added to 2 mL K2PtCl4 (20 mM). The 
mixture was stirred at room temperature for 48 hours to allow full dissolution of the PVP. 
35 mg ascorbic acid was dissolved in 1 mL of water before addition to the above solution. 
After stirring for 1 min, the resulting solution was incubated in a sonication bath (VWR 
Ultrasonic Cleaner Model 75D) at room temperature for 1 h. The appearance of a black 
color indicated the formation of PtNP. Average size of particles was determined to be 74 
nm with DLS (Table 2.1).
preparation of the dox and platinum nanoparticles (ptNp)- loaded stomatocytes
The block copolymer poly(ethylene glycol)
44-b-polystyrene190 (10 mg) was fully dissolved in 
1 mL organic solvent mixture (tetrahydrofuran:dioxane = 4 : 1) before addition of 0.05 mg 
doxorubicin solution in DMF. Deionized water (0.35 mL) was subsequently slowly added 
to the solution, followed by addition of 0.65 mL preformed PtNP aqueous solution. After 
vigorous dialysis for at least 48 hours to remove non-entrapped Dox, Dox-loaded and PtNP 
entrapped stomatocytes were obtained. The average size of the obtained structures was 
determined from dynamic light scattering (DLS) analysis to be 308 nm (Table 2.1). 
Transmission electron microscopy (TeM)
Samples were prepared with the following protocol: Freshly prepared Dox and PtNP loaded 
stomatocytes were diluted to the appropriate concentration. Then 6 μL of diluted sample 
aliquots were dropped onto carbon-coated copper grids. Excessive liquid was removed 
with filter paper and the grid was dried overnight at room temperature. Image acquisition 
was performed with iTEM software (Olympus). TEM images of Dox and PtNP loaded 
stomatocytes are presented in Figure 2.1.
cryo electron microscopy and 3d tomography
A small droplet of Dox and PtNP loaded stomatocytes was placed on an EM Science TEM 
grid, blotted and vitrified through freeze plunging with an automatic vitrification robot, FEI 
Vitrobot™ Mark IV. Electron tomography was performed on a JEOL TEM 2100 with a Gatan 
914 High tilt tomography cryo holder at an acceleration voltage of 200 kV. The region of 
interest was chosen and tilt series were acquired over 74 images from – 54 to 55 degrees. 
A side view of the reconstructed structure clearly showed that PtNP was in the outer cavity 
of the stomatocytes. (Figure 2.2) The average membrane thickness (20 nm) was obtained 
from measurements of 5 different regions (3 images) and analyzed with plot profile tools 
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of ImageJ software, a program developed by NIH and available at imagej.nih.gov/ij/. The 
measurements were made on vesicles with clearly visible boundaries. 
energy-dispersive x-ray spectroscopy (eds)
Element (platinum and nitrogen) analysis was performed on a Bruker Quantax EDS system 
with an STEM detector incorporated.
dynamic light scattering (dls)
Dynamic light scattering analysis of Dox and PtNP loaded stomatocytes, Dox loaded 
stomatocytes, PtNP loaded stomatocytes, empty stomatocytes and PtNP in aqueous 
solution was performed using a Malvern Zetasizer Nano S instrument. Samples were typically 
loaded in Malvern disposable capillary cells. Values are averages of three measurements ± 
standard deviation (Table 2.1).
general procedure for field flow fractionation
Samples were separated and detected by a field flow fractionation system (Eclipse, wyatt 
company) connected with a Shimazu HPLC pump and a DAWN multi-angle light scattering 
detector. MALS detectors were normalized with bovine serum albumin (BSA) before the 
experiment. 50 mM sodium nitrate solution was used as eluent. Membranes used at the 
channel bottom were cellulose (10 kD) RC 10 from Nadir. The channel flow rate was set at 
3.0 mL/min. With an injection rate of 0.2 mL/min, samples were injected into the channel 
through a loop injector with injection amount of 10 μL and concentrated with a focusing 
flow rate of 1.0 mL/min. After focusing, samples were fractionated with a cross flow of 3.0 
mL/min which decreased exponentially to 0 mL/min during the course of 28 min. Data was 
recorded and analyzed with Astra software (Figure 2.3). Spectra of Dox and PtNP loaded 
stomatocytes were deconvoluted with Gaussian distribution fitting, the percentage of PtNP 
loaded stomatocytes was determined to be 59.8 %.
Quantification of doxorubicin encapsulation efficiency with hplc
To 250 μL of Dox and PtNP loaded stomatocytes solution 3 mL of THF was added before 30 
seconds of vortexing. Then the mixture was centrifuged at 3000 g for 15 min. The obtained 
supernatant was evaporated before being reconstituted with 100 μL of HPLC mobile phase 
(methanol:water = 60:40). Standard solutions of Dox with concentrations of 50, 25, 12.5, 
6.25, 3.125 μg/mL were prepared with eluent as calibration standards.
Reversed phase HPLC separation was performed with a column (Inertsil ODS-3, 5 μm, 4.6 
× 150 mm) at room temperature. Isocratic elution was performed with a flow rate at 1.0 
mL/min and a mobile phase consisting of methanol/water (methanol:water=60:40). The UV 
detection wavelength was set at 289 nm. Data was acquired and analyzed using EZ chrome 
software (Figure 2.3). The encapsulation efficiency of Dox was determined to be 78.1%.
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Quantification of doxorubicin encapsulation efficiency with fluorescence spectroscopy
Standard solutions of Dox with concentrations of 50, 25, 12.5, 6.25, 3.125 μg/mL were 
prepared in deionized water. The freshly prepared standard solutions and all samples 
were kept in dark at room temperature. Excitation and emission band widths were both 
15 nm with an excitation wavelength of 530 nm and an emission wavelength of 560 nm. 
The scanning speed was set at 100 nm/min. The fluorescence of Dox loaded stomatocytes 
solution was measured and compared to a calibration curve prepared by the series of Dox 
standard solutions. The encapsulation efficiency of Dox was determined to be 63.7%, lower 
than the HPLC-UV approach (78.1%). We speculate that the lower fluorescence values are 
the result of the formation of either aggregates or bundles of fibres through π−π stacking 
of Dox molecules inside the vesicles.
Procedure to measure nanomotors by nanosight
To investigate the motion of Dox and PtNP loaded stomatocytes and rule out a negative 
effect of Dox encapsulation on the efficiency of the nanomotors, nanoparticle tracking 
analysis was carried out with a nanosight LM10 at a magnification of 20X. Nanoparticle 
tracking analysis combines the laser light scattering technique with a CCD camera and is 
capable of tracking particles of 10 to 1000 nm size moving under Brownian or non-Brownian 
motion in real-time. The Stokes-Einstein equation can be used to correlate the tracking 
coordinates obtained from the movement of the particles with their size. The technique is 
complementary to dynamic light scattering (DLS), however, it provides individual particle-
by-particle analysis rather than an ensemble size distribution information. Since the method 
provides additional visualization of the particles we used this technique to study in detail 
the effect of the fuel concentration on the movement of the platinum-loaded nanomotors 
for concentrations ranging from 2.5, 15, 50, 75 and 100 mM. In this experiment we analysed 
the movement of Dox and PtNP loaded stomatocytes at two concentrations of hydrogen 
peroxide (5 v/v % and 0.5 v/v %).   
30 μL of freshly prepared hydrogen peroxide (5 v/v %, 0.5 v/v %) or Milli Q water was 
added to 1 mL doxorubicin and PtNP loaded stomatocytes solution with the appropriate 
concentration (8×108 particles/mL) before injection into the sample cell. A typical video 
of 90 seconds was recorded. By analyzing the video, x, y coordinates / positions of each 
particle were determined as a function of time intervals. Mean square displacements 
obtained by averaging over 25 particles from the major size distribution observed with 
Nanosight were plotted versus the time intervals (Figure 2.4). Upon 5 v/v % (final 0.15%) 
and 0.5 % (final 0.015%) hydrogen peroxide addition directional movement was observed. 
The average velocity (v) of the stomatocyte motors at these concentrations were extracted 
from the parabolic fit of the MSD (<r2>) dependency in time (t) according to the equation 
<r2> = 4DΔt + (vΔt)2. The velocity of the nanomotors at these two concentrations was 
determined to be 29.4 μm/s and 39.5 μm/s respectively, demonstrating a good efficiency 
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of the nanomotors. The self-diffusiophoretic model proposed by Golestanian and co-
workers postulated that the directional motion of a propelled particle is the result of both 
rotational and translational diffusion with two limiting forms, a parabolic component for 
short periods and a linear component for long periods in respect to the contribution of the 
rotational diffusion. The experimental MSD data obtained for our stomatocyte nanomotor 
indicates only a parabolic component for the Δt currently obtainable with this nanosize 
system, in contrast to micrometre-size particles for which tracking over many seconds is 
readily achievable.
The movement is therefore proportional to the added amount of hydrogen peroxide 
indicating Dox and PtNP loaded stomatocytes accelerate with increasing the concentration 
of hydrogen peroxide. 
demonstration of hydrogen peroxide concentration gradient in glass channel 
A confocal fluorescence laser scanning microscope (Leica TCS SP2 AOBS) with 488 nm argon 
laser lines was used to obtain the data. The laser beam was focused on the sample through 
a 63X oil immersion objective. A pinhole of 400 μm was selected.
2,7-dichlorodihydrofluorescein (DCFH), a rapid and sensitive probe for oxygen-reactive 
species, can be turned into highly fluorescent 2,7-dichlorofluorescein (DCF) upon addition 
of hydrogen peroxide. As DCFH was supplied as 2,7-dichlorodihydrofluoresceindiacetate 
(DCFH-DA), 1.0 mL of 0.01 N NaOH was added to 250 μL of DCFH-DA to remove the ester 
groups. After incubation for 30 min, the mixture was neutralized with 5 mL of 25 mM PBS 
at pH 7.4. The resulting DCFH solution was stored in ice bath before use.
To demonstrate the formation of a hydrogen peroxide concentration gradient, 400 μL of 
freshly prepared DCFH solution was added into a clean and dried glass channel (channel 
height 0.5 cm, middle section length of channel 2 cm) before addition of 5 μL of hydrogen 
peroxide to position 1. DCF was excited with an Ar laser at 488 nm and the emission 
was collected at 510 – 560 nm. Three consecutive images at position 1-5 were acquired 
at predetermined time points and the fluorescence intensity of each image was directly 
quantified with ImageJ software. Using images taken before the addition of hydrogen 
peroxide, the background fluorescence was determined and subtracted from each image. 
There was a clear hydrogen peroxide gradient between position 2 and position 4.  Therefore, 
the middle region (red spot in Figure 2.5a) between position 3 and position 4 was chosen 
as observation area.
glass channel for chemotaxis evaluation
The glass channel was filled with 400 μL of deionized water. Then 5 μL of hydrogen 
peroxide (5 v/v % or 0.5 v/v %) was gently added to position 1 before gentle addition of 
doxorubicin and PtNP loaded stomatocytes to position 5. Particles were irradiated at an 
excitation wavelength of 488 nm and emission was detected using a band pass 530-620 
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nm to collect doxorubicin fluorescence. To visualize particle motion, particles were imaged 
as time series (100 frames, time interval between each frames ∆T = 268 ms) on a Leica 
TCS SP2 AOBS confocal using 63× oil immersion objective. The imaging plane and imaging 
time were carefully chosen and maintained throughout the whole experiment. A pinhole 
of 400 μm was used to achieve maximal tracking of particles before particles move out of 
imaging plane. Bidirectional scanning mode was used and the scanning speed was set at 
1000 Hz to ensure minimal time interval 268 ms. Tracking image sequences were analyzed 
with ImageJ plugin manual tracking. With the x/y coordinates information, the distance 
a particle travelled within 268 ms time interval was determined. By averaging velocity of 
particle over different time intervals, average velocity of particle was obtained. For each 
group 30 nanoparticles were tracked and the velocity determined, giving a final average 
velocity.
To rule out effects of surface tension change induced by hydrogen peroxide addition, 
5 μL of hydrogen peroxide at 0.5% was added to position 1 while doxorubicin loaded but 
PtNP free stomatocytes were added to position 5. No directional motion was observed in 
this case, excluding thus possible influences of the Marangoni effect, while the (random) 
movement of the PtNP-free stomatocytes was calculated to be 10.30 µm/s (Figure 2.5b). 
Although the calculated motion of the empty stomatocytes is similar to that of motors with 
hydrogen peroxide at 0.05% in magnitude it did not show any preferred directionality as 
is the case with chemotactic behaviour. In order to further exclude the possible influence 
of drift effects, deionized water of the same volume was added to position 1 while Dox 
and PtNP loaded stomatocytes were added to position 5. A moving rate of 8.44 µm/s was 
determined for the PtNP loaded stomatocytes. In this case, only typical Brownian-based 
diffusion, random in direction, was detected. 
As observed in the experiment, there was no sign that stomatocytes sedimented or 
adhered/interacted with the glass channel wall. It is therefore unlikely the channel wall 
would influence the flow pattern. As oxygen bubble formation may give rise to convection 
gradients, low concentrations of hydrogen peroxide (0.5% and 0.05%) were used. With the 
addition of both 5 µL 0.5% and 0.05% of hydrogen peroxide, no visible oxygen production 
could be observed during the experiments, we therefore ensured that the directional 
migration towards higher concentrations of hydrogen peroxide was not due to microsized 
bubble formation and perturbation of the fluid.
microfluidic device for chemotaxis evaluation
The chemotaxis of doxorubicin and PtNP loaded stomatocytes was studied with a Leica 
DM2500 fluorescence microscope equipped with a CCD camera. For fluorescence an HXP 
R 120W/45C lamp (Osram) was used. Excitation light (515-560 nm) guided through a 
dichroic mirror (580 nm) was focused onto the microfluidic channel. Excited fluorescence 
was collected after passing through a 590 nm long pass filter. Water and sample solution 
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were injected into a Y shaped microfluidic device (main channel width 3 mm, main channel 
length 2.4 cm) using a syringe pump (Fusion 100 Touch, KR analytical Ltd.). Flow rate for 
each inlet was maintained at 0.6 mL/h. Bright field images and fluorescent images in 
the region of interest (3500 μm down the channel) were acquired for 6–8 minutes after 
stabilization of flow. After being converted into stacks, bright field images were analyzed 
with ImageJ - z project tool. The average intensity of stacks was plotted against the width 
of the microfluidic channel. There was a shift for Dox and PtNP loaded stomatocytes in 
the presence of 0.05 % hydrogen peroxide while no such shift was observed for only Dox 
loaded stomatocytes. 
chemotactic evaluation with activated neutrophils as hydrogen peroxide source
To fresh heparinised rabbit blood, ice cold red blood cell lysing agent (0.16 M ammonium 
chloride, 0.01 M sodium hydrogen carbonate) was added (volume ratio 1:4) and incubated 
for 15 min. Then after centrifugation at 3000 rpm for 15 min, the cell pellet was resuspended 
in 10 mL 1 × HBSS buffer solution. After centrifugation at 3000 rpm for 5 min and 5 mL 
HBSS rinsing for 2 rounds, the cell pellet was resuspended with HBSS buffer solution. For 
neutrophil activation, concentrated neutrophils in HBSS (with calcium, magnesium) buffer 
were incubated with phorbol 12-myristate 13-acetate (final concentration 0.16 µM) at 37 
°C for 2 h. The level of hydrogen peroxide was determined with an amplex red assay to 
be 2 mM. The activated neutrophils was seeded into HBSS soaked cell culture substrate 
(catalogue No SC-C048-0024, SeedEZ, USA) before placing into the center of a petri dish 
(50 mm in diameter, µ-Dish, ibidi, Germany) filled with Dox and PtNP loaded stomatocytes 
in HBSS solution (1.2×1010 vesicles/mL). Time lapse confocal images were taken at different 
positions. For confocal images, bidirectional scanning mode was used and the scanning 
speed was 1000 Hz. The analysis of image sequences was performed with ImageJ manual 
tracking plugin. The average distance nanoparticle travelled in minimal time interval 
was obtained as velocity of the nanoparticle. Velocity distribution diagrams of groups at 
different positions were shown. The median velocity of either Dox loaded stomatocytes in 
presence of stimulated cells or Dox and PtNP loaded stomatocytes in presence of cell-free 
culture substrate was lower than that of Dox and PtNP loaded stomatocytes in presence of 
activated cells. There was also no acceleration tendency from position 3 to position 1 for 
the control groups.
discussion of the motion mechanism
Locomotion in both water and HBSS buffer is observed for our motor system. While our 
stomatocyte motors could be considered as a resemblance of Janus-type nanomotors, up 
till now, the motion mechanism of Janus motors remains under debate. 
We examined the mechanism of directed movement by measuring the diffusion coefficient 
of our motors in deionized water and HBSS buffer upon addition of hydrogen peroxide. The 
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diffusion coefficient of Dox and PtNP loaded stomatocytes in the deionized water solution/
HBSS buffer solution upon addition of 0.05% (final concentration 0.0015%) hydrogen 
peroxide was determined to be 1.85×10-8 cm2/s and 1.79×10-8 cm2/s, respectively. The 
presence of electrolyte in HBSS buffer reduced the diffusion coefficient of motors to some 
extent. It is known that electrolyte diffusiophoresis based on ionic gradients generated by 
hydrogen peroxide decomposition and nonelectrolyte diffusiophoresis can be suppressed 
in strong electrolytes (NaCl, KCl) and neutral molecules (glucose) containing HBSS buffer. 
Poon and Ebbens discovered a strong propulsion reduction of platinum-PS Janus swimmers 
(diameter 2 µm) by addition of ionic species (maximum concentration 1 mM), suggesting a 
diffusiophoresis mechanism or self-electrophoresis resulting from a localized ionic current 
on the surface of catalyst. In our case the diffusion coefficient of motors in HBSS buffer 
(containing 138 mM NaCl, 5.6 mM glucose) with 0.05% hydrogen peroxide addition was 
reduced, yet still higher than that in HBSS without hydrogen peroxide (1.72 × 10-8 cm2/s). 
We expect diffusiophoresis to play a role in our system, however it seems it is not the only 
operating mechanism. As it was reported previously platinum-based Janus nanomotors 
move directionally under either diffusiophoresis or bubble propelled mechanisms at the 
same concentration of hydrogen peroxide, depending on the roughness of catalyst. We 
assume that nanoscale bubbles could account for the locomotion we observed in HBSS 
buffer. It is somewhat surprising that diffusiophoresis is partly accountable for locomotion of 
300 nm sized motors as one would expect rotational motion may interrupt the asymmetric 
distribution of catalyzed products. Recent studies from other groups also experimentally 
showed that motors propelled through phoretic mechanisms could still be operative at a 
size scale as low as 30 nm and are not be disrupted by self-rotation.
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3.1. InTroducTIon
The nature of the hydrophobic cell membrane and its intactness protect cells from the 
influx of exogeneous molecules, making efficient and effective access of therapeutic agents 
into diseased cells a challenging yet attractive problem.[1] Progress made in drug delivery 
over the last decades was considered limited, when compared to the high expectations 
concerning cancer and other vasculature diseases, mainly because it relied on passive 
delivery and accumulation in the diseased tissue. For this purpose next generation active 
delivery devices with strong cell penetrating abilities are in high demand. Self propelled 
micro or nanomotors[2] which demonstrate great potential in the realm of transportation,[3] 
sensing[4] and environmental remediation,[5] have been given growing attention. These 
motors with increased cargo towing force and direction control[6] are capable of efficient 
transportation at the micro and nanometer scale, showing promise in precise active 
delivery.[7] However, applications of nanomotors in a biological context remain still limited 
due to their complicated preparation, size restriction and limited possibilities for further 
modification. Functionalized motors with engineered properties and functions are therefore 
desirable. Self-assembled motors are in particular interesting soft locomotive carriers, as 
they provide more diversity in the choice of the building components, good interface with 
biological systems and could be easily modified.[8] Here we present a new type of self-
assembled nanomotor, which was easily functionalized with a cell penetrating peptide. The 
motion of the nanoscale motors was utilized to actively interact with and facilitate uptake 
by tumor cells. The dynamic movement of the drug loaded nanomotors increases the 
likelihood of interaction between delivery agents and target cells. Cell penetrating peptides 
(CPPs), or protein transduction domains are capable of crossing cell membranes effectively.
[9] Through electrostatic interaction with the plasma membrane, cellular binding and direct 
insertion, cell penetrating peptides can promote rapid membrane crossing of themselves/
tagged biomolecules.[9c] Among these CPPs, one of the most successful is trans-activator 
of transcription (tat) peptide derived from the tat protein of human immunodeficiency 
virus. This basic protein domain is responsible for promoting the efficient cell entry of the 
virus and can facilitate a wide range of cargos to translocate rapidly across cell membranes.
[10] Coupling CPPs onto synthetic nanomotors to enhance further their cell penetrating 
ability has not been reported yet. Such biohybrid nanomotors represent a new class of 
nanomotors bridging the synthetic motors with natural properties. Capability of moving 
efficiently and penetrating effectively, along with easy fabrication makes this nanomotor 
particularly attractive for cargo delivery.
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3.2. results aNd discussioN
Figure 3.1 illustrates the preparation process of tat peptide modified poly(ethylene glycol)-
b-polystyrene stomatocyte nanomotors. Firstly carboxylic acid functional polystyrene190 
and poly(ethylene glycol)44-b-polystyrene190 were synthesized via ATRP polymerization, 
while amine functionalized poly(ethylene glycol)66-b-polystyrene190 was obtained by 
reacting the PS carboxyl end group with α,ω-amine functionalized poly (ethylene glycol) 
(1H NMR spectrum of poly(ethylene glycol)44-b-polystyrene190 and poly(ethylene glycol)66-b-
polystyrene190 with amine ending can be found in Figure 3.2). The amine groups on the poly 
(ethylene glycol) allow easy modification and subsequent functionalization with peptides. 
After synthesis of the block copolymer, platinum loaded block copolymer poly(ethylene 
glycol)-b-polystyrene based stomatocytes were obtained through self-assembly of the 
polymers.[11] 
1% or 5% of amine functionalized poly(ethylene glycol)66-b-polystyrene190 was mixed 
with poly(ethylene glycol)44-b-polystyrene190. During self-assembly, preformed catalytic 
platinum nanoparticles were loaded into the cavity of the stomatocytes.[12] Catalytic 
platinum nanoparticles can provide propulsion by decomposing chemical fuel hydrogen 
peroxide.[6] The poly(ethylene glycol) on the surface imparts the stomatocyte motor with 
stealth properties and good biocompatibility in biological environments.  
Figure 3.1. Schematic illustration of the synthetic process of tat peptide functionalized stomatocyte nanomotors.
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After forming platinum loaded poly(ethylene glycol)-b-polystyrene (1% or 5% 
amine) stomatocytes (Figure 3.3), the bifunctional agent 6-maleimidohexanoic acid 
N-hydroxysuccinimide ester was introduced on the surface via the coupling of the amine 
group with NHS. The maleimide groups present on the surface were then used for 
Figure 3.2. 1H NMR spectrum of a) poly(ethylene glycol)44-b-polystyrene190 and b) amine functionalized poly(ethylene 
glycol)66-b-polystyrene190.
Figure 3.3. TEM images of a) 1% amine functionalized poly(ethylene glycol)-b-polystyrene stomatocytes; b) 5% amine 
functionalized poly(ethylene glycol)-b-polystyrene stomatocytes.
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modifi cati on with fl uorescent fl uorescein isothiocyanate (FITC) functi onalized tat (Figure 
3.4) through maleimide bonding with the cysteine group in tat. 
Three rounds of centrifugati on and washing were used to remove unreacted pepti de. 
The stomatocyte structure remained stable aft er FITC-tat functi onalizati on (Figure 3.5a, 
b). TEM images at diff erent ti lti ng angle along the x axis corroborated that the plati num 
was indeed positi oned in the cavity of the stomatocytes (Figure 3.5c-e). Aft er tat pepti de 
coupling, a decrease in zeta potenti al was observed for both 1% maleimide-functi onalized 
stomatocytes and 5% maleimide-functi onalized stomatocytes. Figure 3.5f shows a summary 
of zeta potenti als before and aft er tat functi onalizati on. For the 1% group, a slight decrease 
in zeta potenti al was observed. For the 5% group, the zeta potenti al experienced a more 
signifi cant change from -29.3 mV for maleimide functi onalized stomatocytes to -15.8 mV 
aft er tat coupling. 
Figure 3.4. Molecular structure and electrospray ionisati on mass spectrometry (ESI-MS) spectrum of FITC labelled tat 
pepti de (expected molecular mass 2056.09), found m/z 344.44 at +6 charge, m/z 412.68 at +5 charge, m/z 515.44 at +4 
charge, m/z 686.68 at +3 charge, m/z 1029.00 at +2 charge.
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Figure 3.5. Transmission electron microscopy images of a) 1% FITC-tat functi onalized stomatocyte motors, b) 5% 
FITC-tat functi onalized stomatocyte motors, scale bar is 100 nm; c-e) TEM images of one plati num loaded FITC-tat 
functi onalized stomatocyte at diff erent ti lti ng angle through 20° to -30°, scale bar represents 100 nm; f) summary of zeta 
potenti al values before and aft er FITC-tat functi onalizati on; g) confocal fl uorescent image of 5% FITC-tat functi onalized 
stomatocyte motors, scale bar represents 10 µm.
Figure 3.6. Zeta potenti al and size distributi on of tat functi onalized stomatocyte nanomotors determined with 
nanoparti cle tracking analysis.
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This indicates a higher modification percentage with tat since tat is a positively charged 
peptide and the introduction of tat is expected to lead to a less negatively charged surface. 
The decrease in the zeta potential for the 5% group was confirmed with zeta-potential 
measurements via nanoparticle tracking analysis (NTA). With this NTA technique it was 
also possible to get zeta potentials of individual particles and allow a demonstration of the 
charge distribution on the whole particle population. An average zeta potential of -17.2 ± 
0.9 mV was obtained (Figure 3.6), correlating well with the data from DLS. 
From the zeta potential distribution data, it could also be observed that relatively high 
conjugation efficiency was obtained. According to IR spectra, a decrease in the peaks 
at 1260 cm-1 and 1040 cm-1 (Figure 3.7) showed the reduction of the =C-H vibration of 
maleimide (RCH=CHR’), indicating the successful conjugation between maleimide and 
cysteine of FITC-tat. Fluorescence observed with confocal fluorescent microscopy also 
Figure 3.7. Infrared spectra of (from top to bottom) 5% maleimide-functionalized poly(ethylene glycol)-b-polystyrene 
stomatocytes; 5% tat functionalized poly(ethylene glycol) -b-polystyrene stomatocytes; 1% maleimide-functionalized 
poly(ethylene glycol)-b-polystyrene stomatocytes; 1% tat functionalized poly(ethylene glycol)-b-polystyrene 
stomatocytes.
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verified the successful ligation of peptides onto the surface of stomatocytes (Figure 3.5g). 
The fluorescent FITC facilitates the visualization by confocal fluorescent microscopy in 
subsequent cell uptake experiments. 
 
The 5% functionalized stomatocytes motors were used for further studies. For tat free 
control groups, 5% amine functionalized stomatocytes were reacted with FITC. The 
utility of the nanomotor for cargo delivery was then tested with its directional moving 
capabilities. In the hydrogen peroxide solution, the tat functionalized motors preserved 
their ability to move. The motors clearly showed faster movement with increased level of 
hydrogen peroxide over the range of 0% to 0.15% (Figure 3.8a). From the MSD-∆t curve, 
the velocity of motors was derived with 9.3 µm/s at 0.015% hydrogen peroxide, 13.91 µm/s 
at 0.06% of hydrogen peroxide and 28.51 µm/s at 0.15% hydrogen peroxide. At the lowest 
hydrogen peroxide concentration used (0.015%), a parabolic curve was still observed, 
indicating a propulsive movement. The trajectory paths of stomatocyte motors at different 
concentrations of hydrogen peroxide solution are given in Figure 3.8b. In the absence of 
hydrogen peroxide, typical Brownian motion with random movement was observed. At 
higher levels of hydrogen peroxide, directional motion with intermittent tumbling was 
demonstrated.
Figure 3.8. a) Plot of mean square displacement versus time intervals at different concentrations of hydrogen peroxide 
solution; b) tracking paths of nanomotors at different hydrogen peroxide levels, scale bar represents 6 µm.
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HeLa cells, human cervical cancer cells were used as a model cell to investi gate the cell 
penetrati ng and entry abiliti es of nanomotors. Aft er incubati ng with FITC PEG-PS Pt 
stomatocytes or FITC-tat PEG-PS Pt stomatocytes for 6 hours with or without 0.015% 
hydrogen peroxide soluti on, confocal microscopy was used to visualize and evaluate 
the cellular uptake. From Figure 3.9, it was observed that in the presence of hydrogen 
peroxide there was an increased uptake of FITC PEG-PS Pt stomatocytes. A further increase 
was observed for the FITC-tat PEG-PS Pt stomatocytes with hydrogen peroxide group. At 
this low level of hydrogen peroxide, FITC-tat was robust and stable to promote eff ecti ve 
penetrati on. For determinati on of the localizati on of FITC-tat PEGPS Pt stomatocytes, both 
cell membrane and nucleus staining agents were used. At this hydrogen peroxide level 
aft er 6 hours, the cell nucleus and cell membrane were demonstrated to remain intact. 
Figure 3.9. a) confocal fl uorescent image and b) confocal bright fi eld image of HeLa cells incubated with FITC PEG-PS Pt 
stomatocytes for 6 hours, c) confocal fl uorescent image and d) confocal bright fi eld image of HeLa cells incubated with 
FITC-tat PEG-PS Pt stomatocytes for 6 hours, e) confocal fl uorescent image and f) confocal bright fi eld image of HeLa 
cells incubated with FITC PEG-PS Pt stomatocytes in presence of 0.015% hydrogen peroxide for 6 hours, g) confocal 
fl uorescent image and h) confocal bright fi eld image of HeLa cells incubated with FITC-tat PEG-PS Pt stomatocytes 
in 0.015% hydrogen peroxide for 6 hours, scale bar represents 60 µm; i) quanti tati ve comparison of cellular uptake 
for FITC PEG-PS Pt stomatocytes without hydrogen peroxide (grey curve), FITC PEG-PS Pt stomatocyte nanomotors 
with 0.015% hydrogen peroxide (green curve) or FITC-tat PEG-PS Pt stomatocytes nanomotors with 0.015% hydrogen 
peroxide (orange curve), while black curve represents basal fl uorescence of HeLa cells.
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Figure	 3.9.	 a)	 confocal	 fluorescent	 image	 and	 b)	 confocal	 bright	 field	 image	 of	 HeLa	 cells	
incubated	with	FITC	PEG-PS	Pt	stomatocytes	for	6	hours,	c)	confocal	fluorescent	image	and	d)	
confocal	bright	field	image	of	HeLa	cells	incubated	with	FITC-tat	PEG-PS	Pt	stomatocytes	for	
6	 hours,	 e)	 confocal	 flu rescent	 image	 and	 f)	 confocal	 brigh 	 field	 image	 of	 HeL 	 ell 	
incubated	with	FITC	PEG-PS	Pt	stomatocytes	in	presence	of	0.015%	hydrogen	peroxide	for	6	
hours,	 g)	 confocal	 fluoresc t	 image	 and	 h)	 confocal	 bright	 field	 image	 of	 HeLa	 cells	
incubated	with	FITC-tat	PEG-PS	Pt	 stomatocytes	 in	0.015%	hydrogen	peroxide	 for	6	hours,	
scale	bar	represents	60	µm;	i)	quantitative	comparison	of	cellular	uptake	for	FITC	PEG-PS	Pt	
stomatocytes	 without	 hydrogen	 peroxid 	 (grey	 curve),	 FITC	 PEG-PS	 Pt	 stomatocyte	
nanomotors	 with	 0.015%	 hydrogen	 peroxide	 (green	 curve)	 or	 FITC-tat	 PEG-PS	 Pt	
stomatocytes	nanomotors	with	0.015%	hydrogen	peroxide	(orange	curve),	while	black	curve	
repres nts	basal	fluorescence	of	HeLa	cells.	
	
HeLa	 cells,	 human	 cervical	 cancer	 cells	 were	 used	 as	 a	 model	 cell	 to	 investigate	 the	 cell	
penetrating	 and	 entry	 abilities	 of	 nanomotors.	 After	 incubating	 with	 FITC	 PEG-PS	 Pt	
stomatocytes	 or	 FITC-tat	 PEG-PS	 Pt	 stomatocytes	 for	 6	 hours	 with	 or	 without	 0.015%	
hydrogen	 peroxide	 solution,	 confocal	 microscopy	 was	 used	 to	 visualize	 and	 evaluate	 the	
cellular	uptake.	From	Figure	3.9,	it	was	observed	that	in	the	presence	of	hydrogen	peroxide	
there	 was	 an	 increased	 uptake	 of	 FITC	 PEG-PS	 Pt	 stomatocytes.	 A	 further	 increase	 was	
observed	for	the	FITC-tat	PEG-PS	Pt	stomatocytes	with	hydrogen	peroxide	group.	At	this	low	
level	of	hydrogen	peroxide,	FITC-tat	was	robust	and	stable	to	promote	effective	penetration.	
For	determination	of	the	localization	of	FITC-tat	PEGPS	Pt	stomatocytes,	both	cell	membrane	
and	nucleus	staining	agents	were	used.	At	this	hydrogen	peroxide	level	after	6	hours,	the	cell	
nucleus	and	cell	membrane	were	demonstrated	to	remain	intact.		
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It could be observed that a signifi cant amount of FITC-tat PEG-PS Pt stomatocytes was 
indeed taken up by the intact cells (Figure 3.10) while a small percentage of parti cles were 
att ached onto the cell membrane which was generally acknowledged as the fi rst step for 
cellular internalizati on. To remove the FITC-tat PEG-PS Pt stomatocytes att ached onto the 
surface of the cell membrane and quanti fy the amount of stomatocytes sequestered by 
the cells, the cells were trypsinized and further analyzed with fl ow cytometry. The trypsin-
EDTA used could eff ecti vely digest and dissociate the pepti de functi onalized stomatocytes 
att ached to the outer membrane of cells. 
An increase in the fl uorescence was observed from FITC PEG-PS Pt stomatocytes (no 
hydrogen peroxide) to FITC PEG-PS Pt stomatocytes (in the presence of hydrogen peroxide 
– acti ve nanomotors) and FITC-tat PEG-PS Pt stomatocytes (with hydrogen peroxide – 
functi onalized acti ve nanomotors) (Figure 3.9i), corroborati ng the results from confocal 
microscopy. For FITC-tat PEG-PS Pt stomatocytes (with hydrogen peroxide) two peaks were 
observed which was explained by the presence of PEG-PS Pt stomatocytes not functi onalized 
with FITC-tat. Furthermore the zeta potenti al measurements with nanosight confi rmed 
the incomplete functi onalizati on. Two populati ons were observed with tat functi onalized 
Figure 3.10. HeLa cells incubated with a) tat functi onalized stomatocyte nanomotors in presence of 0.015% hydrogen 
peroxide for 6 hours and stained with b) cell mask deep red cell membrane stain; c) live cell nucleus dye Hoechst 33342; 
d) bright fi eld image of the cells, scale bar represents 10 µm; e) merged image of a), b), c); f) merged image of a), b), 
c), d).
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Figure	 3.10.	 HeLa	 cells	 incubated	 with	 a)	 tat	 functionalized	 stomatocyte	 nanomotors	 in	
presence	of	0.015%	hydrogen	peroxide	for	6	hours	and	stained	with	b)	cell	mask	deep	red	
cell	membrane	stain;	c)	live	cell	nucleus	dye	Hoechst	33342;	d)	bright	field	image	of	the	cells,	
scale	bar	represents	10	µm;	e)	merged	image	of	a),	b),	c);	f)	merged	image	of	a),	b),	c),	d).	
It	 could	 be	 observed	 that	 a	 significant	 amount	 of	 FITC-tat	 PEG-PS	 Pt	 stomatocytes	 was	
indeed	taken	up	by	the	intact	cells	(Figure	3.10)	while	a	small	percentage	of	particles	were	
attached	 onto	 the	 cell	membrane	which	was	 generally	 acknowledged	 as	 the	 irst	 step	 for	
cellular	 internalization.	 To	 remove	 the	 FITC-tat	 PEG-PS	Pt	 stomatocytes	 attached	onto	 the	
surface	of	the	cell	membrane	and	quantify	the	amount	of	stomatocytes	sequestered	by	the	
cells,	the	cells	were	trypsinized	and	further	analyzed	with	flow	cytometry.	The	trypsin-EDTA	
used	 could	 effectively	 digest	 and	 dissociate	 the	 peptide	 functionalized	 stomatocytes	
attached	to	the	outer	membrane	 	 l s.		
An	 increase	 in	 the	 fluorescence	 was	 observed	 from	 FITC	 PEG-PS	 Pt	 stomatocytes	 (no	
hydrogen	peroxide)	to	FITC	PEG-PS	Pt	stomatocytes	(in	the	presence	of	hydrogen	peroxide	–	
active	 nanomotors)	 and	 FITC-tat	 PEG-PS	 Pt	 stomatocytes	 (with	 hydrogen	 peroxide	 –	
functionalized	 active	 nanomotors)	 (Figure	 3.9i),	 corroborating	 the	 results	 from	 confocal	
microscopy.	For	FITC-t t	PEG-PS	Pt	stomato ytes	(with	hydrogen	per xide)	two	peaks	were	
observed	which	was	explained	by	the	presence	of	PEG-PS	Pt	stomatocytes	not	functionalized	
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stomatocytes at -18 - 10 mV while -50 - -30 mV was observed for unfunctionalized 
stomatocytes. The mean fluorescence value for FITC PEGPS Pt stomatocytes (no hydrogen 
peroxide), FITC PEG-PS Pt stomatocytes (hydrogen peroxide) and FITC-tat PEG-PS Pt 
stomatocytes (hydrogen peroxide) were respectively 26.3 ± 5.4 au, 30.5 ± 3.3 au and 50.4 
± 0.85 au while the basal fluorescence from cells was low with a value of 12.3 ± 3.7 au. 
We attributed the increased cell penetrating abilities for FITC-tat PEG-PS Pt stomatocytes 
to their directional active motion as well as the presence of tat peptide. Continuous 
propulsion of stomatocyte motors results in fast movement in cell culture medium, which 
induced faster and higher chances of motor-cell interaction. It was expected the enhanced 
interaction would lead to improved uptake and penetration into intact cells.
3.3. coNclusioN
In conclusion we have demonstrated a strategy to fabricate peptide functionalized 
nanomotors in a simple and convenient way. By combining nanometer scale biological 
stealth motors with cell penetrating peptides, the motors displayed rapid and effective 
penetration. Such motors hold great promises for delivering agents into cells in a rapid way. 
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3.5. experimeNtal sectioN
Materials
Unless otherwise indicated all reagents are used as received. Copper bromide 
(CuBr), N,N,N’,N”,N”-pentamethyldi-ethylenetriamine (PMDETA), styrene, tert-butyl 
α-bromoisobutyrate, 1-phenyl-1-trimethylsiloxyethene, ethylene diamine tetra acetic acid 
(EDTA), α-ω-amino-poly(ethylene glycol), benzotriazol-1-yl-oxytripyrrolidinophosphonium 
hexafluorophosphate (PyBOP), 6-maleimidohexanoic acid N-hydroxysuccinimide ester, 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), Tris(2-carboxyethyl)
phosphine (TCEP), polyvinylpyrrolidone (Mn10000), potassium tetrachloroplatinate (II) 
and L (+) ascorbic acid were purchased from Sigma-Aldrich. Tetrahydrofuran (THF), anisole 
and N,N-diisopropylethylamine (DIPEA) were obtained from Acros. Hydrochloric acid 
(37%) and hydrogen peroxide were purchased from J.T. Baker. 1,4-dioxane (Biosolve BV), 
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dichloromethane (CH2Cl2, Fisher Chemical) were also used. Methanol of HPLC grade was 
purchased from Avantor Performance Materials and used without further purification. 
Spectra/Por dialysis membrane with a MW cut-off of 12000-14000 was used for dialysis. 
All solutions were prepared with MilliQ water, which was obtained with a MilliQ QPOD 
purification system, with an electrical resistance > 18.2 MΩ. 
Instruments 
Gel permeation chromatography (GPC) was performed on a Shodex GPC column equipped 
with UV SPD 20A detectors (254 nm, 215 nm). THF was used as eluent and the flow rate 
was kept constant at 1 mL/min. 1H nuclear magnetic resonance spectra (1H NMR) were 
measured on a Varian Inova 400 MHz spectrometer, with CDCl
3
 as solvent. Dynamic light 
scattering (DLS) analysis was performed on Malvern Zetasizer Nano S with the following 
settings: temperature 20 °C, He-Ne laser wavelength 633 nm and detector angle 173°. 
Infrared (IR) spectroscopy was performed with an IR-ATR instrument (Bruker TENSOR 27). 
Transmission electron microscopy was performed with a JEOL 1010 Transmission Electron 
Microscope at an acceleration voltage of 60 kV.
synthesis of poly(ethylene glycol)
44-b-polystyrene190 (Peg44-b-Ps190)
Based on a modified literature method poly(ethylene glycol)44-b-polystyrene190 was 
synthesized. For monitoring the polymerization process, 1H NMR and GPC were used to 
determine the molecular weight of the block copolymer. The reaction was terminated 
once the desired MW of 24000 was attained. According to the GPC, a block copolymer was 
obtained with a PDI of 1.07. 
synthesis of Nh2-poly(ethylene glycol)66-b-polystyrene190 (Nh2-Peg66-b-Ps190)
Poly(ethylene glycol)66-b-polystyrene190 with amine as ending group was synthesized as 
following. The schlenk tube with CuBr (45 mg, 0.32 mmol) was evacuated for 15 min and 
refilled with argon for three times. PMDETA (66 μL, 0.32 mmol) in anisole (0.5 mL) was 
added, followed by 15 min of vigorously stirring. Styrene (5.74 mL, 50 mmol) in anisole (0.5 
mL) was added via a syringe and degassed for 15 min. After cooling the mixture to 0 °C, 
tert-butyl α-bromoisobutyrate (27 μL, 0.14 mmol) in anisole was injected and the solution 
was degassed for another 15 min. The Schlenk tube was transferred into an oil bath at 90 
°C. 1H-NMR was used for monitoring the reaction process. Upon attainment of the required 
molecular weight, the reaction was terminated by adding 1-phenyl-1-trimethylsiloxyethene 
(1.91 mL, 9.28 mmol). The mixture was left to stir for 2h. The solution was diluted with 
ch2Cl2 and extracted with an aqueous solution of EDTA (65 mM). The organic layer was 
collected and dried with MgSO4 before concentration with a vacuum pump. The polymer 
obtained was precipitated in MeOH for three times and dried under vacuum overnight, 
giving polymer α-tert-butyloxycarbonyl-polystyrene. Then α-tert-Butyloxycarbonyl-
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polystyrene (3 g) was dissolved in 1, 4-dioxane (30 mL) and concentrated HCl (1.5 mL, 37%) 
was added. The reaction was refluxed at 110 °C overnight. The mixture was dried using a 
rotary evaporator and then dissolved in CH2Cl2. The polymer (α-carboxylic acid-polystyrene) 
was obtained after precipitation in MeOH (3x) and then dried under vacuum overnight. The 
dried polymer α-carboxylic acid-polystyrene (1 g, 43.5 μmol), α-ω-amino-poly(ethylene 
glycol) (521.7 mg, 260 μmol) and DIPEA (17.4 μL, 100 μmol) were dissolved in DMF (12 mL). 
The solution was cooled to 0 °C and PyBOP (42 mg, 80 μmol) was added. The reaction was 
stirred overnight, while slowly warming to room temperature. The progress of the coupling 
was monitored by GPC. After that, the mixture was diluted with CH
2Cl2 and extracted with 
nahco
3
 solution (4 wt%) and saturated NaCl solution. The organic layer was collected and 
dried with MgSO4 and concentrated. The pure polymer was obtained after precipitation 
in MeOH (3x) and dried under vacuum overnight. The final polymer was characterized by 
1H-NMR in CDCl
3
. 
preparation of ptNp with pvp coating
To 2 mL K2PtCl4 (20 mM), 20 mg poly(vinyl pyrrolidone) (PVP, MW≈ 10,000) was added. The 
mixture was allowed to stir at room temperature for 48 hours. Then 1 mL ascorbic acid 
aqueous solution (35 mg/mL) was added to the above solution. After stirring for 1 min, the 
mixture was incubated in a sonication bath (VWR Ultrasonic Cleaner Model 75D) at room 
temperature for 1 h. The appearance of a black color indicated the formation of PtNP. The 
average size of particles was determined to be 74 nm with DLS.
preparation of the platinum nanoparticles (ptNp)- loaded stomatocytes
The block copolymer poly(ethylene glycol)
44-b-polystyrene190 and poly(ethylene glycol)66-
b-polystyrene190 with an amine end group (for 5% functionalization, 9.5 mg: 0.5 mg; 
for 1% functionalization, 9.9 mg: 0.1 mg) were fully dissolved in 1 mL organic solvent 
(tetrahydrofuran:dioxane = 4 : 1). Deionized water (0.35 mL) was subsequently slowly 
added to the solution, followed by addition of 0.65 mL preformed PtNP aqueous solution. 
After dialysis for 48 hours, PtNP entrapped stomatocytes were obtained. 
functionalization of amine ended poly(ethylene glycol)-b-polystyrene stomatocytes with 
fluorescein isothiocyanate labelled tat peptide (fitc-tat)
The amine exposed poly(ethylene glycol)-b-polystyrene (2.5 mg polymer/mL) stomatocytes 
solution (800 µL) was diluted with 333 µL of phosphate buffer (pH 7.4, 80 mM), followed 
by addition of 6-maleimidohexanoic acid N-hydroxysuccinimide ester (2 mg/mL, for 5% 
functionalization 15 µL, 1% functionalization 3 µL). The mixture was allowed to stir vigorously 
for 2 hours before ultrafiltration with (4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid) (HEPES) buffer for three times to remove unreacted 6-maleimidohexanoic acid 
N-hydroxysuccinimide ester and concentrate the solution to 4 mg polymer/mL. To 400 µL 
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of the obtained solution, FITC-tat (1 mg/mL) aqueous solution (for 5% 16 µL, 1% 3.2 µL), 
Tris(2-carboxyethyl)phosphine (TCEP, 1 mg/mL) aqueous solution ( for 5% 8.2 µL, 1% 1.7 µL) 
and 100 µL HEPES buffer was added. The reaction mixture was agitated in the dark for 16 
hours. Then three cycles of wash and centrifugation (6000 rpm, 10 min) were performed to 
remove unreacted FITC-tat and the stomatocytes pellet was redispersed with MilliQ water 
(4 mg polymer/mL).
functionalization of amine ended poly(ethylene glycol)-b-polystyrene stomatocytes with 
fluorescein isothiocyanate (fitc)
The amine exposed poly(ethylene glycol)-b-polystyrene (2.5 mg polymer/mL) stomatocytes 
solution (800 µL) was diluted with 200 µL of borate buffer (pH 9, 80 mM), followed by 
addition of fluorescein isothiocyanate (FITC) in DMSO (2 mg/mL, for 5% 20 µL, 1% 4 µL). 
The reaction mixture was left to stir in dark before ultrafiltration for three times to remove 
unreacted FITC.
Transmission electron microscopy (TeM)
Samples were prepared with the following protocol: 6 μL of diluted sample aliquots were 
dropped onto carbon-coated copper grids. Excessive liquid was removed with filter paper 
and the grid was dried overnight at room temperature. Image acquisition was performed 
with iTEM software (Olympus).
dynamic light scattering (dls)
Dynamic light scattering analysis of PtNP in aqueous solution and zeta potential 
measurement of functionalized stomatocytes were performed using a Malvern Zetasizer 
Nano S instrument. Samples were typically loaded in Malvern disposable capillary cells.
procedure to measure motion of nanomotors by nanosight
To investigate the motion of stomatocytes nanomotors, nanoparticle tracking analysis was 
carried out with a nanosight LM10 at a magnification of 20x. The nanoparticle tracking 
analysis provides visualization of the particles. We used this technique to study the effect of 
fuel concentration on the movement of the stomatocytes. In this experiment we analysed 
the movement of PtNP loaded stomatocytes at four concentrations of hydrogen peroxide 
(final concentration 0 v/v %, 0.015 v/v %, 0.06 v/v %, 0.15 v/v %). 30 μL of Milli Q water 
or freshly prepared hydrogen peroxide (5 v/v %, 2 v/v %, 0.5 v/v %) was added to 1 mL 
stomatocyte nanomotors solution with the appropriate concentration (6×108 particles/
mL) before loading into the sample cell. A typical video of 90 seconds was recorded. By 
analyzing the video, x, y coordinates of each particle were determined as a function of 
time intervals. Mean square displacements obtained by averaging over 25 particles from 
the major size distribution observed with Nanosight were plotted versus the time intervals. 
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cell culture and cellular uptake evaluation by confocal microscopy and flow cytometry
HeLa cells were cultured in a T flask at 37 °C with Dulbecco’s modified Eagle’s medium 
(DMEM) buffer which was supplemented with 100 U/mL penicillin, streptomycin and 10% 
fetal bovine serum. When reaching 90% confluency, cells were harvested by trypsinization 
and centrifugation at 1000 rpm for 5 minutes and then resuspended in fresh culture 
medium (2×105 cells/mL) before being seeded into 8 well micro dish (ibidi GmbH) and 
incubated overnight. After removing the cell culture medium, the cells were rinsed with 
PBS for 3 times and incubated with 200 µL FITC PEG-PS stomatocytes or FITC-tat PEG-
PS stomatocytes (particle concentrations were kept constant at 7×109 particles/mL, as 
determined with nanoparticle tracking analysis) with hydrogen peroxide free or hydrogen 
peroxide added (final hydrogen peroxide concentration is 0.015%) in DMEM buffer at 37 
°C  for 6 hours. After 6 hours, the culture medium was removed followed by two washing 
steps with PBS. Then the cells were stained with live cell nucleus dye Hoechst 33342 and 
cellmask deep red cell membrane dye before another washing step with PBS and addition 
of fresh DMEM buffer. The cellular uptake was examined with a confocal microscope (Leica 
TCS SP2 AOBS). FITC was excited with an Ar laser at 488 nm and the emission was collected 
at 510 – 530 nm. The laser beam was focused on the sample through a 63x oil immersion 
objective. A pinhole of 400 was selected. For cellular uptake analysis with flow cytometry, 
culture medium was removed from the well after 6 hours of incubation followed by one 
washing step with PBS. Then cells were detached by trypsinization (trypsin-EDTA) for 5 
minutes. The cells were collected by centrifugation (1000 rpm, 5 min) and resuspended 
in PBS supplemented with 1% BSA before measurement with a flow cytometer (laser line 
488 nm).
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4.1   InTroducTIon
Synthetic nano- and micro-motors have become a central research topic since the report 
of their first prototype, centimeter sized motor.[1] In mimicking natural molecular motors[2] 
or moving micro-organisms,[3] these motors convert locally supplied chemical energy into 
motion, showing prospects in revolutionizing various fields such as microsurgery,[4] targeted 
drug delivery,[5] sensing,[6] imaging[7] and environmental remediation[8]. However, motors in 
general and especially nanoscale motors, are susceptible to random fluctuations,[9] therefore 
navigation of autonomous motors remains challenging. Compared to natural motors, 
synthetic motors are insufficient to perform complex functions. To tackle this challenge, 
recent efforts have been dedicated to develop motors able to respond to environmental clues 
such as temperature,[10] external field[11] and light.[12] Only few recent reports[13] have shown 
that motors can navigate themselves according to local stimuli and stimulatory gradients. 
Among these, magnetic field and magnetic field gradients provide a wireless, non-invasive 
way to gain control over the motion of these motors. In nature, magnetotactic bacteria 
(Magnetospirillum Magnetotacticum) which possess iron oxide crystals in their body[14] 
can sense the external magnetic field and reorient themselves to the direction of Earth’s 
magnetic field. Inspired by this, we set out to explore the possibility of gaining directional 
control by integrating magnetic segments into our supramolecular motors[5c] (Figure 4.1) and 
steer the motor using both a magnetic field gradient as well as by changing the direction of a 
homogeneous magnetic field. Due to their minimal invasive nature, external magnetic fields 
are compatible with most living systems and widely used for drug delivery[15] and imaging[16]. 
When compared with optical, electrical or acoustic fields, magnetic fields offer the highest 
flexibility concerning achievable forces.[17] Using magnetic fields to remotely manipulate 
nanomotors in a biological medium allows safe maneuvering.[18] However it remains a 
question whether dynamic motors could be precisely manipulated at nanometer scale and 
move within a micron sized confined space such as a tumor tissue-related environment.
Here we demonstrate the design of magnetically actuated stomatocyte nanomotors, 
which achieve guided autonomous motion. Going beyond the conventional top-down 
method to incorporate a magnetic component,[19] we adopted a bottom-up approach 
which is familiar to natural systems and introduced magnetic metallic nickel in situ with the 
catalytic platinum nanoparticles (PtNP). In this way the geometric asymmetry of the system 
was not compromised and the co-presence of both nickel and platinum in stomatocytes 
was ensured. The movement of our original supramolecular nanomotors was powered 
by catalytic decomposition of hydrogen peroxide, which is an interesting biologically 
relevant signaling compound related with tumor cell metastasis and invasion.[20] After 
incorporating the magnetic nickel component, the synthetic motor was able to function in 
dual mode (catalytically powered by PtNP or magnetically powered by magnetized nickel). 
Furthermore, this design also provided the possibility for simultaneous guiding and steering 
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of catalytically powered motors with additional magnetic fields. A human cervical cancer 
(HeLa) cell laden collagen gel matrix was used as a tumor tissue model to demonstrate the 
guided motion of nickel incorporated nanomotors. Being in the nanometer scale regime, 
the nanomotors were readily guided into the micrometer sized gel mesh. In addition, like 
other self-assembled motors,[21] the supramolecular motors can be easily fabricated and 
easily loaded with drugs and have good biocompatibility in a biological setting. Able to 
operate with multiple energy sources, nanomotors presented in this chapter promise to 
expand the applicability of the motors in biomedicine. 
4.2. results aNd discussioN
Figure 4.1.  Preparation scheme of doxorubicin incorporated, platinum-nickel loaded stomatocytes.
Bowl shaped polymersomes or stomatocytes were assembled from diblock polymer 
poly(ethylene glycol)44-b-polystyrene190 via a controlled shape transformation.
[22] The 
poly(ethylene glycol) segment allows the vesicles to be biologically stealthy and reduces 
the possibilities of immune attack and clearance. By adding preformed dendritic platinum 
nanoparticles into the polymer organic solution during self-assembly, nanoparticles were 
entrapped into the outer cavity of the stomatocytes (Figure 4.1). The loaded platinum 
nanoparticles serve as catalyst to decompose hydrogen peroxide into oxygen and are 
responsible for the propulsion of the entire system. Fluorescent anticancer drug doxorubicin 
(Dox), as a model drug, was mixed with the organic solvent containing the polymer, and 
was enclosed in the original lumen of the stomatocyte. After self-assembly and shape 
transformation into doxorubicin- and PtNP-loaded stomatocytes, metallic nickel was grown in 
situ directly onto the platinum nanoparticles which served both as catalyst and substrate.[23] 
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Figure 4.2.  EDX mapping of a) platinum, yellow; b) nickel, green; c) corresponding STEM image of the assembled 
nanomotors, scale bar is 100 nm; d) 3D surface plot profile over the cross section of a doxorubicin platinum-nickel 
loaded stomatocyte, indicated by the red square in a) and b), giving intensity (z axis) with distance over the cross 
section (x, y axis); e) confocal fluorescence microscope image of doxorubicin platinum-nickel loaded stomatocytes, 
scale bar represents 1 µm; f) concentration of platinum and nickel by ICP-MS; g) comparison of reaction rate of platinum 
catalyzed tetramethylbenzidine-H2o2 reaction for doxorubicin platinum loaded stomatocytes (before nickel growth or 
nickel growth time 0 hours, blue) and doxorubicin platinum-nickel loaded stomatocytes with different nickel growth 
times of 1 hour (green), 2 hours (red), 3 hours (purple) and 5 hours (cyan).
Figure 4.1 summarizes the experimental procedure for preparing the platinum-nickel loaded 
stomatocytes. In the presence of reducing agent hydrazine, a nickel ion-hydrazine complex 
was first formed, followed by the reduction to metallic nickel by the platinum catalyst. No 
additives or stabilizers were needed.  The reduction reaction was allowed to run at 40°C 
for 2 hours. After 2 hours, the reaction was stopped. Ultrafiltration was used to remove 
unreacted hydrazine and nickel ions before the Energy-dispersive X-ray spectroscopy 
(EDX) analysis. EDX was used to show the element distribution of the structure (platinum, 
yellow color and nickel, green color) (Figure 4.2a-c). ImageJ 3D surface plot plugin was 
used to analyze EDX mapping data, allowing the imaging of the elements distribution in 
all directions. At a rotation angle of 0°, it was shown that nickel (green color) covered the 
surface of this side (Figure 4.2d) and increased the surface thickness. When changing the 
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rotation angle to 120°, it could still be observed that nickel (green) was deposited on the 
surface (Figure 4.3a, pointed by the red arrow) while in certain areas platinum (yellow) was 
still present on the surface (Figure 4.3a, pointed by the blue arrow). 
Figure 4.3.  3D surface plot profile of a cross section of platinum loaded stomatocytes after growing nickel for 2 hours, 
giving intensity (z axis) with distance of the cross section (x, y axis), platinum, yellow and nickel, green; a) at an angle of 
120°, The cross section is indicated by the red square in Figure 4.2a, b. b) 2D plot profile of intensity versus distance of 
direction 1, pointed by red arrows; c) 2D plot profile of intensity versus distance of direction 2, pointed by blue arrows.
Figure 4.4.  Selected area electron diffraction pattern of one platinum-nickel loaded stomatocyte. The obtained index 
of the rings and interplanar distance confirm the presence of nickel metal. 
Inductively coupled plasma emission-mass spectrometry (ICP-MS) further confirmed the 
presence of nickel (Figure 4.2f). High magnification TEM in the selected area of one platinum-
nickel loaded stomatocyte, showed the diffraction pattern typical for crystalline metallic 
nickel, demonstrating again the presence of nickel (Figure 4.4). As mild conditions were used 
for the reaction, the in situ growth of nickel did not induce a change of the stomatocyte 
morphology or encapsulation efficiency, as was observed from representative TEM images 
of only platinum loaded stomatocytes and platinum-nickel loaded stomatocytes (Figure 4.5). 
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Figure 4.5.  TEM images of (a, b) doxorubicin and platinum nanoparticles loaded stomatocytes; (c, d) doxorubicin and 
platinum-nickel loaded stomatocytes, scale bar represents 100 nm.
Figure 4.6.  Cryo-TEM images at different rotation angles from -45° to 45 ° of doxorubicin and platinum-nickel 
nanoparticles loaded stomatocytes, scale bar represents 100 nm. 
For platinum loaded stomatocytes, the positioning of the platinum nanoparticles in the 
cavity of stomatocytes has been demonstrated with TEM tomography in a previous report 
by our group.[24] In the case of doxorubicin platinum-nickel loaded stomatocytes, cryo-TEM at 
different rotation angles along the x-axis was performed, showing as expected, the entrapment 
of the particles inside the cavity of the stomatocytes (Figure 4.6). The fluorescence signal 
present inside the stomatocytes demonstrated the successful loading of the fluorescent 
antitumor model drug Dox (Figure 4.2e). The fluorescence of Dox facilitates the tracking of 
motion with confocal fluorescence microscopy. After growing nickel in situ, catalytic activity 
of platinum was examined to assess whether the hydrogen peroxide decomposing capability 
was maintained. Adding a solution of platinum-nickel loaded stomatocytes to concentrated 
hydrogen peroxide (0.5% v/v) led to bubble formation, indicating the preserved catalytic 
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activity. To quantitatively determine the catalytic activity, a 3,3’,5,5’-tetramethylbenzidine-
h2o2 assay was used.
[25] 3,3’,5,5’-tetramethylbenzidine (TMB) was oxidized by hydrogen 
peroxide in the presence of platinum nanoparticles to blue 3,3’,5,5’-tetramethylbenzidine 
diimine and the reaction speed was quantitatively related with the catalytic activity of 
platinum. As demonstrated in Figure 4.2g, catalytic activities experienced a decrease after 
nickel growth for 2 hours, yet a clear residual activity was still present. 
We speculate that the preservation of Pt catalytic activity is caused by a partial surface 
coverage of the platinum nanoparticles by the nickel layer and the high branching and 
porosity of the dendritic platinum nanoparticles. It was speculated that catalytic activity 
can be therefore preserved as long as the grown nickel does not form a complete shell 
over the particle which can block all the catalytic branches. To verify this, we followed 
the reduction process of the nickel precursor in time and explored different nickel growth 
times of 1 hour, 2 hours, 3 hours and 5 hours. A decrease in the catalytic activity was 
observed with increasing the reduction time/nickel growth time (Figure 4.2g). However the 
catalytic activity of platinum was preserved with nickel growth times shorter than 5 hours, 
indicating a partial coverage of the platinum surface. After growing nickel for 5 hours, 
platinum catalytic activity was finally hindered, indicating that 5 hours is the time point for 
complete coverage and formation of a closed nickel shell. 
After confirming the structure of doxorubicin platinum-nickel loaded stomatocytes, we 
next tested the magnetic response of nickel containing stomatocytes. An NdFeB magnet 
(12 mm× 12 mm×12 mm) was used to generate a magnetic field gradient. With a hand held 
gauss meter, the decay of field strength with increasing distance from the magnetic pole 
was verified and measured (Figure 4.7a). The gradient field resulted in movement of the 
doxorubicin platinum-nickel loaded stomatocytes to the vicinity of the magnet, which was 
clearly visible as demonstrated by the inhomogeneous distribution of the particles in the 
bulk solution (Figure 4.7 b, c). 
Figure 4.7.  a) Plot of field strength with increasing distance away from the magnetic pole; Photographs of doxorubicin 
and platinum-nickel loaded stomatocytes b) in the absence of magnet and c) in the presence of magnet. The 
gradient magnetic field generated by the NdFeB magnet (12 mm× 12 mm× 12 mm) resulted in a movement of the 
doxorubicin platinum-nickel loaded stomatocytes to the vicinity of the magnet while the bulk solution became visibly 
inhomogeneous.
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Figure 4.8.  a) Schematic illustration of the doxorubicin platinum-nickel loaded stomatocytes movement to the left 
towards higher gradient magnetic field generated by an NdFeB magnet; Moving paths over 5 consecutive frames 
(time intervals= 268 ms) of the doxorubicin platinum-nickel loaded stomatocytes b) at position 0 (1 ± 0.1 cm away 
from the magnet) magnet-induced; c) at position 1 (3.5 ± 0.1 cm away from magnet) magnet-induced; d) at position 
1, magnet/hydrogen peroxide induced. Starting points were normalized to the point of origin; e) summary table 
of translation velocity, directionality and displacement of center of mass for doxorubicin platinum-nickel loaded 
stomatocytes at position 0 with magnet in the left (25 stomatocytes analyzed), at position 1 with magnet in the left 
(26 stomatocytes analyzed) or at position 1 with both magnet and hydrogen peroxide (24 stomatocytes analyzed); f) 
Schematic illustration of the experimental set-up for homogeneous magnetic field generated by two parallel magnets; 
g-j) Confocal fluorescence images of the doxorubicin and platinum-nickel loaded stomatocyte movement in hydrogen 
peroxide solution (1.5% v/v) and their sequential steering by changing the direction of the field, time interval between 
video snapshots = 2304 ms, scale bar is 10 µm.
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To remotely control the motion, magnetized nickel containing stomatocytes were exposed 
to the gradient magnetic field and visualized with confocal microscopy. When the magnet 
was placed to the left, collective motion of stomatocytes towards areas of higher field 
strength (left area) was observed (Figure 4.8a scheme). At a distance of 3.5 cm away (max 
distance used) from the magnet, the magnetic force of magnetized nickel was still sufficient 
to direct the motion of the stomatocytes. The field strength applied yielded approximately 
a magnetic torque of 6.0 × 10-19 J on the stomatocyte nanomotors. This was calculated 
from the formula τ = μ × B (where μ is the magnetic dipole moment μ  = M × mni = 12 
emu/g × 1.1 × 10-14 g; M, the saturation magnetization is the reference value[26] while mni or 
mass of nickel assuming a thickness of nickel layer of 25 nm (from EDX data); B is the field 
strength 50 Gauss), exceeding the value of rotational thermal energy (2.06 × 10-21 J) by 2 
orders of magnitude. The nickel-containing stomatocytes navigated towards the magnet 
at the left as indicated by the trajectory path (Figure 4.8b-d). Three parameters: average 
velocity, directionality and displacement of center of mass were used to quantitatively 
evaluate the directed motion. Directionality, averaged value of euclidian distance divided 
by accumulated distance, is a measure of the straightness of motion. The displacement of 
center of mass describes the average spatial distance between the starting and end point 
of the stomatocytes, which indicates the migration length. The applied magnetic field could 
provide a driving force as well as a guiding force to stomatocytes, as illustrated in Figure 
4.8b-d, at both position 0 and position 1, respectively 1.0 ± 0.1 cm and 3.5 ± 0.1 cm away 
from the magnet. From Figure 4.7a, the exerted field strengths at the two distances were 
estimated to be 732 ± 28 Gauss and 50 ± 1 Gauss, respectively (hence a gradient of 1576 
Gauss/cm and 67 Gauss/cm).  
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Figure 4.9.  Velocity distribution of doxorubicin and platinum-nickel loaded stomatocytes motors a) with magnet at 
position 1; b) with magnet at position 0; c) with magnet and 0.025% hydrogen peroxide at position 1; d) with magnet 
and 0.25% hydrogen peroxide at position 1; e) with magnet and 1.5% hydrogen peroxide at position 1.
By moving towards the magnet, the stomatocyte motors experienced an increase in average 
velocity from 10.4 (position 1) to 15.0 µm/s (position 0) as well as a change in directionality 
from 0.64 to 0.85 (for velocity distribution of stomatocyte motors at both positions, see 
Figure 4.9a, b). The driving force increases with a decreased distance from the magnet. 
This is because gradient force increases as well as a higher torque induced by increasing 
field strength. When both a magnetic field and a hydrogen peroxide solution (1.5% v/v) 
were present (Figure 4.8d), at position 1 the translation velocity and displacement of 
center of mass experienced were increased to 13.1 µm/s and 8.0 µm (compared to 10.4 
µm/s and 5.2 µm for the magnet-only system, Figure 4.8c). Therefore the combination of 
hydrogen peroxide fuel and magnetic attraction led to a directional motion towards the 
magnetic pole, yet at a higher velocity compared to applying the magnetic field alone. In 
the presence of the magnet and at position 1, the influence of different hydrogen peroxide 
concentrations over the movement was investigated. The stomatocyte motors moved 
faster with increasing levels of hydrogen peroxide (Figure 4.9c, d, e). Hydrogen peroxide 
is a bio-relevant chemical overproduced by human tumor cell lines[20] although there are 
also reports about its potential harm to cells including DNA lesions.[27] Here we used it 
as a proof of concept to use bio-relevant chemicals for propulsion. Attraction towards 
the magnet was not disturbed at all these hydrogen peroxide levels. In the absence of 
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both fuel and magnetic field, typical Brownian motion was observed (Figure 4.10a). The 
displacement of the center of mass was 2.0 µm. No favored moving direction was observed. 
The directionality was 0.45, significantly lower than in the presence of magnetic field/
hydrogen peroxide. The average mean square displacement (MSD) versus time interval 
curve (Figure 4.10b) showed a linear fit typical for Brownian motion, demonstrating that 
the stomatocytes move with random motion when without fuel and magnetic field. 
Figure 4.10.  a) Tracking paths over 5 consecutive frames (time interval = 268 ms) of doxorubicin and platinum-nickel 
loaded stomatocytes without magnet/hydrogen peroxide (20 trajectories); b) average MSD versus time interval of the 
doxorubicin and platinum-nickel loaded stomatocytes motors in the absence of both hydrogen peroxide and magnetic 
field.
In addition to velocity as discussed above, moving direction can be governed by the profile 
of the applied field. Nickel-containing stomatocytes could readily sense the position change 
of the magnet and reorient their motion accordingly (Figure 4.11). The reorientation could 
be achieved repeatedly.
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Figure 4.11.  Tracking paths over 5 consecutive frames (time interval = 268 ms) of doxorubicin and platinum-nickel 
loaded stomatocytes after magnet position changed from left to top.
 
Besides the gradient field, we can also apply a homogeneous magnetic field by sandwiching 
the magnetized doxorubicin platinum-nickel loaded stomatocytes solution between two 
parallel magnets (NdFeB magnet, 12 mm× 12 mm×12 mm). By changing only the direction 
of the magnetic field (Figure 4.8g-j) not the positions of the magnets, we could precisely 
control the moving direction of the motors. After removing the external homogeneous field, 
dispersive movement with no favoured direction was observed. To test the transportation 
abilities of the stomatocyte motors in tissue, a tissue model was established by using 
microfluidic technology (illustrated in Figure 4.12). The micro slide consists of two chambers, 
which are connected through a narrow channel in the middle. In mimicking tissue,[28] firstly 
collagen (1 mg/mL) was used to form a gel network (mesh size approximately 10 µm, in 
agreement with previous report[29]) (Figure 4.12a, c, scanning electron microscope image 
and bright field image) in the left chamber and middle channel. After the gel formation, 
a diluted motor solution was added to the right channel. A low concentration of motors 
was used to avoid instant formation of bundles and hindered entrance into gel (2.8 × 109 
particles/mL). The motors demonstrated Brownian motion. 
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Figure 4.12.  a) Cryo-SEM image of gel matrix, scale bar = 10 µm; b) SEM image of doxorubicin and platinum-nickel 
loaded stomatocytes, scale bar = 100 nm; c) confocal bright field image of gel matrix, scale bar = 10 µm; d) fluorescent 
image of doxorubicin and platinum-nickel loaded stomatocytes, scale bar represents 1 µm; e) scheme of the magnetic 
guidance of doxorubicin and platinum-nickel loaded stomatocytes towards the gel matrix; f-k) Doxorubicin platinum-
nickel loaded stomatocytes could be guided through a collagen gel matrix by applying an external magnetic field 
(particle in red circle), video snapshots, time intervals 1.34 s, scale bar = 10 µm.
Then a magnet (NdFeB, 12 mm× 12 mm×12 mm) was placed on the left. Figure 4.12 f-k 
shows the gel boundary area. Stomatocyte motors could sense the magnetic field and 
be readily guided towards the gel mesh on the left. Upon entering the gel matrix (the 
blue arrows in Figure 4.12f point to the fibrils in a triangular gel mesh), the nanomotors 
demonstrated a guided motion through the gel mesh. 
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Figure 4.13.  The tracking paths over 5 consecutive frames (time interval = 268 ms) of doxorubicin and platinum-nickel 
loaded stomatocytes through the gel mesh.
 
Figure 4.14.  a) Schematic representation of the magnetic guidance of doxorubicin and platinum-nickel loaded 
stomatocytes through HeLa cell laden gel matrix; b) confocal bright field image of HeLa cell laden gel, scale bar 
represents 10 µm; c-e) Doxorubicin platinum-nickel loaded stomatocytes could be guided towards a cell in the collagen 
gel mesh by applying an external magnetic field (particle pointed by the red arrow), left: bright field, right: fluorescent 
field, tracking trajectories over 3 fames, time intervals 268 ms, scale bar = 10 µm.
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The velocity of motors was 12.4 µm/s. The tracking path of motors was shown in Figure 
4.13. Tuning the collagen concentration can vary the gel mesh density/crosslinking density 
of the collagen gel. By increasing the concentration to 1.5 mg/mL from 1 mg/mL, we 
obtained a gel with a decreased mesh size of 6 µm, which is in agreement with the literature 
data.[29] At this gel pore size, the movement of the stomatocytes remained unhindered 
in their guided motion towards the magnetic pole. After demonstrating the possibility of 
achieving guided motion in a pure gel, we replaced it with a gel loaded with human cervical 
cancer HeLa cells as a mimic of a tumour tissue. Figure 4.14a shows schematically the 
experimental design of magnetic guided motion of nickel containing stomatocytes towards 
the cell-laden gel. After placing the magnet to the left, doxorubicin and platinum-nickel 
loaded stomatocytes moved forward towards the magnet and travelled through the HeLa 
cell laden gel matrix. Collective motion towards left where the magnetic field strength was 
stronger was observed.
4.3. coNclusioN
We fabricated magnetic nanomotors by using a convenient and mild bottom-up approach 
and presented a method to achieve directional control over nanometer scale stomatocyte 
motors. The nickel-platinum particles incorporated into the stomatocytes allowed both 
hydrogen peroxide/magnetic locomotion and remote magnetic guidance. Finally we have 
also shown that nanomotors can be guided through a tissue model formed from a collagen 
gel. Capable of steerable motion at a relatively high speed, the motors could transport 
drug molecules in a targeted specific way and hold promise for precise localized tissue drug 
delivery. 
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4.5. experimeNtal sectioN
Materials
Poly(vinyl pyrrolidone) (MW10000), potassium tetrachloroplatinate (II), L (+) ascorbic acid, 
hydrazine monohydrate, dimethylformamide, 3,3’,5,5’-tetramethylbenzidine (TMB) and 
collagen solution from bovine skin were purchased from Sigma-Aldrich. Doxorubicin (Dox) 
was purchased from Bioconnect BV. Nickel chloride anhydrous was obtained from Alfa 
Aesar. Spectra/Por dialysis membrane with a MW cut-off of 12000-14000 Da was used 
for dialysis. All aqueous solutions were prepared with MilliQ water, purified with a MilliQ 
QPOD purification system (18.2 MΩ).
Instruments 
1H nuclear magnetic resonance spectra (1H NMR) were performed on a Varian Inova 400 
MHz spectrometer, with CDCl3 as solvent. Gel permeation chromatography (GPC) was 
obtained on a Shodex GPC column equipped with UV SPD 20A detectors (254 nm, 215 nm). 
THF was used as eluent and the flow rate was kept constant at 1 mL/min. Dynamic light 
scattering (DLS) analysis was performed on a Malvern Zetasizer Nano S with the following 
settings: temperature 25 °C, He-Ne laser wavelength 633 nm and detector angle 173°. 
Inductively Coupled Plasma - Mass Spectrometry (ICP-MS) measurement was carried out 
with a Thermo Fisher Scientific Xseries I quadrupole machine. For transmission electron 
microscopy (TEM), a JEOL 1010 Transmission Electron Microscope with MegaView Soft 
Imaging camera at an acceleration voltage of 60 kV was used. Energy-dispersive X-ray 
spectroscopy (EDX) and selected area electron diffraction (SAED) were performed on a JEOL 
TEM 2100 with high-quality Gatan 895 ultrascan 4000 bottom mount camera (4080x4080 
pixels) incorporated. A Bruker Quantax EDS system with an STEM detector incorporated 
was used for element mapping (platinum and nickel). Scanning electron microscope 
(SEM) images were recorded on a JEOL 6330 field emission scanning electron microscope. 
Magnetic field strength was measured with a hand held Gaussmeter HGM09s (MAGSYS 
magnet system GmbH). 
synthesis of poly(ethylene glycol)
44-b-polystyrene190 (Peg44-b-Ps190)
The block copolymer poly(ethylene glycol)44-b-polystyrene190 was synthesized via the 
atom transfer radical polymerization method. The polymerization process was monitored 
by determining the molecular weight of the block copolymer with 1H NMR and GPC. The 
reaction was terminated once the desired MW of 21 kg/mol was attained. 
preparation of platinum nanoparticles (ptNp) with pvp coating
To 2 mL K2PtCl4 (20 mM), 20 mg poly(vinyl pyrrolidone) (PVP, MW≈ 10,000) was added. The 
solution was left to stir at room temperature. After 48 hours, 1 mL ascorbic acid (0.2 M) was 
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added to the above solution. Then the mixture was incubated in a sonication bath (VWR 
Ultrasonic Cleaner Model 75D) at room temperature for 1 h. Average size of particles was 
determined to be 70 nm with DLS.
preparation of the dox and platinum nanoparticles (ptNp)-loaded stomatocytes
Poly(ethylene glycol)44-b-polystyrene190 (10 mg) was allowed to dissolve in 1 mL organic 
solvent mixture (tetrahydrofuran:dioxane = 4:1) for 30 min. Then 0.05 mg doxorubicin 
solution in DMF was added. After stirring for 5 minutes, MilliQ water (0.35 mL) was 
delivered to the solution with a syringe pump (1 mL/h), followed by addition of 0.65 mL 
PtNP aqueous solution. After delivery, the mixture was sealed in a dialysis bag and dialyzed 
for 48 hours. With dynamic light scattering (DLS), the diameter of the obtained structures 
was determined to be 308 nm. 
preparation of the dox and platinum-nickel loaded stomatocytes
The above obtained Dox and PtNP loaded stomatocytes solution (500 µL) was ultra-filtered 
(Ultrafree-MC VV Centrifugal filter, pore size 0.1 µm, EMD Millipore) for 5 times to remove 
free PtNP and resuspended with MilliQ to 500 µL. To the solution, an aqueous nickel 
chloride solution (1.7 x 10-2 M, 1 mL) was added. The mixture was left to stir for 20 minutes 
before addition of hydrazine (17 µL). Then the mixture was stirred vigorously for 2 hours. 
After reaction ultrafiltration was used to remove unreacted nickel ions, salts and hydrazine. 
inductively coupled plasma-mass spectrometry (icp-ms) measurement
The purified Dox and platinum-nickel loaded stomatocytes solution (10 µL) was destructed 
in 65% nitric acid (1.5 mL) at 80 °C for 3 hours. Then the volume was adjusted to 10 mL with 
MilliQ before measurement with Thermo Fisher Scientific Xseries I quadrupole machine. 
Transmission electron microscopy (TeM)
6 μL of diluted sample aliquots were casted onto carbon-coated copper grids. The grids 
were allowed to dry overnight at room temperature. Image acquisition was performed 
with iTEM software (Olympus). 
determination of platinum catalytic activities
To prepare 3,3’,5,5’-tetramethylbenzidine (TMB) assay solution, TMB in DMF solution (250 
μL) was mixed with 300 μL hydrogen peroxide solution (30%, v/v). To the above mixture 
4450 μL sodium citrate-citric acid buffer (pH = 4) was added. The catalytic reaction was 
carried out at 25 °C with 2 μL Dox and platinum-nickel loaded stomatocytes/Dox or platinum 
loaded stomatocytes (particle number maintained the same 3 × 1011 particles/mL) in 238 
μL of TMB assay solution. For particle number measurement, NanoSight NS 500 (Malvern 
instrument) was used. A sample solution was pumped into the sample chamber. Then five 
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videos were recorded (rate 30 frames/s, each video duration time 60 s) and processed 
with Nanoparticle Tracking Analysis software. Particle concentration was obtained by 
determining the average particle number in one frame. Reaction kinetics were monitored 
by recording absorption at 650 nm with a microplate reader (TECAN, Infinite 200).
scanning electron microscopy (sem) sample preparation
For SEM visualization of the gel matrix structure, a JEOL 6330 field emission scanning 
electron microscope was used. 200 μL collagen gel matrix was rapidly frozen in liquid 
nitrogen and freeze fractured in the cooling prechamber of the microscope. After etching 
for 5 min, the sample was subjected to palladium-gold sputtering before transferring to 
the SEM microscope chamber maintained at -120 °C. For Dox and platinum-nickel loaded 
stomatocytes, 6 μL of diluted aliquots were casted onto carbon-coated copper grids. 
The grids were allowed to dry overnight at room temperature and then sputtered with 
palladium-gold (Cressington 208HR sputter coater) before analysis with the microscope.  
magnetic guided motion in solution 
A confocal fluorescence laser scanning microscope (Leica TCS SP2 AOBS) was used to record 
the motion. The laser beam (488 nm argon laser) was focused on the sample through a 63x oil 
immersion objective. A pinhole of 400 μm was selected. Emission of particles was detected 
using a band pass 530-620 nm. To visualize particle motion, time lapse series were recorded 
(100 frames, time interval between each frames ∆T = 268 ms). Bidirectional scanning mode 
was used and the scanning speed was set at 1000 Hz to ensure a minimal time interval of 268 
ms. Tracking image sequences were analyzed with ImageJ plugin manual tracking. With the x/y 
coordinates information, the distance a particle travelled within the 268 ms time interval was 
determined. By averaging the velocity of a particle over different time intervals, the average 
velocity of the particle was obtained. For each group 25 nanoparticles were tracked and 
the velocity determined, giving a final average velocity. The propulsion was performed with 
µ-Slide 8 Well (ibidi). For magnetization, 200 μL Dox and platinum-nickel loaded stomatocytes 
aqueous suspensions were magnetized by collecting them at the side of an eppendorf tube 
(1 mL) with a magnet for 1 min and redisperse them before being transferred to the well 
of µ-Slide. When an external magnetic field was applied, the stomatocyte nanomotors in 
solution gradually assembled to form chain-like structures (after 15 minutes). The as-formed 
chain-like bundles could be aligned in the direction of the field. Such self-assembly behaviour 
was not observed for platinum-only loaded stomatocytes. For dual mode propulsions, the well 
was filled with 200 μL magnetized Dox and platinum-nickel loaded stomatocytes hydrogen 
peroxide solution. For magnetic steering, by changing the field direction of the homogeneous 
field, magnetized Dox and platinum-nickel loaded stomatocyte suspensions were placed in a 
µ-Slide well between two parallel magnets (NdFeB magnet, 12 mm× 12 mm×12 mm), which 
generate constant field strength of 210 Gauss in the well for measurement and observation.
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cell culture
HeLa cells were cultured in a T flask at 37°C with Dulbecco’s modified Eagle’s medium 
(DMEM) buffer, which was supplemented with 100 U/mL penicillin, streptomycin and 10% 
fetal bovine serum. When reaching 90% confluency, cells were harvested by trypsinization 
and centrifugation at 1000 rpm for 5 minutes and then re-suspended in fresh culture 
medium (2×105 cells/mL) before use. 
magnetic guided motion in gel
For fabricating a gel matrix with mesh size of approximately 10 μm, the pH of 300 μL collagen 
solution (3 mg/mL) was adjusted to neutral with 21 μL of sodium bicarbonate (7.5%) in an 
ice bath and diluted to a final volume of 900 μL (collagen concentration 1 mg/mL). To 
obtain a gel with a mesh size of 6 μm, 150 μL collagen solution (3 mg/mL) was mixed with 
10 μL of sodium bicarbonate (7.5%), followed by dilution to 300 μL (collagen concentration 
1.5 mg/mL) with (DMEM) buffer. For HeLa cell laden gel matrix with 10 μm mesh size, 
300 μL collagen solution (3 mg/mL) was mixed with 21 μL of sodium bicarbonate (7.5%) 
and diluted with cells suspension to 900 μL. A well-mixed pH-adjusted collagen suspension 
(without/with cells) was obtained after pipetting up and down for several times. Then 
the suspension (65 μL) was added to the left reservoir of a µ-Slide Chemotaxis (ibidi) and 
incubated at 37°C overnight. For magnetic guidance towards the gel matrix, 65 μL of Dox 
and platinum-nickel loaded stomatocytes (2.8 × 109 particles/mL) solution was added to 
the right reservoir of the µ-Slide Chemotaxis.
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5.1. InTroducTIon
Polymersomes are bilayer structures self-assembled from amphiphilic polymers.[1] Both the 
lumen and the polymersome membrane provide high loading efficiencies of hydrophilic 
and hydrophobic cargos, respectively. Being more robust and tunable[2] than their lipid-
based counterparts, polymersomes have attracted increasing attention with regard to 
applications in pharmaceutics,[1b] cosmetics,[3] imaging[4] and catalysis.[5] To fabricate 
these polymersomes, cosolvent methods[6] and rehydration methods[7] have been applied 
traditionally. These methods have the limitation that it is difficult to vary size and they 
usually yield polymersomes with broad size distribution. Post-processing steps, such as 
membrane extrusion[8] and sonication[9] are therefore required to reduce the polydispersity 
of the polymersomes produced. However, these post-treatment steps could lead to 
undesired material membrane interactions and loss of encapsulated cargo.
In order to directly create polymersomes with well-defined sizes, microfluidic techniques 
have been developed. Weitz’s group fabricated monodisperse polymersomes through 
droplet formation using two immiscible liquids.[10] The formed W/O/W double emulsions 
act as templates to form vesicles after removing residual organic solvent.[11] Monodisperse 
micrometer sized vesicles were fabricated in this way.[12] To generate vesicles in the nanometer 
size range, laminar mixing of two miscible liquids in a fluidic channel has been shown to be a 
promising approach.[13] Well-defined nanometer sized vesicles, especially those in the range 
of 50 nm - 200 nm, are important in drug delivery by ensuring a long circulation time in vivo 
and an optimal cellular uptake without interference of the cell metabolism.[14]
Besides size, shape is another important feature that can affect polymersome properties. 
Although a few batch processes are described to create vesicles with non-spherical 
morphologies,[15] to the best of our knowledge no continuous flow procedures have been 
reported on the shape control of polymersomes. In this chapter we report the use of a 
flow device to fabricate nanometer-sized vesicles and nanotubes through laminar mixing 
of a polymer organic solution and water,[16] ensuring high production rate as well as high 
reproducibility. In addition, the ease of combining this vesicle production method with 
cargo loading makes this a versatile method for the preparation of polymeric assemblies 
for various applications.
5.2. results aNd discussioN
For the preparation of the polymeric vesicles, the amphiphilic block copolymer 
poly(ethylene glycol)44-b-polystyrene190 was used, which was synthesized via atom-transfer 
radical polymerization (see experimental section, Figure 5.1).[17] A flow device was used as 
depicted in Figure 5.2. 
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Figure 5.1. 1H NMR spectrum in CDCl
3
 at room temperature of a) PEG initiator δ: 1.94 ppm (s, 6H, (CH
3
)2CBr), 3.38 ppm 
(s, 3H, CH
3
och2), 3.64 ppm (br. s, PEG backbone), 4.33 ppm (t, 2H, CH2ch2OC(O)C(CH3)2Br);  b) poly(ethylene glycol)44-b-
polystyrene190 1.42-2.17 ppm (br. m, PS backbone), 3.38 ppm (s, 3H), 3.56 – 3.66 ppm (br. s, PEG backbone), 6.46 – 7.51 
ppm (br. m, aromatic ring of PS).
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Figure 5.2. The fluidic platform for preparation of polymeric vesicles and nanotubes by varying the mode of collection 
and initial polymer concentration. The polymer dissolved in THF/dioxane was injected into the main channel (C2) and 
brought in contact with water in the two side channels (C1, C3) of the fluidic device.
Figure 5.3. a) confocal microscopy image; b) corresponding bright field image of the section where the flows from 3 
inlets meet, the white arrows point to the phase boundary. The scale bar represents 200 µm. Polymer/Nile red organic 
solution was injected through the middle inlet while aqueous solution was pumped in through 2 side inlets. Polymeric 
structures were formed at the periphery of the two phases.
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An aqueous solution was injected through two side channels while the diblock copolymer 
in an organic solvent (THF/dioxane) solution was introduced in the middle channel (Figure 
5.3). This device is a flow-focusing channel with the continuous phase flanking the dispersed 
one. Flow focusing has been used for the generation of spherical vesicles.[18] For the middle 
phase, both boundaries at the two sides are available for mixing. As both organic solvents 
are miscible with water, the diffusion between the two liquid phases resulted in a solution 
gradient, which induced self-assembly. With a traditional cosolvent method, the self-
assembly process of PEG
44-b-pS190 starts when the THF content drops below approximately 
77%. In the fast fluidic system, the steep solvent gradient at the two-phase boundary led to 
a small distance where the THF/dioxane content dropped to this limit. This short distance 
as well as the high surface to volume ratio resulted in a shortened timescale of mixing.[19]
In the traditional cosolvent method, the formation of structures starts with nucleation of 
a few unimer polymers, followed by a diffusion limited growth in size.[20] The final step is a 
slow exchange of unimer polymers to reach equilibrium. To study this process, copolymer 
was firstly dissolved in the organic solution in a batch experiment. Then water was delivered 
to it via a syringe pump. This process was monitored via dynamic light scattering (DLS) in a 
flow mode.[21] Both relaxation time and vesicle formation kinetics can be derived from the 
plot of the scattered light intensity against time, large positive amplitudes indicating vesicle 
Figure 5.4. Scattered light intensity as a function of time (black squares); the plot was fitted with a double exponential 
function (red curve) I=1-(C1*exp(-t/τ1)+C2*exp(-t/τ2)). Relaxation approach is very useful for kinetics determination in 
liquid phase. In this experiment, the curve can be fitted with a double exponential function indicating a two step process 
involved in the initial stages of vesicle formation before it experience a longer process towards final equilibrium. The τ1 
was derived as 33.7 s while τ2 was obtained as 152.1 s. The time was higher than the mixing time (in the range of 500 
ms – 3 s) in a fluidic channel.
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formation. In the case of the fluidic channel set-up, the calculated solvent mixing time is 
smaller than the aggregation time as determined from the batch experiment (see Figure 5.4). 
In addition, the polymer diffusion inside the organic solvent is two orders of magnitude lower 
than that of the two organic and aqueous phases.[22] The formation of polymeric assemblies 
is therefore dependent on flow rate/hydrodynamic conditions and the induced local polymer 
concentration, leading to kinetically trapped shapes instead of dynamic stable structures.  
As flow rate and polymer concentration are expected to play an important role in control 
of self-assembly, we sought to vary the size and morphology of the structures by tuning the 
mixing factors employing this fluidic device. Additionally we hypothesized that maintaining 
flow conditions or not during collection would also affect the final morphology, so different 
collection methods were studied. 
As initial conditions, we used a concentration of 10 mg/mL of PEG
44-b-pS190 and a flow 
rate of C1:C2:C3 = 10:10:10 mL/h. The self-assembled structures were collected in two 
ways: i) via the “insertion method” in which the collecting tube was inserted into water, ii) 
Figure 5.5.  a) Scanning electron microscope (SEM) images of polymeric nanotubes, scale bar represents 500 nm; b) 
transmission electron microscope (TEM) images of polymeric nanotubes at lower magnification (scale bar = 2 µm); 
c) polymeric nanotubes at higher magnification (scale bar = 500 nm); d) plot profile of a vesicle unit/cross section 
in the polymeric nanotubes indicated by the red dashed line in c); showing intensity as function of distance over 
the cross section; e) size/diameter distribution diagram of the vesicle units in polymeric nanotubes (80 assemblies 
were counted); f) SEM images of polymeric vesicles, scale bar represents 150 nm, the white arrows pointing to the 
openings of stomatocyte vesicles; (g, h) TEM images of fabricated stomatocyte vesicles, scale bar is 100 nm and 50 nm 
respectively; (i, ii) TEM images of a polymersome stomatocyte at a tilting angle of 0° and 20°, respectively; (note the 
top and side view of the stomach) (iii, iv) corresponding 3D intensity profiles of the same stomatocyte, the white arrow 
pointing to the opening of the stomatocyte vesicle.
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via the “dripping method” in which the output was dripped into water. Via both methods 
the outflow of the samples in a large excess of water led to the final vitrification of the 
vesicular structures. For determination of size and shape, the collected samples were then 
characterized by TEM without additional processing. In the case of the “dripping method”, 
vesicles were observed, while notably necklace-like nanotubes were generated via the 
“insertion method”. There are only a few reports about tubular structures, or necklace-
like nanotubes. Helmerson et al. described the fabrication of necklace-like nanotubes 
with poly(butadiene-b-ethylene oxide) using a combination of optical tweezer pulling and 
micropipetting.[15d] In our case, necklace-like nanotubes could be generated in a simple and 
continuous way (Figure 5.5a, b, c).
The nanotube membrane was clearly observed in the TEM images, reflecting its vesicular 
properties. The average diameter of the polymeric nanotubes was 152 nm. (Shown in Figure 
5.5d is the intensity profile of a vesicle unit in a polymeric nanotube. The diameter of this 
vesicle unit was approximately 150 nm.) Average diameter at the neck of the polymeric 
nanotubes was 45 nm. The tube lengths could reach 35 µm at maximum. For tuning the 
length of polymeric nanotubes, shearing forces (introduced by vigorous magnetic stirring) 
during collection were varied. When the stirring rate was increased to 500 rpm and 1000 
rpm, the average tubes length decreased to 10.8 µm and 7.6 µm while the average length of 
tubes obtained without agitation was 14.8 µm (Figure 5.6a-c). In all other cases the outflow 
was collected without stirring. The membrane thickness of the polymeric nanotube was close 
to that of spherical vesicles obtained by the dripping method (20 nm). Polymeric nanotubes 
were only observed with the “insertion method”. Furthermore, sampling of the outflow 
directly from the device exit tube and fast quenching of the structures into liquid nitrogen 
shows the presence of vesicles by TEM. This indicates that the nanotube formation occurs 
outside of the device. We think that the high concentration of flexible vesicles pushed by the 
flow and slowed down at the exit in water as well as the presence of high concentration of 
plasticizing agent in a small local volume facilitate the colliding and merging of the vesicles.
Figure 5.6. TEM analysis of the length of polymeric nanotubes collected with the insertion method a) at a stirring rate 
of 0 rpm; b) at a stirring rate of 500 rpm; c) at a stirring rate of 1000 rpm; For each analysis 80 assemblies were counted.
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Figure 5.7. Transmission electron microscopy image of polymer nanotubes. a) Shown in rectangle is the connecting 
section of two neighbouring vesicles in hemifusion state; b) within the rectangle is the area where two neighbouring 
vesicles are more connected. The scale bar represents 300 nm.
The flow direction and shear force favour the formation of one-directional polymeric 
nanotubes instead of merged large vesicles. The fusion could be indicated by the fact that 
in certain sections, the neighbouring vesicle unit was not completely connected but instead 
shared a center wall and was in a hemifusion state (Figure 5.7a). This was suggested previously 
as an intermediate state of unilamilar polymersomes fusion.[23] Previous reports[24] have 
shown that vesicle to fused nanorod transition occurs two order of magnitude more rapid 
than its reverse way. Therefore we think the likelyhood of first formation of giant vesicles 
and later fission into polymersome necklaces is relatively low. Another possibility to explain 
the nanotube formation was previously suggested to be unimer insertion, however this 
was connected to an experiment in a dilute batch system with no possibility for fusion.
[25] In this case, the growth rate (insertion of new unimers) is faster than the birth rate of 
new vesicles. Due to immiscibility of constitutional polymer chains in the bilayer vesicle 
membrane, one copolymer has to overcome very high-energy barrier to go from the outer 
layer into the inner layer of the vesicles. Therefore the outer membrane would grow faster 
than the inner ones. To reduce the resulting tension, elongated structures are obtained. In 
this case vesicle curvature is expected to decrease. This could be an explanation for the less 
curved section in the nanotubes (Figure 5.7b). 
With the “dripping method”, the vesicles and plasticizing agent were diluted and quenched 
by a large amount of water in a short time, therefore only vesicles were obtained. It is 
interesting to observe that among polymeric vesicles, bowl shaped vesicles/“stomatocytes” 
could be formed (Figure 5.5f, g, h). In Figure 5.5f, the openings of stomatocytes were clearly 
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shown. To be noted only openings facing towards the front were visible in the SEM images. 
In TEM images (Figure 5.5g, h), the polymer membrane fold-in and the formed cavities 
were clear. The stomatocytes structure could account for maximum 54% in the vesicle 
population (based on 155 specimen assessed by TEM). Shown in Figure 5.5i-iv was the 
TEM of stomatocytes at different angles (top view and side view), in which the top view 
of the stomatocyte should be differentiated from the multilamellar vesicle. One possible 
mechanism could be that during the fast mixing process at the interface of two liquid 
phases, the inner compartment of the formed spherical vesicles is still filled with THF/
dioxane. 
With the tuned ratio of THF/dioxane, the swelling extent of PS can be so well controlled 
that the newly formed membrane is only permeable to organic solvent but not to water. 
At the phase boundary, the solvent gradient induced organic solvent outward diffusion and 
evaporation of the organic solvent entrapped inside could be responsible for the formation of 
an osmotic gradient, leading to membrane folding and bowl-shaped structures formation.[26]
Besides the collecting methods, we also explored the impact of initial polymer concentration 
Figure 5.8. a) Morphologies of polymeric structures were tuned by changing collecting methods and polymer 
concentration; b) sizes of vesicles were tuned by changing flow rate; particles intensity percentage was plotted against 
the diameter of the vesicles (dynamic light scattering/DLS data); c) Tuning size/diameter (DLS data) of vesicles by 
changing polymer concentration and flow ratio between main channel and side channel.
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on the morphology. We already know at a concentration of 10 mg/mL vesicles were obtained 
with the dripping method and nanotubes were generated with the insertion method. At 
a lower concentration (1 mg/mL) we found that only vesicles were observed using either 
“insertion method” or “dripping method”, while nanotube structures were observed in both 
cases for the higher initial polymer concentration of 20 mg/mL (Figure 5.8a).
Next, we explored the ability to control the size of the vesicles via modifying the 
hydrodynamic parameters. A low concentration of polymer solution (1 mg/mL) was used 
to avoid the formation of polymeric nanotube structures. The dripping method was used 
to collect outflow from the fluidic channel. Keeping the flow ratio of polymer solution and 
aqueous solution constant at 1:1, the vesicles experienced a decrease in diameter from 
218 to 123 nm when the flow rate was elevated from 5 mL/h to 30 mL/h (Figure 5.8b, DLS 
data). This is a result of the faster mixing process, which leads to a lower local polymer 
Figure 5.9. Vesicle size experienced a decrease by increasing flow rate a) 5 mL/h; b) 10 mL/h; c) 20 mL/h; d) 30 mL/h 
(nanoparticle tracking analysis/NTA data). Shown above are 3D plots of particle size (x axis) vs. intensity (y axis, 100 nm 
per division) vs. particle concentration (z axis).The red bars (within the red dashed circle) represent the main particle 
population. The NTA technique is based on particle-by-particle tracking and can translate the obtained diffusion data 
to size using Stokes- Einstein equation. The NTA approach is not biased towards subgroups in a particle population.
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concentration available to form vesicles. The results were also confirmed with nanoparticle 
tracking analysis (NTA) technique (Figure 5.9). 
This NTA technique allows individual particle detection with a minimum detection limit 
as low as 10 nm. At a constant flow rate of polymer solution and aqueous solution of 30 
mL/h, an increasing trend in size was observed when the initial polymer concentration was 
increased from 1 mg/mL to 10 mg/mL (Figure 5.8c). In addition with a concentration of 1 
mg/mL polymer solution, the size of vesicles decreased from 214 to 189 nm when the flow 
Figure 5.10. a) Schematic illustration of in situ loading of Nile red/platinum nanoparticles into stomatocyte vesicles and 
polymeric nanotubes. The Nile red/polymer in THF/dioxane solution was injected into the main channel (C2); platinum 
nanoparticles aqueous solution was pumped through the two side channels (C1/C3) of the fluidic device into the main 
fluidic channel; b) confocal fluorescent microscopy image of Nile red loaded vesicles, scale bar represents 2 µm; (c, 
d) TEM images of platinum nanoparticles loaded stomatocytes fabricated through the microfluidic method, scale bar 
represents 50 nm; e) confocal fluorescent microscopy image of Nile red loaded vesicles, scale bar represents 500 nm; 
(f, g) TEM images of polymeric nanotubes functionalized with PVP coated platinum nanoparticles. Scale bar is 50 nm.
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ratio of polymer solution and aqueous solution (C2: C1/C3) was changed from 1:1 to 1:2. 
It should be noted that all the vesicles prepared above were narrowly distributed in size as 
indicated by the polydispersity value in Figure 5.8c.
After obtaining the polymeric nanotube and vesicle structures, we investigated the ability 
to incorporate hydrophobic cargo, by mixing the fluorescent dye Nile red with the polymer 
organic solution before injection into the middle channel (Figure 5.10a). An initial polymer 
concentration of 10 mg/mL was used and the flow rate of side and main channels was 
maintained at 10 mL/h. Polymeric nanotubes obtained by insertion method and vesicles 
generated by dripping method could be clearly visualized with confocal fluorescence 
microscopy using Nile red’s fluorescence (Figure 5.10b, e) Since the diffraction limit of the 
confocal microscope is about 200 nm,[27] it could not be differentiated whether Nile red was 
localized on the membrane or the inner compartments. Besides the hydrophobic Nile red, 
the hydrophilic fluorescent drug doxorubicin could also be loaded. (Figure 5.11)
We subsequently explored the possibility of entrapping nanoparticles in the stomatocyte 
and nanotube structures by addition of platinum nanoparticles (PtNPs) to the aqueous 
solution. The initial polymer concentration in THF/dioxane was kept at 10 mg/mL. PtNPs 
were fabricated through reduction of  KPtCl
4 and capped with poly(vinyl pyrrolidone) (PVP, 
MW 10000 Da).[28] The platinum nanoparticles were well dispersed in water (48.9 ± 3.3 nm, 
5.06 ± 0.1 × 1011 particles/mL). With a flow rate of 10 mL/h, PtNPs-loaded stomatocytes 
were obtained with the “dripping method” (Figure 5.10c, d). The PtNPs loading efficiency 
reached approximately 42% (TEM assessment on 50 specimens). Smaller PtNPs loaded 
stomatocytes (189 nm) were obtained, compared to stomatocytes prepared by the 
conventional cosolvent method (325 nm). In previous reports inorganic nanoparticles were 
Figure 5.11. Confocal microscopy fluorescent images of hydrophilic doxorubicin hydrochloride loaded a) nanotubes, 
scale bar = 500 nm; b) vesicles, scale bar = 2 µm.
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loaded into the membrane of polymersomes so only nanoparticles smaller than membrane 
thickness could be loaded.[29] In our case PtNPs were loaded in the cavity of polymersome 
stomatocytes. Therefore there will be no influence on the vesicle membrane and the 
stability of the vesicles. When the “insertion method” was applied, polymeric nanotubes 
were obtained which were functionalized with PtNPs (Figure 5.10f, g). The PVP capped 
PtNPs were found to be preferentially located in the junction of the nanotube where the 
curvature was highest.
5.3. coNclusioN
A fast and simple method has been developed to fabricate self-assemblies with non-
spherical morphology. With our method, nanotubes and stomatocytes could be produced 
in a continuous and well-defined fashion. Furthermore, injection of an aqueous solution 
containing PtNPs into the microfluidic channel resulted in encapsulation of the particles in 
both types of structures. This versatile approach can be used for scaled-up production of 
polymeric vesicles with non-spherical morphologies.
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5.5. experimeNtal sectioN
Materials
Styrene, N, N, N’, N”, N”-pentamethyl diethylene triamine (PMDETA), methoxy poly(ethylene 
glycol) (MW 2000 Da), poly(vinyl pyrrolidone) (MW 10000 Da), potassium tetrachloro 
platinate (II), L (+) ascorbic acid were purchased from Sigma-Aldrich. Nile red was obtained 
from Chem-Impex. Doxorubicin hydrochloride was purchased from LC Laboratories. 
Styrene was purified by distillation under reduced vacuum prior to use. Copper bromide 
was obtained from Fluka. Anisole and tetrahydrofuran (THF) were purchased from Acros. 
Dioxane was from Biosolve. All chemicals are used as received unless otherwise indicated. 
Aqueous solutions were prepared with MilliQ water, which was double deionized with a 
MilliQ QPOD purification system (18.2 MΩ). 
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Instruments 
1H nuclear magnetic resonance spectra (1H NMR) were measured on a Varian Inova 400 
MHz spectrometer, with CDCl
3
 as solvent. The hydrodynamic diameter of polymeric 
vesicles was determined with a Malvern Zetasizer Nano S using the following conditions: 
temperature 25°C, He-Ne laser wavelength 633 nm and detector angle 173°. Transmission 
electron microscopy was performed on a JEOL 1010 Transmission Electron Microscope 
with MegaView Soft Imaging camera at an acceleration voltage of 60 kV. Scanning electron 
microscopy images were obtained with JEOL 6330 Cryo Field Emission Scanning Electron 
Microscope (FESEM). For nanoparticle tracking measurements, a NanoSight NS500 
(Malvern Instruments) was used.  
synthesis of poly(ethylene glycol)
44-b-polystyrene190 (Peg44-b-Ps190)
Poly(ethylene glycol)44-b-polystyrene190 was synthesized by atom transfer radical 
polymerization, via a protocol reported in literature.[17a] To monitor the polymerization 
process, 1H NMR spectroscopy was used for determining the molecular weight of the block 
copolymer. The reaction was terminated once the desired MW 21 kg/mol was reached. 
The crude product was purified by precipitation three times from dichloromethane in 
methanol. The 1H NMR spectra of the PEG initiator and purified copolymer are shown in 
Figure 5.1. 
fabrication of platinum nanoparticles/ptNps with pvp coating
Platinum nanoparticles capped with poly(vinyl pyrrolidone) (PVP) were synthesized 
according to a previously reported method. Briefly, PVP (MW = 10000 Da, 20 mg) was 
mixed with an aqueous solution of K2PtCl4 (20 mM, 2 mL). After magnetic stirring for 48 
hours at room temperature, 1 mL of reducing agent ascorbic acid (0.2 mM) was rapidly 
injected to the above solution. After stirring for 1 min, the resulting solution was incubated 
in a sonication bath (VWR Ultrasonic Cleaner Model 75D) at room temperature for 40 
min. The appearance of a black color indicated the completion of reduction. The obtained 
platinum nanoparticles were centrifuged (12000 rpm, 10 min) and washed 3 times with 
MilliQ water to remove remaining salt. Before each use, the above obtained platinum 
solution was sonicated for 20 seconds and diluted with MilliQ water. The concentration 
and size of platinum nanoparticles were determined by the Nanosight. 
preparation of polymer vesicles with co-solvent method
10 mg poly(ethylene glycol)
44-b-polystyrene190 was dissolved in 1 mL THF/dioxane (4:1, 
v:v) and stirred for 30 min. Then MilliQ water (3 mL) was slowly added into the polymer 
organic solvent through a syringe pump (Fusion 100, KR analytical) with a rate of 1 mL/h. 
After addition of water, the solution was immediately transferred to a dialysis bag (MW 
cutoff 12000-14000 Da) and dialyzed against MilliQ water (800 mL) for at least 48 hours to 
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remove remaining organic solvent. For monitoring the kinetic process of vesicle formation, 
MilliQ water was delivered to the polymer organic solution in a flow cuvette. The plot of 
scattered light intensity along time was recorded under the flow mode of dynamic light 
scattering (DLS). 
preparation of platinum nanoparticles/ptNps loaded stomatocytes with co-solvent 
method 
Poly(ethylene glycol)
44-b-polystyrene190 (10 mg) was allowed to be fully dissolved in 1 mL 
THF/dioxane (4:1) solvent. Then MilliQ water (0.35 mL), followed by a platinum nanoparticle 
solution (0.65 mL) was slowly delivered into the polymer organic solvent through a syringe 
pump (Fusion 100, KR analytical) (1 mL/h) with vigorous stirring. After 1 h, the solution was 
transferred to a dialysis bag (MW cutoff 12000-14000 Da) and dialyzed against MilliQ water 
(800 mL) for at least 48 hours with frequent change of water. 
preparation of polymer vesicles with fluidic channels
The fluidic channel (glass/plastic) consisted of three inlet channels (0.4 mm deep, 1 
mm wide, 12 mm long) and a main channel (0.4 mm deep, 3 mm wide, 24 mm long). 
Poly(ethylene glycol)
44-b-polystyrene190 was dissolved in THF/dioxane (4:1, v:v) to obtain 
the desired polymer concentration, and injected into the main channel via the middle 
inlet channel, while water was injected into the two side channels using syringe pumps 
(Fusion 100, KR analytical) at a set flow rate. For Nile red loading, 20 μL of Nile red in 
DMF (6 mg/mL) was added to the polymer solution. In case doxorubicin hydrochloride 
was loaded, a 0.5 mg/mL aqueous solution instead of water was pumped through the two 
side channels. For the loading of platinum nanoparticles an aqueous PtNPs solution (PtNPs 
concentration 5.06 ± 0.1 × 1011 particles/mL) instead of water was injected into the side 
channels. For polymeric nanotubes collection with shearing force, outflow was collected 
while magnetically stirred at 0, 500, 1000 rpm (IKA® Big Squid magnetic stirrers).
Transmission electron microscopy (TeM)
Sample specimens were prepared by casting 6 μL of diluted fresh sample aliquots onto 
300 mesh copper grids coated with carbon films. The grid was allowed to dry for at least 8 
hours at room temperature. For the “freezing” sample preparation, 6 μL of channel outflow 
was quickly casted onto the carbon film coated grid and transferred to liquid nitrogen 
(approximately 3 s) for structure “freezing”. Then the grid was left to dry under vacuum 
overnight. Image acquisition was operated with iTEM software (Olympus). For diameter 
and membrane thickness measurement, ImageJ software plot profile plugin was used. 
80 vesicles or nanotubes were measured to determine an average diameter/membrane 
thickness.
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scanning electron microscopy (seM)
6 μL of aqueous sample was applied on a copper grid and allowed to dry overnight. The grid 
was placed on a SEM mount with a double sided tape, followed by gold (60%)/palladium 
(40%) sputtering for 30 seconds in a Cressington 208 HR sputter coater. Then the grid was 
transferred to the microscope chamber for imaging.
dynamic light scattering (dls)
Dynamic light scattering analysis of samples was performed on a Malvern Zetasizer Nano 
S instrument. Samples were typically loaded in Malvern microcuvettes with a minimum 
volume of 60 µL. The data acquired was processed with Malvern Instruments Dispersion 
Technology software.  
Nanoparticle tracking analysis technique (Nta) 
The sample solution was diluted 2000 times and pumped into the NanoSight NS500 sample 
chamber. Five videos (each video duration time 60 seconds, rate 30 frames/sec) were 
recorded and the particle movement was analyzed with nanoparticle tracking technique 
software. Particle concentration was based on the average particle number in a frame. 
After averaging the values obtained from 5 videos, the concentration of the platinum 
nanoparticles solution before dilution was determined to be 5.06 ± 0.1 × 1011 particles/mL 
while the mean size of the particles was obtained as 48.9 ± 3.3 nm.
confocal laser scanning microscope (clsm)
Fluorescent Nile red/doxorubicin hydrochloride loaded polymer structures were visualized 
with a confocal fluorescence laser scanning microscope (Leica TCS SP2 AOBS). To observe 
Nile red, an argon laser line (514 nm) with a detection window of 590 – 650 nm was used. 
Doxorubicin hydrochloride was excited with an argon laser line (488 nm) and the resulting 
emission was collected between 550-650 nm. The laser beam was focused on the sample 
through a 63X oil immersion lens. A pinhole of 400 µm was selected. An average of two 
scans was used. 
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PERSPECTIVE AND OUTLOOK
from coNceptioN to realizatioN
The visionary talk given by Richard Feynman “there is plenty room in the bottom” has very 
much inspired the start and development of nanotechnology. The field of synthetic motors 
has evolved from a centimeter sized motor prototype to micron sized and nanometer sized 
motors (as small as 30 nm). Synthetic motility is demonstrated not only at a macroscopic 
range but also at the nanometer scale where different physical parameters are dominant. 
The miniaturized devices promise to interact with and manipulate objects through directed 
and controlled motion, from micrometer scale to nanometer scale. Developing the ability 
to manipulate at smaller dimensions and with increasing speeds has the potential to bring 
revolutionary transformation to multiple fields.
Over the past decade, the research field of micron- and nano-sized motors has expanded 
considerably, with objects of different composition, different designs and different 
propulsion mechanisms being developed. With the broadened choices of devices, 
extending the application scope is a logical next step. Using intelligent miniaturized motors 
for the biomedical domain is an interesting direction.
Micro- and nano-sized devices are excellent candidates for carrying out non-invasive 
investigations of organ, tissue, even cell behavior. How intelligent the devices could be is a 
frequently asked question. Being small, the motors usually lack the sophistication of their 
biological counterparts and more macroscopic synthetic objects. It would be exciting and 
feasible to incorporate multiple functions, for instance diagnosis, therapy and post-therapy 
evaluation, into a single motor system. In addition developing motors that are interactive 
with an external field or communicative with controlling software is attractive.  A motor 
system with a built-in communication module may function as a diagnose-therapy platform 
for personalized medication. 
Besides a field responsive motor, a motor system that is responsive to local stimuli and 
can be self guided to the biological target (taxis) seems mandatory when considering the 
complex vasculature network system. A next step would therefore be the development 
of motors that can smartly sense different stimuli (besides hydrogen peroxide) and 
automatically make decisions. An in-depth investigation of taxis mechanism is required to 
guide the future design of motors with taxis behavior.
In a general sense, micro/nanomotors belong to the family of micro/nano machines/
robotics. The tasks performed by micro/nano machines should also be possible for motors 
to carry out, yet at higher velocity. For the micro/nanomachines, many opportunities arise 
in the fields of microbiology (transport or being transported by microorganism), hematology 
(oxygen transporting, clotting), dentistry (penetrating dental tubules, root canal procedure), 
neurosurgery (axon transection). In principle these are also applicable to motor systems at 
a higher speed. The applications for motors are not necessarily limited to those already 
found with existing micro/nanomachine systems. Very interesting advantages arise from 
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using the autonomous motion of fast moving particle. With autonomous motion, it is 
envisioned that the device is not restricted by the blood/lymphatic fluid flow and enables 
more facile access to diseased tissues or deep solid tumors. The motion induced liquid 
mixing can be also used for drug dispensing. 
When applied in a clinical setting, biocompatibility, biodegradability and recyclability 
are important issues to consider. As a large amount of motor systems (especially motors 
powered via electrophoresis) are non-degradable metal-based, the fate of these motors in 
biological systems needs to be carefully examined. Developing motors that can be recycled 
or composed of biodegradable/biocompatible materials will be a solution.
Other practical issues involve the mass production of motors. Most motors now are 
synthesized via complicated construction procedures which rely on expensive instruments, 
such as micro-electro-mechanical techniques for fabrication. For commercialization and 
realistic use, simplification of the production process is needed.
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Summary
Nature has been a great inspiration for the science community. Taking inspiration from 
the highly efficient biological motors, scientists are aiming to develop their synthetic 
counterparts. After a decade of booming research interest, micro and nanomotors 
comprising a diverse set of materials, sizes and propulsion mechanisms are presented. How 
to translate the proof-of-concept research into realistic application remains an interesting 
yet challenging question. chapter 1 first describes briefly the development of the micro/
nanomotors, followed by an overview of the efforts to implement these motor systems for 
diverse in vivo applications. In this chapter the emerging applications of nanomotors at the 
cell, tissue, and body fluid level are illustrated. Successful trials and possible limitations 
lying ahead are discussed.
As drug delivery is an important aspect for biomedical applications, we explore the 
possibility of using our nanoscale bowl shaped polymersome based motors for drug 
delivery in the rest of the thesis. The utilities of bowl shaped polymersome motors in 
different biologically relevant environments are explored.
Achieving precise delivery in complicated biological environments has been a long 
standing problem for medication therapy. Especially regarding treatment of cancer and 
other chronic diseases, nanomedicine has not fully lived up to its promises. Conventional 
targeted delivery relies on “enhanced permeation and retention” through leaky tumor 
vasculatures and recognition of antigens. Side effects caused by “off-target” drugs are 
often high, however. Alternative approaches are therefore required. Nature uses the 
idea of “taxis” for organism guidance. In chapter 2 we found the motility (diffusion) of 
nanomotors increases with elevated fuel concentrations. In a fuel gradient, there is a net 
displacement towards fuel rich regions, thus chemotaxis. With this we demonstrated the 
possibility of guiding nanomotors loaded with the antitumor drug doxorubicin towards 
hydrogen peroxide secreting neutrophils.
The hydrophobic nature and intactness of the cell membrane protect the cells from 
external molecules as well as therapeutic agents. For effective delivery, the cell membrane 
is one important barrier to overcome. After demonstrating targeted delivery towards 
model cells, in chapter 3 we aimed to deliver drugs into the cell with the aid of peptide 
functionalized nanomotors. The nanomotors were grafted with a tat cell-penetrating 
peptide. For peptide modification, we used the reaction between cysteine group in tat 
and maleimide introduced on the nanomotor surface. The tat peptide, a basic domain 
from the tat protein of HIV, is responsible for facilitating efficient virus entry into host cells. 
By combining the cell penetrating peptide with autonomously moving motors, efficient 
penetration into intact cells was observed with confocal fluorescent microscopy. 
In nature magnetotaxis is an interesting behavior observed in bacteria. These 
magnetotactic bacteria, for instance Magnetospirillum magnetotacticum, can produce a 
chain of nanometer sized iron oxide particles inside their body through a biomineralization 
process. With the chain of iron oxide nanoparticles coated with protein (magnetosome), 
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the bacteria can orient with the earth magnetic field direction as well as being attracted 
by an external magnetic field. Such magnetotaxis behavior shows profound potential in 
isolation/ accumulation, targeted delivery and magnetically induced hyperthermia therapy. 
in chapter 4 we set out to mimic this behavior. Starting with doxorubicin incorporated and 
platinum nanoparticles preloaded stomatocytes, nickel metal was deposited in situ on the 
Pt surface in a controllable way using the catalytic activity of the platinum nanoparticles. 
The drug and Pt-Ni loaded stomatocytes in solution were found to be responsive to 
external magnetic fields. The system was dual-propelled (hydrogen peroxide powered 
and/or magnetic powered). The moving direction was varied on demand by changing the 
magnetic position or the field direction. This behavior was also demonstrated in a tumor 
tissue model with human cervical cancer cell (HeLa) loaded collagen gels. With an external 
field, the motors demonstrated guided motion in the tissue mimicking model and moved 
through the meshes of the gel.
It is known that the shape factor is very important for the circulation time and uptake 
process. In chapter 5 we developed a flow method for fabricating non-spherical vesicles. 
As the mixing time of the flow device is shorter than the vesicle formation time, we 
could easily tune the hydrodynamic parameters and obtain kinetically trapped vesicles. 
With different flow rates/ratios and different initial polymer concentrations, vesicles of 
different shape (bowl shaped vesicles and vesicle necklaces) and size were produced. The 
collecting methods were also found to influence the final morphology of vesicles. Multiple 
payloads including hydrophilic and hydrophobic dyes/drugs and platinum nanoparticles 
were readily loaded. The incorporation of platinum nanoparticles makes it possible for the 
vesicles to act as motor systems. As the approach provides the possibility for up-scaling 
and continuous production of vesicles or vesicle based motors, new horizons are opened 
for practical applications. 
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